
<html lang="en"     class="pb-page"  data-request-id="6bb14cca-f463-4d4b-adea-fc8c75fc2eea"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2014.57.issue-23;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm5010607;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Phenylimidazoles as Potent and Selective Inhibitors of Coagulation Factor XIa with in Vivo Antithrombotic Activity" /></meta><meta name="dc.Creator" content="Jon J.  Hangeland" /></meta><meta name="dc.Creator" content="Todd J.  Friends" /></meta><meta name="dc.Creator" content="Karen A.  Rossi" /></meta><meta name="dc.Creator" content="Joanne M.  Smallheer" /></meta><meta name="dc.Creator" content="Cailan  Wang" /></meta><meta name="dc.Creator" content="Zhong  Sun" /></meta><meta name="dc.Creator" content="James R.  Corte" /></meta><meta name="dc.Creator" content="Tianan  Fang" /></meta><meta name="dc.Creator" content="Pancras C.  Wong" /></meta><meta name="dc.Creator" content="Alan R.  Rendina" /></meta><meta name="dc.Creator" content="Frank A.  Barbera" /></meta><meta name="dc.Creator" content="Jeffrey M.  Bozarth" /></meta><meta name="dc.Creator" content="Joseph M.  Luettgen" /></meta><meta name="dc.Creator" content="Carol A.  Watson" /></meta><meta name="dc.Creator" content="Ge  Zhang" /></meta><meta name="dc.Creator" content="Anzhi  Wei" /></meta><meta name="dc.Creator" content="Vidhyashankar  Ramamurthy" /></meta><meta name="dc.Creator" content="Paul E.  Morin" /></meta><meta name="dc.Creator" content="Gregory S.  Bisacchi" /></meta><meta name="dc.Creator" content="Srinath  Subramaniam" /></meta><meta name="dc.Creator" content="Piramanayagam  Arunachalam" /></meta><meta name="dc.Creator" content="Arvind  Mathur" /></meta><meta name="dc.Creator" content="Dietmar A.  Seiffert" /></meta><meta name="dc.Creator" content="Ruth R.  Wexler" /></meta><meta name="dc.Creator" content="Mimi L.  Quan" /></meta><meta name="dc.Description" content="Novel inhibitors of FXIa containing an (S)-2-phenyl-1-(4-phenyl-1H-imidazol-2-yl)ethanamine core have been optimized to provide compound 16b, a potent, reversible inhibitor of FXIa (Ki = 0.3 nM) ha..." /></meta><meta name="Description" content="Novel inhibitors of FXIa containing an (S)-2-phenyl-1-(4-phenyl-1H-imidazol-2-yl)ethanamine core have been optimized to provide compound 16b, a potent, reversible inhibitor of FXIa (Ki = 0.3 nM) ha..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 2, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm5010607" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm5010607" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm5010607" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm5010607" /></link>
        
    
    

<title>Phenylimidazoles as Potent and Selective Inhibitors of Coagulation Factor XIa with in Vivo Antithrombotic Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm5010607" /></meta><meta property="og:title" content="Phenylimidazoles as Potent and Selective Inhibitors of Coagulation Factor XIa with in Vivo Antithrombotic Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0019.jpeg" /></meta><meta property="og:description" content="Novel inhibitors of FXIa containing an (S)-2-phenyl-1-(4-phenyl-1H-imidazol-2-yl)ethanamine core have been optimized to provide compound 16b, a potent, reversible inhibitor of FXIa (Ki = 0.3 nM) having in vivo antithrombotic efficacy in the rabbit AV-shunt thrombosis model (ID50 = 0.6 mg/kg + 1 mg kg–1 h–1). Initial analog selection was informed by molecular modeling using compounds 11a and 11h overlaid onto the X-ray crystal structure of tetrahydroquinoline 3 complexed to FXIa. Further optimization was achieved by specific modifications derived from careful analysis of the X-ray crystal structure of the FXIa/11h complex. Compound 16b was well tolerated and enabled extensive pharmacologic evaluation of the FXIa mechanism up to the ID90 for thrombus inhibition." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm5010607"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm5010607">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm5010607&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm5010607&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm5010607&amp;href=/doi/10.1021/jm5010607" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 9915-9932</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm501021n" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm501126u" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Phenylimidazoles as Potent and Selective Inhibitors of Coagulation Factor XIa with in Vivo Antithrombotic Activity</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jon+J.++Hangeland">Jon J. Hangeland</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Todd+J.++Friends">Todd J. Friends</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karen+A.++Rossi">Karen A. Rossi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joanne+M.++Smallheer">Joanne M. Smallheer</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cailan++Wang">Cailan Wang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhong++Sun">Zhong Sun</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+R.++Corte">James R. Corte</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tianan++Fang">Tianan Fang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pancras+C.++Wong">Pancras C. Wong</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan+R.++Rendina">Alan R. Rendina</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frank+A.++Barbera">Frank A. Barbera</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey+M.++Bozarth">Jeffrey M. Bozarth</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+M.++Luettgen">Joseph M. Luettgen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carol+A.++Watson">Carol A. Watson</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ge++Zhang">Ge Zhang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anzhi++Wei">Anzhi Wei</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vidhyashankar++Ramamurthy">Vidhyashankar Ramamurthy</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+E.++Morin">Paul E. Morin</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gregory+S.++Bisacchi">Gregory S. Bisacchi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Srinath++Subramaniam">Srinath Subramaniam</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Piramanayagam++Arunachalam">Piramanayagam Arunachalam</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arvind++Mathur">Arvind Mathur</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dietmar+A.++Seiffert">Dietmar A. Seiffert</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ruth+R.++Wexler">Ruth R. Wexler</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mimi+L.++Quan">Mimi L. Quan</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Research and Development, Bristol-Myers Squibb, P.O. Box 5400, Princeton, New Jersey 08543, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: +1 609 818 4958. Fax: +1 609 818 3560. E-mail: <a href="/cdn-cgi/l/email-protection#ea808584c4828b848d8f868b848eaa888799c4898587"><span class="__cf_email__" data-cfemail="5e34313070363f30393b323f303a1e3c332d703d3133">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm5010607&amp;href=/doi/10.1021%2Fjm5010607" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 9915–9932</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 18, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 July 2014</li><li><span class="item_label"><b>Published</b> online</span>2 December 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 December 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm5010607" title="DOI URL">https://doi.org/10.1021/jm5010607</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9915%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJon%2BJ.%2BHangeland%252C%2BTodd%2BJ.%2BFriends%252C%2BKaren%2BA.%2BRossi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D23%26contentID%3Djm5010607%26title%3DPhenylimidazoles%2Bas%2BPotent%2Band%2BSelective%2BInhibitors%2Bof%2BCoagulation%2BFactor%2BXIa%2Bwith%2Bin%2BVivo%2BAntithrombotic%2BActivity%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9932%26publicationDate%3DDecember%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm5010607"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2079</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">28</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm5010607" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Phenylimidazoles as Potent and Selective Inhibitors of Coagulation Factor XIa with in Vivo Antithrombotic Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jon&quot;,&quot;last_name&quot;:&quot;J. Hangeland&quot;},{&quot;first_name&quot;:&quot;Todd&quot;,&quot;last_name&quot;:&quot;J. Friends&quot;},{&quot;first_name&quot;:&quot;Karen&quot;,&quot;last_name&quot;:&quot;A. Rossi&quot;},{&quot;first_name&quot;:&quot;Joanne&quot;,&quot;last_name&quot;:&quot;M. Smallheer&quot;},{&quot;first_name&quot;:&quot;Cailan&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Zhong&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;R. Corte&quot;},{&quot;first_name&quot;:&quot;Tianan&quot;,&quot;last_name&quot;:&quot;Fang&quot;},{&quot;first_name&quot;:&quot;Pancras&quot;,&quot;last_name&quot;:&quot;C. Wong&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;R. Rendina&quot;},{&quot;first_name&quot;:&quot;Frank&quot;,&quot;last_name&quot;:&quot;A. Barbera&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;M. Bozarth&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;M. Luettgen&quot;},{&quot;first_name&quot;:&quot;Carol&quot;,&quot;last_name&quot;:&quot;A. Watson&quot;},{&quot;first_name&quot;:&quot;Ge&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Anzhi&quot;,&quot;last_name&quot;:&quot;Wei&quot;},{&quot;first_name&quot;:&quot;Vidhyashankar&quot;,&quot;last_name&quot;:&quot;Ramamurthy&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;E. Morin&quot;},{&quot;first_name&quot;:&quot;Gregory&quot;,&quot;last_name&quot;:&quot;S. Bisacchi&quot;},{&quot;first_name&quot;:&quot;Srinath&quot;,&quot;last_name&quot;:&quot;Subramaniam&quot;},{&quot;first_name&quot;:&quot;Piramanayagam&quot;,&quot;last_name&quot;:&quot;Arunachalam&quot;},{&quot;first_name&quot;:&quot;Arvind&quot;,&quot;last_name&quot;:&quot;Mathur&quot;},{&quot;first_name&quot;:&quot;Dietmar&quot;,&quot;last_name&quot;:&quot;A. Seiffert&quot;},{&quot;first_name&quot;:&quot;Ruth&quot;,&quot;last_name&quot;:&quot;R. Wexler&quot;},{&quot;first_name&quot;:&quot;Mimi&quot;,&quot;last_name&quot;:&quot;L. Quan&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;02&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;9915-9932&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm5010607&quot;},&quot;abstract&quot;:&quot;Novel inhibitors of FXIa containing an (S)-2-phenyl-1-(4-phenyl-1H-imidazol-2-yl)ethanamine core have been optimized to provide compound 16b, a potent, reversible inhibitor of FXIa (Ki = 0.3 nM) having in vivo antithrombotic efficacy in the rabbit AV-shunt thrombosis model (ID50 = 0.6 mg/kg + 1 mg kg–1 h–1). Initial analog selection was informed by molecular modeling using compounds 11a and 11h overlaid onto the X-ray crystal structure of tetrahydroquinoline 3 complexed to FXIa. Further optimization was achieved by specific modifications derived from careful analysis of the X-ray crystal structure of the FXIa/11h complex. Compound 16b was well tolerated and enabled extensive pharmacologic evaluation of the FXIa mechanism up to the ID90 for thrombus inhibition.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5010607&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5010607" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5010607&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5010607" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5010607&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5010607" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm5010607&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5010607&amp;href=/doi/10.1021/jm5010607" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm5010607" /></input><a href="/doi/pdf/10.1021/jm5010607" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm5010607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm5010607%26sid%3Dliteratum%253Aachs%26pmid%3D25405503%26genre%3Darticle%26aulast%3DHangeland%26date%3D2014%26atitle%3DPhenylimidazoles%2Bas%2BPotent%2Band%2BSelective%2BInhibitors%2Bof%2BCoagulation%2BFactor%2BXIa%2Bwith%2Bin%2BVivo%2BAntithrombotic%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D23%26spage%3D9915%26epage%3D9932%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291763" title="Noncovalent interactions">Noncovalent interactions</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=291754" title="Molecules">Molecules</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jmcmar.2014.57.issue-23/20141211/jmcmar.2014.57.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010607&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Novel inhibitors of FXIa containing an (<i>S</i>)-2-phenyl-1-(4-phenyl-1<i>H</i>-imidazol-2-yl)ethanamine core have been optimized to provide compound <b>16b</b>, a potent, reversible inhibitor of FXIa (<i>K</i><sub>i</sub> = 0.3 nM) having in vivo antithrombotic efficacy in the rabbit AV-shunt thrombosis model (ID<sub>50</sub> = 0.6 mg/kg + 1 mg kg<sup>–1</sup> h<sup>–1</sup>). Initial analog selection was informed by molecular modeling using compounds <b>11a</b> and <b>11h</b> overlaid onto the X-ray crystal structure of tetrahydroquinoline <b>3</b> complexed to FXIa. Further optimization was achieved by specific modifications derived from careful analysis of the X-ray crystal structure of the FXIa/<b>11h</b> complex. Compound <b>16b</b> was well tolerated and enabled extensive pharmacologic evaluation of the FXIa mechanism up to the ID<sub>90</sub> for thrombus inhibition.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27408" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27408" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Thromboembolic disorders such as stroke, myocardial infarction, and deep vein thrombosis remain a leading cause of death in developed countries.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Normal hemostasis is a tightly regulated process that balances the need for blood to maintain a fluid state under normal physiologic conditions while providing a mechanism for the rapid formation of hemostatic plugs at sites of injury to prevent life threatening loss of blood. The coagulation cascade contains multiple plasma serine protease zymogens organized in a cascade that serves to amplify an initiation event such as blood vessel wall injury, leading to the formation of a hemostatic plug under normal physiologic conditions or the pathophysiologic formation of an interarterial thrombus at the site of a ruptured atherosclerotic plaque.<a onclick="showRef(event, 'cit1a'); return false;" href="javascript:void(0);" class="ref cit1a">(1a)</a> The cascade can be divided into three interdependent pathways; the extrinsic, intrinsic, and common pathways.<a onclick="showRef(event, 'cit2a cit2b cit2c cit2d'); return false;" href="javascript:void(0);" class="ref cit2a cit2b cit2c cit2d">(2a-2d)</a> Initiation of the extrinsic pathway occurs when injury to the blood vessel wall exposes FVII or its activated form (FVIIa) to the integral membrane protein tissue factor (TF) to form the TF/FVIIa complex. This complex converts factor X and factor IX to their active forms (FXa and FIXa, respectively) via limited proteolysis. Factor Xa in turn catalyzes the conversion of prothrombin to thrombin which produces fibrin from fibrinogen. Thrombin has additional roles in the coagulation cascade. These include (1) activation of factor XIII to its activated form, FXIIIa, which catalyzes the cross-linking of fibrin to form a fibrin clot, (2) amplification of its own generation by activating two other coagulation cofactors, FV and FVIII, (3) activation of blood platelets, (4) activation of thrombin-activatable fibrinolysis inhibitor (TAFI), thereby inhibiting fibrinolysis, and (5) converting FXI to its active form, FXIa, which is positioned near the head of the intrinsic coagulation pathway. FXIa subsequently catalyzes the production of activated FIX (FIXa), which produces more FXa, thus amplifying the amount of thrombin formed at the site of the growing thrombus. FXIa can be formed independent of thrombin via self-activation and by activated FXII (FXIIa), which is activated by polyanionic surfaces (e.g., collagen platelet polyphosphates released by activated platelets),<a onclick="showRef(event, 'cit2e'); return false;" href="javascript:void(0);" class="ref cit2e">(2e)</a> by self-activation, or by plasma kallikrein.<a onclick="showRef(event, 'cit2f'); return false;" href="javascript:void(0);" class="ref cit2f">(2f)</a> Current data indicate that nascent blood clots formed through the extrinsic pathway are unstable and relatively short-lived. Thus, initiation of the intrinsic pathway and formation of FXIa by thrombin or FXIIa is thought to be important for maintaining clot integrity,<a onclick="showRef(event, 'cit3a'); return false;" href="javascript:void(0);" class="ref cit3a">(3a)</a><sup>–</sup><a onclick="showRef(event, 'cit3c'); return false;" href="javascript:void(0);" class="ref cit3c">(3c)</a> especially in tissues with high fibrinolytic activity.<a onclick="showRef(event, 'cit3b'); return false;" href="javascript:void(0);" class="ref cit3b">(3b)</a></div><div class="NLM_p">While FXIa appears to play a key role in stable thrombus formation, it is not required for normal hemostasis. Persons deficient in FXI (hemophilia C) may experience bleeding associated with invasive surgical procedures but rarely spontaneous bleeding.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> In contrast, deficiencies in FIX, or its cofactor FVIII, are associated with a severe bleeding diathesis (hemophilia B and A, respectively).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Preclinical studies have shown that FXI-deficient mice were protected against ferric chloride (FeCl<sub>3</sub>) induced carotid artery thrombosis and venous thrombosis while maintaining normal tail bleeding times as compared to wild-type mice. Similar levels of protection against FeCl<sub>3</sub>-induced thrombus formation provided by heparin or argatroban, a thrombin inhibitor, resulted in increased bleeding times that were >10-fold longer than that observed in untreated wild type controls.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Other studies indicate that elevated FXI levels are associated with venous thrombosis, myocardial infarction among men, increased odds ratio for cerebrovascular events, and coronary artery disease.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Conversely, reduced incidence of ischemic stroke, but not myocardial infarction, is observed in subjects with severe FXI deficiency.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Taken together, these data support the hypothesis that inhibition of FXIa has the potential to effectively inhibit thrombus formation without significant bleeding liability.<a onclick="showRef(event, 'cit3c'); return false;" href="javascript:void(0);" class="ref cit3c">(3c)</a><sup>–</sup><a onclick="showRef(event, 'cit3d'); return false;" href="javascript:void(0);" class="ref cit3d">(3d)</a></div><div class="NLM_p">The first pharmacologic proof of concept studies in rats<a onclick="showRef(event, 'ref9 cit10a'); return false;" href="javascript:void(0);" class="ref ref9 cit10a">(9, 10a)</a> and rabbits<a onclick="showRef(event, 'cit10b'); return false;" href="javascript:void(0);" class="ref cit10b">(10b)</a> were conducted with irreversible FXIa small molecule inhibitors using ketothiazoles <b>1a</b> and <b>1b</b> (FXIa IC<sub>50</sub> = 6 and 12 nM, respectively)<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and BMS-262084 (<b>2</b>) (FXIa IC<sub>50</sub> = 2.8 nM),<a onclick="showRef(event, 'cit10a'); return false;" href="javascript:void(0);" class="ref cit10a">(10a)</a> a 4-carboxy-2-azetidinone mechanism based inhibitor (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> These studies demonstrated that inhibition of FXIa significantly reduced thrombus formation in multiple models while causing minimal increase in provoked bleeding times relative to controls. Importantly, the compounds increased in vitro aPTT but not PT, consistent with a FXIa inhibitory mechanism with selectivity over FVIIa, FXa, and thrombin. More recently, tetrahydroquinoline <b>3</b>,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> a small molecule, reversible inhibitor of FXIa (<i>K</i><sub>i</sub> = 0.2 nM), exhibited a potent dose dependent antithrombotic effect in the rabbit AV-shunt model with no increase in provoked bleeding time relative to untreated controls.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Consistent with a selective FXIa mechanism, ex vivo aPTT was prolonged while PT remained unchanged. These studies further support the hypothesis that selective inhibition of FXIa via a small molecule has the potential to be efficacious with a low bleeding liability.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Published active site inhibitors of FXIa.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010607&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Additional small molecule FXIa inhibitors have been reported. Two natural products isolated from the sponge <i>Subera clavata</i>, clavatadine A (<b>4a)</b> and B (<b>4b</b>), were shown to be irreversible inhibitors of FXIa (IC<sub>50</sub> = 1.3 and 27 μM, respectively).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Arylboronic ester <b>5</b> (human FXIa IC<sub>50</sub> = 1.4 μM, 30- and 9-fold selective over FXa and thrombin) represents the most potent inhibitor from an effort to identify arylboronic esters capable of bonding covalently either reversibly or irreversibly to the active site serine.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Previous work from our laboratories culminated in the discovery of two series of potent, reversible FXIa inhibitors: the tetrahydroquinoline series (e.g., compound <b>3</b>, FXIa <i>K</i><sub>i</sub> = 0.2 nM)<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and the indole series (e.g., compound <b>6</b>, FXIa <i>K</i><sub>i</sub> = 0.3 nM).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Compound <b>6</b> was highly selective against a broad panel of serine proteases including thrombin (27 000-fold), FXa (12 000-fold), FVIIa (>35 500-fold), and plasma kallikrein (PK, 3870-fold) and showed potent in vivo antithrombotic efficacy<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> in the rabbit ECAT model.<a onclick="showRef(event, 'cit18a'); return false;" href="javascript:void(0);" class="ref cit18a">(18a)</a> All the aforementioned FXIa inhibitors bind to the active or orthosteric site of the enzyme competing with the peptide substrate for binding. Alternatively, binding to the heparin-binding sites (HBS) on FXIa can inhibit the enzyme via an allosteric mechanism through induction of conformational changes that disfavor efficient enzyme catalysis leading to full or partial inhibitors.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p last">In order to provide additional chemotypes to test the FXIa mechanism in preclinical models, we developed a third, novel chemotype built on the phenylimidazole scaffold. We report herein optimization of the potency for FXIa inhibition of novel, reversible FXIa inhibitors resulting in the identification of <i>trans</i>-<i>N</i>-((<i>S</i>)-1-(4-(3-amino-1<i>H</i>-indazol-6-yl)-5-chloro-1<i>H</i>-imidazol-2-yl)-2-phenylethyl)-4-(aminomethyl)cyclohexanecarboxamide (<b>16b</b>, Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) having potent in vivo antithrombotic activity.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01281" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01281" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The first example in the new series, compound <b>11a</b> (<i>S</i>-configuration), was discovered by focused-deck screening against FXIa. It was modestly potent against FXIa (<i>K</i><sub>i</sub> = 120 nM) and plasma kallikrein (PK, <i>K</i><sub>i</sub> = 330 nM) and selective against FVIIa (<i>K</i><sub>i</sub> > 10 900 nM) and FXa (<i>K</i><sub>i</sub> > 8180 nM) and increased aPTT 1.4-fold at a plasma concentration of 40 μM (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The enantiomer of <b>11a</b> (<i>R</i>-configuration) (FXIa <i>K</i><sub>i</sub> = 3500 nM) was 30-fold less potent against FXIa; hence, the SAR was developed using the series with the <i>S</i>-configuration. Computer assisted modeling of compound <b>11a</b> docked with the X-ray crystal structure of compound <b>3</b> complexed to FXIa<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> revealed that the phenylimidazole phenyl ring of <b>11a</b> could potentially overlap with the terminal phenyl ring of the biphenyl moiety of compound <b>3</b> (model not shown). Furthermore, the structure of the compound <b>3</b>/FXIa complex (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) showed the amide nitrogen located at C-4 of the terminal phenyl ring of the biphenyl moiety to participate in key hydrogen bond contacts with the backbone carbonyls of Leu41 and His40 located in the S2′ pocket of FXIa. When this functionality was added to the phenylimidazole phenyl ring of the model of compound <b>11a</b> giving compound <b>11h</b> (R<sup>4′</sup> = CONH<sub>2</sub>; Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), the hydrogen bond interactions between compound <b>3</b> and Leu41 and His40 were closely mimicked. Thus, the modeling exercise provided key design insights that focused the initial set of analogs to include functionalities capable of hydrogen bond interactions within the S2′ pocket of the enzyme. Selectivity versus other relevant serine proteases was tracked to see if selectivity for FXIa inhibition was maintained.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Computer model of compound <b>11h</b> (salmon) overlaid onto the X-ray crystal structure of compound <b>3</b>/FXIa complex (cyan). Hydrogen bonds between the amide nitrogen located at C-4 of the terminal phenyl ring of the biphenyl contained in compound <b>3</b> are represented by a series of gray prolate ellipsoids. Figure was prepared with PyMol (Schrödinger).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010607&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro and aPTT Data for Compounds <b>3</b>, <b>11a</b>–<b>h</b>, and <b>11l</b>–<b>s</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0014.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center"><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>3′</sup></th><th class="colsep0 rowsep0" align="center">R<sup>4′</sup></th><th class="colsep0 rowsep0" align="center">FXIa</th><th class="colsep0 rowsep0" align="center">FVIIa</th><th class="colsep0 rowsep0" align="center">FXa</th><th class="colsep0 rowsep0" align="center">PK</th><th class="colsep0 rowsep0" align="center">EC<sub>2X</sub> (μM),<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> aPTT</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">630</td><td class="colsep0 rowsep0" align="left">340</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">120</td><td class="colsep0 rowsep0" align="left">>10900</td><td class="colsep0 rowsep0" align="left">>8180</td><td class="colsep0 rowsep0" align="left">330</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">230</td><td class="colsep0 rowsep0" align="left">>10900</td><td class="colsep0 rowsep0" align="left">>8180</td><td class="colsep0 rowsep0" align="left">940</td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11c</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="left">800</td><td class="colsep0 rowsep0" align="left">>10900</td><td class="colsep0 rowsep0" align="left">>8180</td><td class="colsep0 rowsep0" align="left">1924</td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11d</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CO<sub>2</sub>Et</td><td class="colsep0 rowsep0" align="left">495</td><td class="colsep0 rowsep0" align="left">>10900</td><td class="colsep0 rowsep0" align="left">>8180</td><td class="colsep0 rowsep0" align="left">1360</td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11e</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1120</td><td class="colsep0 rowsep0" align="left">>10900</td><td class="colsep0 rowsep0" align="left">>8180</td><td class="colsep0 rowsep0" align="left">1170</td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11f</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CO<sub>2</sub>Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">630</td><td class="colsep0 rowsep0" align="left">>10900</td><td class="colsep0 rowsep0" align="left">>8180</td><td class="colsep0 rowsep0" align="left">1470</td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11g</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">1340</td><td class="colsep0 rowsep0" align="left">>10900</td><td class="colsep0 rowsep0" align="left">>8180</td><td class="colsep0 rowsep0" align="left">5540<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11h</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">>10900</td><td class="colsep0 rowsep0" align="left">>9000</td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11l</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="left">590</td><td class="colsep0 rowsep0" align="left">>10900</td><td class="colsep0 rowsep0" align="left">>8180</td><td class="colsep0 rowsep0" align="left">3820</td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11m</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CONHMe</td><td class="colsep0 rowsep0" align="left">350</td><td class="colsep0 rowsep0" align="left">>10900</td><td class="colsep0 rowsep0" align="left">>8180</td><td class="colsep0 rowsep0" align="left">220</td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11n</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CON(Me)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">2860</td><td class="colsep0 rowsep0" align="left">>10900</td><td class="colsep0 rowsep0" align="left">>8180</td><td class="colsep0 rowsep0" align="left">5270<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11o</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="left">150</td><td class="colsep0 rowsep0" align="left">>10900</td><td class="colsep0 rowsep0" align="left">>8180</td><td class="colsep0 rowsep0" align="left">765</td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11p</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">400</td><td class="colsep0 rowsep0" align="left">>10900</td><td class="colsep0 rowsep0" align="left">>8180</td><td class="colsep0 rowsep0" align="left">1310</td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11q</b></td><td class="colsep0 rowsep0" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1100</td><td class="colsep0 rowsep0" align="left">>10900</td><td class="colsep0 rowsep0" align="left">>8180</td><td class="colsep0 rowsep0" align="left">910</td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11r</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">275</td><td class="colsep0 rowsep0" align="left">>10900</td><td class="colsep0 rowsep0" align="left">>8180</td><td class="colsep0 rowsep0" align="left">920</td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11s</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">545</td><td class="colsep0 rowsep0" align="left">>10900</td><td class="colsep0 rowsep0" align="left">>8180</td><td class="colsep0 rowsep0" align="left">1902</td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last"><i>K</i><sub>i</sub> values were obtained from purified human enzymes and are averaged from duplicate IC<sub>50</sub> determinations.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Activated partial thromboplastin time (aPTT) was measured according to the method described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Values reported from a single determination (<i>n</i> = 1).</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">NT = not tested.</p></div></div></div><div class="NLM_p">A focused set of functional groups able to form hydrogen bonds appended onto the terminal phenyl ring at C-4′ generally provided compounds with weaker potency than <b>11a</b> (see compounds <b>11b</b>–<b>d</b>, <b>11g</b>, and <b>11l</b>–<b>p</b>). The single exception from this set was compound <b>11h</b>, which was 4-fold more potent against FXIa (<i>K</i><sub>i</sub> = 30 nM), ∼2-fold more potent versus PK (<i>K</i><sub>i</sub> = 60 nM), retained excellent selectivity against FVIIa and FXa, and increased aPTT by 1.8-fold at a plasma concentration of 40 μM. Extending the amide one carbon away from the phenyl ring gave compound <b>11p</b>, which was ∼10-fold less potent than <b>11h</b> against FXIa. Replacing one or both of the primary amide hydrogens of <b>11h</b> with a methyl group (compounds <b>11m</b> and <b>11n</b>, respectively) resulted in an incremental loss of potency against FXIa. A subset of the functional groups tested at C-4′ were added to C-3′ (compounds <b>11e</b>, <b>11f</b>, and <b>11q</b>–<b>s</b>). All of these compounds were less potent compared to compounds <b>11a</b> and <b>11h</b>.</div><div class="NLM_p">The X-ray crystal structure of compound <b>11h</b> complexed to FXIa, determined to 1.85 Å resolution, revealed key hydrogen bonds and hydrophobic contacts between the inhibitor and enzyme and an extensive hydrogen bond network between the inhibitor and enzyme formed by crystallographic water molecules and one ethylene glycol molecule (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The nitrogen of the primary amide at C-4′ of the phenylimidazole moiety formed a hydrogen bond to the backbone carbonyl of His40, located in the S2′ pocket, and to the backbone nitrogen of the same residue via two intervening water molecules. The carbonyl formed a hydrogen bond to the backbone nitrogen of Ile151 via one intervening water molecule and to the hydroxyl group of Tyr143 via two intervening water molecules. The phenyl ring formed a hydrophobic contact with side chain of Ile151 and Gly193 within the same pocket. The N-3 nitrogen of the imidazole participated in a hydrogen bond with the backbone carbonyl of Leu41 via an intervening water molecule, whereas N-1 formed a hydrogen bond with a water molecule that was part of a network of three water molecules and one ethylene glycol molecule linking the inhibitor to backbone nitrogens of Gly216 and Gly218. The C-5 methine of the imidazole was located nearby the hydrophobic side chain of Lys192. The benzyl side chain phenyl ring participated in a hydrophobic edge-on contact with the disulfide bridge formed between Cys42 and Cys58 in the S1′ pocket. The NH of the P1 group amide linker formed a hydrogen bond to Ser214 via a single intervening water molecule and Gly216 via two intervening water molecules. The carbonyl oxygen of the amide linker was positioned over the oxyanion hole formed by Ser195, Asp194, and Gly193. The tranexamic acid moiety was located in the S1 pocket where the primary amine formed a salt bridge with the carboxylate of Asp189 and the backbone carbonyl of Gly218. Thus, compound <b>11h</b> formed a hydrogen bond network with the same two S2′ pocket protein backbone carbonyls as compound <b>3</b> (His40 and Leu41), albeit in a different manner owing to the phenylimidazole phenyl ring of <b>11h</b> penetrating deeper into the S2′ binding pocket compared to the terminal phenyl ring of the biphenyl moiety of compound <b>3</b>.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray crystal structure of compound <b>11h</b> complexed to FXIa. The initial <i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> electron density contoured at 3 rmsd is shown with the final model. The protein is shown with yellow carbon atoms and secondary structural elements, and <b>11h</b> is shown with orange carbon atoms. Nitrogen atoms are shown in blue, oxygen atoms in red, and sulfur atoms in a darker yellow. The red spheres represent crystallographic water molecules. A single crystallographic ethylene glycol molecule is present. Hydrogen bonds are represented by a series of gray prolate ellipsoids. Figure was prepared with PyMol (Schrödinger).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010607&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Closer examination of hydrogen bond opportunities available in the S2′ pocket revealed the backbone carbonyl of His40, the C-4′ amide of the inhibitor, and the hydroxyl group of Tyr143, located opposite the backbone carbonyl in the S2′ pocket, to be coplanar. We hypothesized that fusing the C-4′ amide onto the phenyl ring to form a five- or six-membered ring containing a heteroatom able to form a hydrogen bond to the hydroxyl group of Tyr143 might improve potency. This hypothesis was tested by modifying the terminal phenyl ring to give aminoindazole <b>16a</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) having a FXIa <i>K</i><sub>i</sub> = 3 nM, which was 10-fold more potent than <b>11h</b> against FXIa, ∼10-fold selective versus PK (<i>K</i><sub>i</sub> = 50 nM), and showed potent aPTT activity (EC<sub>2<i>x</i></sub> = 2 μM). Thus, two novel modifications to the original compound in this series (<b>11a</b>) provided a 40-fold overall improvement to FXIa potency.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In vitro and aPTT Data for Compounds <b>11h</b>–<b>k</b> and <b>16a</b>–<b>c</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0015.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0016.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last"><i>K</i><sub>i</sub> values were obtained from purified human enzymes and are averaged from duplicate IC<sub>50</sub> determinations.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Activated partial thromboplastin time (aPTT) was measured according to the method described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Rabbit aPTT value.</p></div></div><div></div></div><div class="NLM_p">The effect of substitution at the C-5 position of the imidazole was first investigated by adding bromine to compound <b>11h</b> giving compound <b>11i</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). A 3-fold improvement in potency was realized (FXIa <i>K</i><sub>i</sub> = 9 nM), and the aPTT assay showed it to have good in vitro anticoagulant activity (EC<sub>2<i>x</i></sub> = 10 μM). Substituting the bromine with chlorine gave compound <b>11j</b> (FXIa <i>K</i><sub>i</sub> = 4 nM, aPTT EC<sub>2<i>x</i></sub> = 6 μM), which showed a similar improvement in potency compared to compound <b>11h</b>. The C-5 fluoride (<b>11k</b>) was as potent against FXIa as compound <b>11j</b> but was less selective against FXa (<i>K</i><sub>i</sub> = 1370 nM) and PK (<i>K</i><sub>i</sub> = 8 nM). Combining all the modifications that improved potency against FXIa into a single molecule gave compound <b>16b</b> having subnanomolar potency against FXIa (<i>K</i><sub>i</sub> = 0.3 nM), 17-fold selectivity versus PK, potent in vitro aPTT activity (EC<sub>2<i>x</i></sub> = 1 μM), and >1000-fold selectivity versus other relevant proteases (see Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> for a compilation of data for <b>16b</b>). The enantiomer of <b>16b</b> (<i>R</i>-configuration) (FXIa <i>K</i><sub>i</sub> = 21 nM) was 70-fold less potent. The C-5 fluoride analog of <b>16b</b>, compound <b>16c</b>, was equally potent against FXIa (<i>K</i><sub>i</sub> = 0.3 nM) and equally selective against FVIIa, FXa, and PK.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Serine Protease Selectivity and aPTT and PT Data for Compound <b>16b</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="9" align="center"><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="2" align="center">EC<sub>2<i>x</i></sub> (μM)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">FXIa</th><th class="colsep0 rowsep0" align="center">FXa</th><th class="colsep0 rowsep0" align="center">FVIIa</th><th class="colsep0 rowsep0" align="center">FXIIa</th><th class="colsep0 rowsep0" align="center">FIXa</th><th class="colsep0 rowsep0" align="center">thrombin</th><th class="colsep0 rowsep0" align="center">PK</th><th class="colsep0 rowsep0" align="center">trypsin</th><th class="colsep0 rowsep0" align="center">chymotrypsin</th><th class="colsep0 rowsep0" align="center">aPTT</th><th class="colsep0 rowsep0" align="center">PT</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">6390</td><td class="colsep0 rowsep0" align="left">4220</td><td class="colsep0 rowsep0" align="left">9218</td><td class="colsep0 rowsep0" align="left">>34900</td><td class="colsep0 rowsep0" align="left">>12610</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">>20800</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">>40</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last"><i>K</i><sub>i</sub> values were obtained from purified human enzymes and are averaged from duplicate IC<sub>50</sub> determinations.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Activated partial thromboplastin time (aPTT) and prothrombin time (PT) were measured according to the method described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div></div></div><div class="NLM_p">X-ray crystal data (2.09 Å resolution) showed the binding modes of compounds <b>16b</b> and <b>11h</b> to be virtually identical (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). The exocyclic nitrogen of the aminoindazole moiety formed a hydrogen bond to the backbone carbonyl of His40 and, via two intervening water molecules, to the backbone nitrogen of the same residue (cf. the amine of the primary amide of <b>11h</b>). The N-1 nitrogen of the indazole ring was within hydrogen bonding distance to the hydroxy group of Tyr143 as designed. The N-2 nitrogen participated in a hydrogen bond with the backbone nitrogen of Ile151 via an intervening water molecule (cf. the carbonyl of the primary amide of <b>11h</b>). In addition, the C-5 chlorine formed a hydrophobic contact to the aliphatic portion the Lys192 side chain. Combined, the modifications made to compound <b>11a</b>, guided by key computer modeling exercises, resulted in a 400-fold improvement in potency for FXIa. In addition, compound <b>16b</b> maintained excellent selectivity against a panel of serine proteases found in the coagulation pathway and had good selectivity against PK.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray crystal structure of compound <b>16b</b> complexed to FXIa. The initial <i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> electron density contoured at 4 rmsd is shown with the final model. The protein is shown with yellow carbon atoms and secondary structural elements, and <b>16b</b> is shown with green carbon atoms. Nitrogen atoms are shown in blue, oxygen atoms in red, sulfur atoms in a darker yellow, and the chlorine atom in orange. The red spheres represent crystallographic water molecules. Hydrogen bonds are represented by a series of gray prolate ellipsoids. Figure was prepared with PyMol (Schrödinger).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010607&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Other five-membered ring heterocycle replacements of the imidazole were surveyed in parallel with the SAR development of the phenylimidazole series (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). 5-Phenyloxazole <b>20</b> (FXIa <i>K</i><sub>i</sub> = 1440 nM) was 12-fold less potent for FXIa compared to compound <b>11a</b> (FXIa <i>K</i><sub>i</sub> = 120 nM) with good selectivity over FVIIa and FXa and moderate selectivity over PK (2-fold). Replacing the C-5 methine of compound <b>11a</b> with nitrogen to give 3-phenyltriazole <b>22</b> resulted in an 8-fold loss in potency while maintaining a similar selectivity profile versus FVIIa, FXa, and PK. Interchanging the C-5 methine with the N-3 nitrogen of the imidazole provided 3-phenylpyrazole <b>27</b> (FXIa <i>K</i><sub>i</sub> = 6940 nM) resulting in significant loss of potency for FXIa (∼60-fold). The 5-oxo-1-phenyltriazole <b>30</b> was ∼25-fold less potent than imidazole <b>11a</b> but retained good selectivity over FVIIa and FXa. The 2-phenylimidazole regioisomer of <b>11a</b>, compound <b>33</b> (FXIa <i>K</i><sub>i</sub> = 1640 nM), was similar in potency and selectivity to oxazole <b>20</b>. In conclusion, the 5-phenylimidazole regioisomer contained in <b>11a</b> remained the most potent five-membered ring heterocycle analog among the small set surveyed.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro Data for Compounds <b>11a</b>, <b>20</b>, <b>22</b>, <b>27</b>, <b>30</b>, <b>33</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0017.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0018.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last"><i>K</i><sub>i</sub> values were obtained from purified human enzymes and are averaged from duplicate IC<sub>50</sub> determinations.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last"><i>K</i><sub>i</sub> > 10 900 nM and <i>K</i><sub>i</sub> > 8180 nM for FVIIa and FXa, respectively.</p></div></div><div></div></div><div class="NLM_p">Compound <b>16b</b> exhibited reversible enzyme inhibition kinetics at 37 °C (FXIa <i>K</i><sub>i</sub> = 0.82 nM, on rate = 3.0 μM<sup>–1</sup> s<sup>–1</sup>, <i>t</i><sub>1/2</sub> off = 4.6 min), with similar potency for rabbit coagulation factor orthologs (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Pharmacokinetic profiling of compound <b>16b</b> in rabbits by iv administration at 0.5 mg/kg showed the compound to be relatively rapidly cleared and to have a relatively low volume of distribution (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). The compound was 85% protein bound in rabbit serum. Compound <b>16b</b> was not orally bioavailable; however, the bis-HCl salt had ample solubility (946 μg/mL in 100 mM phosphate buffer, pH 7.4; amorphous solid) for iv administration. When tested using the rabbit AV-shunt model<a onclick="showRef(event, 'cit18a'); return false;" href="javascript:void(0);" class="ref cit18a">(18a)</a> at three doses administered as a single loading dose followed by continuous iv infusion to maintain steady state blood levels of drug, the bis-HCl salt of compound <b>16b</b> showed potent dose dependent in vivo antithrombotic activity relative to untreated controls with a calculated ID<sub>50</sub> = 0.6 mg/kg +1 mg kg<sup>–1</sup> h<sup>–1</sup> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Inhibition of plasma kallikrein (PK) may contribute to the antithrombotic effect of compound <b>16b</b>, since the selectivity of compound <b>16b</b> for rabbit FXIa versus rabbit PK inhibition is modest (35-fold) and PK KO mice have been shown to be resistant to thrombus formation in mouse venous and arterial FeCl<sub>3</sub>-induced thrombosis models.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Rabbit AV-shunt data. Compound <b>16b</b> was given as a single loading dose followed by continuous iv infusion at three doses: 0.1 mg/kg + 0.16 mg kg<sup>–1</sup> h<sup>–1</sup>, 0.5 mg/kg + 0.8 mg kg<sup>–1</sup> h<sup>–1</sup>, 2.5 mg/kg + 4 mg kg<sup>–1</sup> h<sup>–1</sup>. Thrombi formed were removed from the shunt and weighed. % inhibition values are relative to thrombus formation prior to drug treatment. ID<sub>50</sub> = 0.6 mg/kg + 1 mg kg<sup>–1</sup> h<sup>–1</sup>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010607&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Comparison of Human and Rabbit Selectivity Profile and in Vitro aPTT for Compound <b>16b</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center"><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">FXIa</th><th class="colsep0 rowsep0" align="center">FXa</th><th class="colsep0 rowsep0" align="center">thrombin</th><th class="colsep0 rowsep0" align="center">FVIIa</th><th class="colsep0 rowsep0" align="center">PK</th><th class="colsep0 rowsep0" align="center">EC<sub>2<i>x</i></sub> (μM),<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a> aPTT</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">0.3 (0.8)<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">6390</td><td class="colsep0 rowsep0" align="left">>12610</td><td class="colsep0 rowsep0" align="left">4220</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rabbit</td><td class="colsep0 rowsep0" align="left">0.6 (1.2)<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">>10000</td><td class="colsep0 rowsep0" align="left">>20000</td><td class="colsep0 rowsep0" align="left">10000<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last"><i>K</i><sub>i</sub> values were obtained from purified human enzymes and are averaged from duplicate IC<sub>50</sub> determinations.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Activated partial prothrombin time (aPTT) was measured according to the method described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Values were determined at 37 °C.</p></div></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Rabbit Pharmacokinetic and Protein Binding Data for Compound <b>16b</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (nM)</th><th class="colsep0 rowsep0" align="center">CL (L h<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center">MRT (h)</th><th class="colsep0 rowsep0" align="center">protein binding<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">2472 ± 456</td><td class="colsep0 rowsep0" align="left">1.2 ± 0.1</td><td class="colsep0 rowsep0" align="left">0.7 ± 0.1</td><td class="colsep0 rowsep0" align="left">1.0 ± 0.3</td><td class="colsep0 rowsep0" align="left">0.6 ± 0.1</td><td class="colsep0 rowsep0" align="left">85</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Determined using rabbit plasma.</p></div></div></div></div><div id="sec2_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12251" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12251" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Phenylimidazoles <b>9a</b>–<b>g</b> were synthesized using a three-step sequence<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). The cesium salt of (<span class="smallcaps smallerCapital">l</span>)-<i>N</i>-Boc-phenylalanine (<b>7</b>), formed using cesium carbonate in ethanol/water (1:1), was combined with the appropriately substituted bromoacetophenones <b>8a</b>–<b>g</b>. The resulting β-keto esters were condensed with ammonium acetate (refluxing xylenes, Dean–Stark trap) to give the phenylimidazoles <b>9a</b>–<b>g</b>. Yields for this three-step sequence ranged between 40% and 60%. Removal of the Boc group with 10% trifluoroacetic acid (v/v) in methylene chloride at room temperature was followed by amide bond formation (BOP reagent or EDC/HOBT) with <i>N</i>-Boc-tranexamic acid to give intermediates <b>10a</b>–<b>g</b>. Nitriles <b>10b</b> and <b>10e</b> were hydrolyzed to the primary amides <b>10h</b> and <b>10q</b>, respectively, using 30% hydrogen peroxide and potassium carbonate in DMSO. Addition of magnesium oxide to the reaction with <b>10h</b> helped to accelerate an otherwise sluggish hydrolysis. Addition of bromine to C-5 of the imidazole ring was accomplished by reacting intermediate <b>10h</b> with bromine in methylene chloride at room temperature to give <b>10i</b>. Synthesis of the C-5 chloro analog <b>10j</b> began with hydrolysis of nitrile <b>9b</b> using potassium carbonate, hydrogen peroxide, and magnesium oxide followed by chlorination of the C-5 carbon of the imidazole with <i>N</i>-chlorosuccinimide in refluxing acetonitrile. Removal of the Boc group with TFA and addition of <i>N</i>-Boc-tranexamic acid using BOP/pyridine gave <b>10j</b>. The C-5 fluoro analog <b>10k</b> was obtained by reaction of <b>10h</b> with SelectFluor in DMF/H<sub>2</sub>O (10:1). Esters <b>10c</b>, <b>10d</b>, and <b>10f</b> were hydrolyzed to the corresponding acids <b>10l</b>, <b>10o</b>, and <b>10r</b> using methanolic sodium hydroxide at room temperature. Again, use of magnesium oxide accelerated the otherwise slow hydrolysis of ester <b>10c</b>. Carboxylic acid <b>10l</b> was converted to monomethylamide <b>10m</b> or dimethylamide <b>10n</b> using methylamine or dimethylamine, respectively (EDC/HOBt). The primary phenylacetamides <b>10p</b> and <b>10s</b> were synthesized from the corresponding phenylacetic acids <b>10o</b> and <b>10r</b> using EDC/HOAt and <i>N</i>-methylmorpholine followed by concentrated aqueous ammonia. The Boc group on the tranexamic acid moiety for intermediates <b>10a</b>–<b>s</b> was removed using 10% trifluoroacetic acid (v/v) in methylene chloride at room temperature to provide compounds <b>11a</b>–<b>s</b> as bis-trifluoroacetic acid salts.</div><figure id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Phenylimidazoles <b>11a</b>–<b>s</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010607&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <b>7</b>, Cs<sub>2</sub>CO<sub>3</sub>, EtOH/H<sub>2</sub>O (1:1), rt, 1 h; (b) Cs salt from (a), <b>8a</b>–<b>g</b>, DMF, rt, 1 h; (c) NH<sub>4</sub>OAc, xylenes, reflux (Dean–Stark), 3 h; (d) 10–30% (v/v) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (e) <i>N</i>-Boc-tranexamic acid, BOP, pyridine, DMF, rt, 16 h or EDC, HOBt, <i>N</i>-methylmorpholine, DMF, rt, 16 h; (f) K<sub>2</sub>CO<sub>3</sub>, 30% aq H<sub>2</sub>O<sub>2</sub>, MgO, DMSO, rt, 4 h; (g) NaOH, MgO, CH<sub>3</sub>OH/EtOAc (5:1), rt, 5 h; (h) NaOH, MeOH, rt, 16 h; (i) Br<sub>2</sub>, CHCl<sub>3</sub>, rt, 16 h; (j) NCS, ACN, reflux, 7 h; (k) Selectfluor, DMF/H<sub>2</sub>O (10:1), rt, 2 h; (l) methylamine (<b>10m</b>) or dimethylamine (<b>10n</b>), HOBt, EDC, <i>N</i>-methylmorpholine, DMF, rt, 16 h; (m) conc NH<sub>4</sub>OH, HOAt, EDC, <i>N</i>-methylmorpholine, DMF, rt, 16 h.</p></p></figure><figure id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Aminoindazole Analogs <b>16a</b>–<b>c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010607&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Zn(CN)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF, 90 °C, 3 h; (b) (i) oxalyl chloride, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h, then reflux, 1 h, (ii) TMSCH<sub>2</sub>N<sub>2</sub>, ACN, −15 °C, 1 h, (iii) HBr (33% by mass) in HOAc, −15 °C, 20 min (39% over two steps); (c) <b>7</b>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 15 °C, 1 h (61%); (d) NH<sub>4</sub>OAc, xylenes, reflux (Dean–Stark), 2.5 h (41%); (e) NCS, ACN, reflux, 7 h (99%); (f) Selectfluor, DMF/H<sub>2</sub>O (10:1), rt, 2 h (27%); (g) 20% TFA (v/v), CH<sub>2</sub>Cl<sub>2</sub>, rt, 30 min; (h) <i>N</i>-Boc-tranexamic acid, BOP, TEA, THF, 75 °C, 15 min; (i) 20% TFA (v/v), CH<sub>2</sub>Cl<sub>2</sub>, rt, 30 min (>67% for three steps for <b>15b</b>); (j) NH<sub>2</sub>NH<sub>2</sub>·H<sub>2</sub>O, <i>n</i>-BuOH, 120 °C, 1 h (54% for <b>16b</b>).</p></p></figure><div class="NLM_p">Aminoindazoles <b>16a</b>–<b>c</b> were accessed starting from commercially available 4-bromo-3-fluorobenzoic acid (<b>12</b>), which was treated with zinc(II) cyanide and tetrakis(triphenylphosphine)palladium(0) in dimethylformamide at 90 °C to give 4-cyano-3-fluorobenzoic acid (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). The carboxylic acid was converted to α-bromoketone <b>13</b> by a three-step, one-pot transformation: (1) formation of the acid chloride using oxalyl chloride in methylene chloride, (2) conversion of the acid chloride to the methyl ketone with trimethylsilyldiazomethane in acetonitrile (1 h at −15 °C, then reflux for 1 h), and (3) bromination of the methyl ketone (33% hydrobromic acid in acetic acid, −15 °C). The sequence carrying bromoketone <b>13</b> forward to imidazole <b>14a</b> (R<sup>5</sup> =H) was the same as described for compounds <b>10a</b>–<b>g</b>. Refluxing <b>14a</b> with <i>N</i>-chlorosuccinimide in acetonitrile gave chloroimidazole <b>14b</b>. SelectFluor in DMF/H<sub>2</sub>O (10:1) gave fluoroimidazole <b>14c</b> from <b>14a</b>. Imidazoles <b>14a</b>–<b>c</b> were carried forward to <b>15a</b>–<b>c</b>, respectively, using the reaction sequence described for converting compounds <b>9a</b>–<b>g</b> to <b>11a</b>–<b>g</b>. Compounds <b>15a</b>–<b>c</b> were treated with hydrazine hydrate in <i>n</i>-butanol at 120 °C for 1 h to give the corresponding aminoindazoles <b>16a</b>–<b>c</b>, which were isolated as bis-trifluoroacetic acid salts. Alternatively, the final two steps in the sequence (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, steps i and j) could be reversed. Formation of the bis-HCl salt of <b>16b</b> used in the rabbit AV-shunt model was obtained using reverse phase HPLC with a mobile phase containing HCl.</div><div class="NLM_p">Synthesis of 5-phenyloxazole <b>20</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) began with amide coupling between (<i>S</i>)-2-(1,3-dioxoisoindolin-2-yl)-3-phenylpropanoic acid (<b>17</b>) and 2-amino-1-phenylethanone (<b>18</b>; Bop/pyridine), followed by dehydration of the intermediate diketoamide with POCl<sub>3</sub> in DMF to give (<i>S</i>)-2-(2-phenyl-1-(5-phenyloxazol-2-yl)ethyl)isoindoline-1,3-dione (<b>19</b>). Removal of the phthalimide group with hydrazine in refluxing EtOH was followed by acylation of the free amine with the tranexamic side chain as previously described. The four-step synthesis of 3-phenyltriazole <b>22</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>) began with coupling hydrazine and <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-phenylalanine <b>7</b> using BOP and anhydrous pyridine. The intermediate acyl hydrazide was condensed with ethyl benzimidate hydrochloride in refluxing acetonitrile and TEA to give triazole <b>21</b>. Removal of the Boc group with TFA and subsequent conversion of the free amine to compound <b>22</b> were carried out as before. Synthesis of 3-phenylpyrazine <b>27</b> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>) began with hydrolysis of ethyl 3-oxo-3-phenylpropanoate (<b>23</b>) to give 3-oxo-3-phenylpropanoic acid, followed by formation of magnesium 3-oxo-3-phenylpropanoate using magnesium ethoxide in methanol. The salt was combined with 1,1′-carbonyldiimidazole activated <i>N</i>-CBz-<span class="smallcaps smallerCapital">l</span>-phenylalanine (<b>24</b>), which resulted in the decarboxylative addition of acetophenone enolate to the mixed anhydride of <b>24</b> to give (<i>S</i>)-benzyl (3,5-dioxo-1,5-diphenylpentan-2-yl)carbamate (<b>25</b>). The diketone <b>25</b> was then condensed with hydrazine in EtOH to give pyrazine <b>26</b>. Hydrogenation with 10% palladium on carbon followed by installation of the transexamic side chain provided 3-phenylpyrazine <b>27</b>. (<i>S</i>)-Benzyl (1-cyano-2-phenylethyl)carbamate <b>28</b> was converted to the oxotriazine <b>29</b> by a three-step process (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>). First, the methyl imidate of compound <b>28</b> was formed using sodium methoxide. Next, the imidate was condensed with phenylhydrazine to give an iminohydrazide. Third, the iminohydrazide was combined with carbonyl diimidazole in refluxing THF to give the oxotriazole <b>29</b>. Synthesis of 5-oxo-1-phenyltriazine <b>30</b> from compound <b>29</b> was carried out as previously described. Synthesis of 2-phenylimidazole <b>33</b> (Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>) began by combining bromoketone <b>31</b> with sodium formate in refluxing EtOH, followed by addition of benzamidine and sodium bicarbonate to give the imidazole <b>32</b>. Removal of the CBz group by hydrogenation as described was followed by acylation with <i>N</i>-Boc-tranexamic acid, and subsequent removal of the Boc group with TFA completed the synthesis of 2-phenylimidazole <b>33</b>.</div><figure id="sch3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <i>trans</i>-4-(Aminomethyl)-<i>N</i>-((<i>S</i>)-2-phenyl-1-(5-phenyloxazol-2-yl)ethyl)cyclohexanecarboxamide (<b>20</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010607&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) BOP, anhyd pyridine, rt, 16 h (100%); (b) POCl<sub>3</sub>, DMF, 90 °C, 30 min (41%); (c) hydrazine, EtOH, reflux, 2 h (90%); (d) <i>N</i>-Boc-tranexamic acid, HOAt, EDC, <i>N</i>-methylmorpholine, DMF, rt, 1 h; (e) 10% (v/v) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h (26% over two steps).</p></p></figure><figure id="sch4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of <i>trans</i>-4-(Aminomethyl)-<i>N</i>-((<i>S</i>)-2-phenyl-1-(3-phenyl-1<i>H</i>-1,2,4-triazol-5-yl)ethyl)cyclohexanecarboxamide (<b>22</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010607&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Hydrazine, BOP-Cl, anhydrous pyridine, rt, 16 h (100%); (b) ethyl benzimidate·HCl, Et<sub>3</sub>N, ACN, reflux, 24 h (42%); (c) 10% (v/v) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h; (d) <i>N</i>-Boc-tranexamic acid, BOP-Cl, anhydrous pyridine, rt, 12 h; (e) 30% (v/v) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 h (28% over three steps).</p></p></figure><figure id="sch5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of <i>trans</i>-4-(Aminomethyl)-<i>N</i>-((<i>S</i>)-2-phenyl-1-(3-phenyl-1<i>H</i>-pyrazol-5-yl)ethyl)cyclohexanecarboxamide (<b>27</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010607&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (i) <b>23</b>, 1 N NaOH/EtOH (1:1), rt, 72 h; (ii) Mg(OEt)<sub>2</sub>, MeOH, 4 h; (b) (i) <b>24</b>, CDI, DMF, 2 h, rt; (ii) intermediate from (a), DMF, rt, 24 h (13%); (c) anhydrous hydrazine, EtOH, 60 °C, 3 h (100%); (d) 10% Pd/C, MeOH, 1 atm H<sub>2</sub>, 4 h (57%); (e) <i>N</i>-Boc-tranexamic acid, BOP-Cl, anhydrous pyridine, rt, 12 h; (f) 30% (v/v) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 h (46% over two steps).</p></p></figure><figure id="sch6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <i>trans</i>-4-(Aminomethyl)-<i>N</i>-((<i>S</i>)-1-(5-oxo-1-phenyl-4,5-dihydro-1<i>H</i>-1,2,4-triazol-3-yl)-2-phenylethyl)cyclohexanecarboxamide (<b>30</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010607&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (i) NaOCH<sub>3</sub>, MeOH, 30 °C, 3 h, (ii) HOAc, phenylhydrazine, rt, 18 h (28%); (b) carbonyl dimidazole, THF, reflux, 48 h (66%); (c) 10% Pd/C, MeOH, 1 atm H<sub>2</sub>, 4 h (57%); (d) <i>N</i>-Boc-tranexamic acid, BOP-Cl, anhydrous pyridine, rt, 12 h; (e) 30% (v/v) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 h (46% over two steps).</p></p></figure><figure id="sch7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of <i>trans</i>-4-(Aminomethyl)-<i>N</i>-((<i>S</i>)-2-phenyl-1-(2-phenyl-1<i>H</i>-imidazol-4-yl)ethyl)cyclohexanecarboxamide <b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010607&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (i) sodium formate, EtOH, reflux, 14 h, (ii) add benzamidine, NaHCO<sub>3</sub>, reflux, 24 h (8%); (b) 10% Pd/C, MeOH, 1 atm H<sub>2</sub>, 4 h (57%); (c) <i>N</i>-Boc-tranexamic acid, BOP-Cl, anhydrous pyridine, rt, 12 h; (d) 30% (v/v) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 h (46% over two steps).</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88110" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88110" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Optimization of compound <b>11a</b> for FXIa potency and selectivity over other relevant serine proteases resulted in the identification of compound <b>16b</b>, a subnanomolar, reversible inhibitor of FXIa. Compound <b>16b</b> showed potent dose dependent antithrombotic activity in the rabbit AV-shunt model. It was used extensively in preclinical rabbit efficacy models (AV-shunt,<a onclick="showRef(event, 'cit18a'); return false;" href="javascript:void(0);" class="ref cit18a">(18a)</a> ECAT,<a onclick="showRef(event, 'cit18b'); return false;" href="javascript:void(0);" class="ref cit18b">(18b)</a> cuticle bleeding<a onclick="showRef(event, 'cit18c'); return false;" href="javascript:void(0);" class="ref cit18c">(18c)</a><sup>–</sup><a onclick="showRef(event, 'cit18d'); return false;" href="javascript:void(0);" class="ref cit18d">(18d)</a>) to benchmark in vivo efficacy (antithrombotic effect) and safety (bleeding) parameters for this mechanism of action. Compound <b>16b</b> was well tolerated in these models and enabled the studies to be conducted up to the ID<sub>90</sub> for thrombus inhibition. A full description of the pharmacology of <b>16b</b> and studies identifying orally bioavailable analogs will be published separately.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01601" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01601" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All reactions were run under an atmosphere of dry nitrogen or argon unless otherwise noted. Solvents and reagents were obtained from commercial vendors in the appropriate grade and used without further purification unless otherwise indicated. NMR spectra were obtained on Joel ECP500 (500 MHz) or ECP400 (400 MHz) NMR spectrometers with chemical shift in ppm downfield from TMS as an internal reference standard. <sup>1</sup>H assignment abbreviations are the following: singlet (s), doublet (d), triplet (t), quartet (q), pentet (p), broad singlet (bs), doublet of doublets (dd), doublet of triplets (dt), and multiplet (m). Flash chromatography was done using Teledyne-ISCO automated flash chromatography instruments. Reverse phase analytical HPLC was performed on Shimadzu LC10AS systems and reverse phase analytical HPLC/MS on Shimadzu LC10AS systems coupled with Waters ZMD mass spectrometers using MeOH/H<sub>2</sub>O containing 0.01% TFA or 10 mM NH<sub>4</sub>OAc as the mobile phase. HPLC purification was performed using a Shimadzu preparative HPLC system composed of a SPD-20A prominence detector, two LC-8A pumps, a SCL-10 vp controller, and a FRC-10 fraction collector using C18 reverse phase columns with MeOH/H<sub>2</sub>O containing 0.05% TFA as the mobile phase. HPLC purity was determined on a Shimadzu LC10AT system equipped with Sunfire C18 and Xbridge phenyl reverse phase columns (3.0 mm × 150 mm) operating at a flow rate of 0.5 mL/min with a mobile phase consisting of H<sub>2</sub>O/acetonitrile containing 0.05% TFA and detector wavelengths set to 220 and 254 nm. All final compounds were found to be >95% pure by HPLC analysis unless otherwise noted.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Enzyme Affinity Assays</h3><div class="NLM_p">Factors IXa, Xa, and XIa were purchased from Haematologic Technologies. Factor XIIa was purchased from American Diagnostica. Plasma kallikrein and α-thrombin were purchased from Enzyme Research Laboratories. Trypsin and chymotrypsin were purchased from Sigma-Aldrich. Recombinant factor VIIa was purchased from Novo Nordisk. Recombinant soluble tissue factor residues 1–219 was produced at Bristol-Myers Squibb.</div><div class="NLM_p">Factor XIa, factor XIIa, and chymotrypsin assays were conducted in 50 mM HEPES, pH 7.4, 145 mM sodium chloride, 5 mM potassium chloride, and 0.1% PEG 8000. Factor Xa, thrombin, trypsin, and plasma kallikrein assays were conducted in 100 mM sodium phosphate, pH 7.5, 200 mM sodium chloride, and 0.5% PEG 8000. Factor VIIa assays were conducted in 50 mM HEPES, pH 7.4, 150 mM sodium chloride, 5 mM calcium chloride, and 0.1% PEG 8000. Factor IXa assays were conducted in 50 mM Tris, pH 7.4, 100 mM sodium chloride, 5 mM calcium chloride, 0.5% PEG 8000, and 2% DMSO. The peptide substrates were the following: pyro-Glu-Pro-Arg-pNA(<i>p</i>-nitroaniline) (Diapharma) for factor XIa and thrombin; <i>N</i>-benzoyl-Ile-Glu-(OH, OMe)-Gly-Arg-pNA (Diapharma) for factor Xa and trypsin; H-(D)-Ile-Pro-Arg-pNA (Diapharma) for factor VIIa; H-(D)-CHT-Gly-Arg-pNA (American Diagnostica) for factor XIIa; H-(D)-Leu-Ph-Gly-Arg-AMC(7-amino-4-methylcoumarin) (Pentapharm) or H-(D)-Pro-Phe-Arg-pNA (Diapharma) for plasma kallikrein; MeO-Suc-Arg-Pro-Tyr-pNA (Diapharma) for chymotrypsin.</div><div class="NLM_p">All assays were conducted at room temperature except where noted in 96-well microtiter plate spectrophotometers or spectrofluorimeters (Molecular Devices) with simultaneous measurement of enzyme activities in control and inhibitor containing solutions. Compounds were dissolved and diluted in DMSO and analyzed at a final concentration of 1% DMSO except where noted. Assays were initiated by adding enzyme to buffered solutions containing substrate in the presence or absence of inhibitor. Hydrolysis of the substrate resulted in the release of pNA (<i>p</i>-nitroaniline), which was monitored spectrophotometrically by measuring the increase in absorbance at 405 nm, or the release of AMC (7-amino-4-methylcoumarin), which was monitored spectrofluorometrically by measuring the increase in emission at 460 nm with excitation at 380 nm. The rate of absorbance or fluorescence change is proportional to enzyme activity. A decrease in the rate of absorbance or fluorescence change in the presence of inhibitor is indicative of enzyme inhibition. Assays were conducted under conditions of excess substrate and inhibitor over enzyme. The Michaelis constant, <i>K</i><sub>m</sub>, for substrate hydrolysis by each protease was determined by fitting data from independent measurements at several substrate concentrations to the Michaelis–Menten equation:<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/jm-2014-010607_m001.gif" alt="" /></img></span>where <i>v</i> is the observed velocity of the reaction, <i>V</i><sub>max</sub> is the maximal velocity, [S] is the concentration of substrate, and <i>K</i><sub>m</sub> is the Michaelis constant for the substrate.</div><div class="NLM_p">Values of IC<sub>50</sub> were determined by allowing the protease to react with the substrate in the presence of the inhibitor. Reactions were allowed to go for periods of 10–120 min (depending on the protease), and the velocities (rate of absorbance or fluorescence change versus time) were measured.</div><div class="NLM_p">The following relationship was used to calculate IC<sub>50</sub> values:<span class="NLM_disp-formula"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/jm-2014-010607_m002.gif" alt="" /></img></span>where <i>v</i><sub>o</sub> is the velocity of the control in the absence of inhibitor, <i>v</i><sub>s</sub> is the velocity in the presence of inhibitor, <i>I</i> is the concentration of inhibitor, <i>A</i> is the minimum activity remaining (usually locked at zero), <i>B</i> is the maximum activity remaining (usually locked at 1.0), <i>n</i> is the Hill coefficient, a measure of the number and cooperativity of potential inhibitor binding sites, and IC<sub>50</sub> is the concentration of inhibitor that produces 50% inhibition.</div><div class="NLM_p last">When negligible enzyme inhibition was observed at the highest inhibitor concentration tested, the value assigned as a lower limit for IC<sub>50</sub> is the value that would be obtained with either 25% or 50% inhibition at the highest inhibitor concentration. In all other cases IC<sub>50</sub> values represent the average of duplicate determinations obtained over 8–11 concentrations. Competitive inhibition was assumed for all proteases. IC<sub>50</sub> values were converted to <i>K</i><sub>i</sub> values by the the following relationship:<span class="NLM_disp-formula"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/jm-2014-010607_m003.gif" alt="" /></img></span></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> aPTT and PT in Vitro Coagulation Assays</h3><div class="NLM_p last">Standard clotting assays were performed in a temperature-controlled automated coagulation device (Sysmex CA-6000, Dade-Behring). Blood was obtained from healthy volunteers by venipuncture and anticoagulated with one-tenth volume 0.11 M buffered sodium citrate (Vacutainer, Becton Dickinson). Plasma was obtained after centrifugation at 2000<i>g</i> for 10 min and kept on ice prior to use. An initial stock solution of the inhibitor at 10 mM was prepared in DMSO. Subsequent dilutions were done in plasma. Clotting time was determined on control plasma and plasma containing up to seven different concentrations of inhibitor. The activated partial thromboplastin time (aPTT) was performed using Alexin (Trinity Biotech) according to the reagent instructions. Plasma (50 μL) was warmed to 37 °C for 1 min before adding aPTT reagent (50 μL). Two minutes later calcium chloride (50 μL) was added. The prothrombin time (PT) was performed using Thromboplastin C-Plus (Dade-Behring) according to the reagent instructions. Plasma (50 μL) was warmed to 37 °C for 3 min before adding PT reagent (100 μL). Determinations were performed in duplicate and expressed as a mean ratio of treated vs baseline control. The concentrations required to prolong clotting time by 2-fold (EC<sub>2<i>x</i></sub>) were calculated by linear interpolation (Microsoft Excel, Redmond, WA, USA) and are expressed as total plasma concentrations, not final assay concentrations after addition of clotting assay reagents.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Recombinant FXI Catalytic Domain Cloning and Expression</h3><div class="NLM_p last">A gene encoding the expression of amino acids D357 to V607 of FXI catalytic domain with the following modifications was made: point mutations N473G, T475G to mitigate lattice hindrance, an N-terminal addition of MDDDD which improved solubility and handling of the protein, and a six membered poly-histidine tail on the C-terminus to enable metal chelation affinity chromatography (sequence 1). The gene was inserted into pET14b T7 expression plasmid (EMD-Millapore). The sequence confirmed plasmid was transformed into competent Origami B, BL21(DE3) <i>E. coli</i> cells. The catalytic domain of FXI has eight cysteines and four disulfide bonds. Use of Origami B enabled a small portion of the protein product to have the correctly oxidized pairings of these cysteines, which are ultimately purified from mismatched cousins by selection on a benzamidine affinity resin. Fermentation of cells was undertaken at 37 °C until the logarithmic growth phase was reached. Expression was induced with IPTG at 20 °C. Cells were harvested 12–16 h later by centrifugation, and the cell pellets were frozen for future use.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Sequence 1</h3><div class="NLM_p">The amino acid sequence 1 of the FXI catalytic domain used to clone and express the protein is the following:</div><div class="NLM_p"><u class="uu">MDDDD</u>KMDNECTTKIKPR<sup>∧</sup>IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTV<u class="uu">G</u>Y<u class="uu">G</u>DSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV<u class="uu">HHHHHH</u></div><div class="NLM_p last">In the amino acid sequence, the ∧ denotes the thrombin activation cleavage site. Underlined amino acids are modifications and termini additions employed.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Recombinant FXIa Catalytic Domain Purification</h3><div class="NLM_p last">An amount of 40 g of cells (wet packed cell weight) was thawed and suspended in 150 mL of lysis buffer (50 mM Na/KPO<sub>4</sub>, pH 8.0, 0.3 M NaCl, 20 mM imidazole) per gram of packed cells and lysed mechanically in an Emulsiflex homogenizer. The lsyate suspension was clarified by centrifugation at 10 °C, and the supernatant was combined with 6 mL of Ni-NTA Superflow resin (Qiagen Inc.) pre-equilibrated with buffer A (50 mM Na/KPO<sub>4</sub>, pH 8.0, 0.3 M NaCl, and 20 mM imidazole) and the mixture incubated for 2 h at 4 °C. The mixture was then packed into a column and was washed with 50 mL of buffer A. Crude FXI catalytic domain protein was eluted from the column with the buffer A supplemented with 300 mM imidazole. Fractions containing the protein were identified by molecular weight using SDS–PAGE and were pooled and dialyzed overnight against buffer B (50 mM triethanolamine, 100 mM NaCl, 1 mM EDTA, pH 7.9) at 4 °C. The next morning, dextran sulfate sodium salt was added to a final concentration of 20 μg/mL. Thrombin (1000 units; Calbiochem, catalog no. 605160) was added, and the mixture was incubated for 30 min at 37 °C to convert the FXI catalytic domain to the active form (FXIa catalytic domain). To arrest the reaction, polybrene and MgCl<sub>2</sub> were added up to 100 ug/mL and 20 mM, respectively. Imidazole was then added up to 10 mM, and the solution was loaded onto a 5 mL column of Ni-NTA Superflow, washed with buffer A, and eluted in buffer A supplemented with 300 mM imidazole. Fractions containing FXIa catalytic domain as determined by SDS–PAGE were pooled and filtered. Final purification of FXIa catalytic domain from inactive contaminants was accomplished by loading the Ni-NTA eluate onto a 5 mL benzamidine Sepharose (GE, Healthcare) column pre-equilibrated in 50 mM Tris, pH 7.4, 1 M NaCl, and the column was washed with this buffer until baseline was achieved. FXIa catalytic domain protein able to bind to benzamidine was eluted in the same buffer supplemented with 40 mM benzamidine sulfate. The purified yield from this process was 2–4 mg of protein.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Formation of Crystals Using Purified Recombinant FXIa Catalytic Domain Complexed to Compound <b>11h</b> or <b>16b</b></h3><div class="NLM_p last">Crystals of FXIa catalytic domain complexed to benzamidine were grown at 4 °C by the hanging-drop vapor diffusion method. FXIa catalytic domain from the last step of purification (10 mg/mL) was saturated with benzamidine. A solution of 0.2 M (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, 25% polyethylene glycol methyl ether-2000, and 100 mM NaOAc, pH 4.6, was used as the precipitant. Benzamidine was replaced by compound <b>11h</b> or <b>16b</b> by soaking the FXIa catalytic domain/benzamidine crystals in a solution containing 2 mM replacement inhibitor in matched precipitant. Crystals were cryoprotected in 20% ethylene glycol for mounting prior to X-ray diffraction.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> X-ray Crystal Structure Data Collection and Structure Refinement (See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for Tabulated Parameters)</h3><div class="NLM_p last">Data for FXIa crystals in complex with compound <b>11h</b> or <b>16b</b> were collected at the Advanced Photon Source (APS) beamline 17-ID or in the laboratory. Raw data were processed with the program HKL2000.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The atomic coordinates of human factor XIa<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> were used as a search model. Original refinement was carried out with CNX (Accelrys), and inhibitor restraint dictionaries were built with QUANTA (Accelrys), which was also used for modeling. Later the structures were rerefined using BUSTER/TNT<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (GlobalPhasing, Ltd.), MakeTNT, or GRADE (GlobalPhasing, Ltd.) for inhibitor restraint dictionaries, and COOT<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and PROCHECK<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> for modeling. The PDB deposition numbers for compounds <b>11h</b> and <b>16b</b> complexed to FXIa are <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TY6">4TY6</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TY7">4TY7</a>, respectively.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Molecular Modeling Studies</h3><div class="NLM_p last">Compounds <b>11a</b> and <b>11h</b> were docked into the crystal structure of FXIa complexed to compound <b>3</b> using Glide XP (Schrodinger LLC, New York, NY) and OPLS2001 force field. Twenty-five docked poses were requested as output and were visually inspected. Binding poses were selected from these sets based on previous knowledge of docking outcomes and SAR. Additional refinement was completed by minimizing the selected molecule poses using MacroModel (Schrodinger LLC, New York, NY) with the OPLS2001 force field constraining all atoms outside 5 Å from the ligand binding site.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> AV-Shunt Thrombosis Model</h3><div class="NLM_p last">For a full description of the model see Wong et al.<a onclick="showRef(event, 'cit18a'); return false;" href="javascript:void(0);" class="ref cit18a">(18a)</a> Arterial blood from the femoral artery of anesthetized (ketamine, 50 mg/kg im, and xylazine, 10 mg/kg im; supplemented as needed) New Zealand male white rabbits was diverted through a PE60 cannula to a AV-shunt device, which is composed of a double tygon tubing with the inner tubing containing a 2.5 cm long 2-0 silk thread, and returned to the animal via a PE60 cannula inserted into the opposite femoral vein. Significant thrombus formation was initiated through contact with the silk thread. After 40 min the AV-shunt was disconnected from the arterial and venous catheters. The silk thread, which was covered with the thrombus, was removed and weighed. The thrombus weight formed on the thread was calculated by subtracting the average weight of a clean 2.5 cm long 2-0 silk thread. After obtaining the thrombus formation induced by the AV-shunt in the control period, the compound or vehicle was given as a bolus iv followed by a continuous iv infusion via the jugular vein started 30 min prior to the insertion of a new AV-shunt. The thrombus formation induced by the AV-shunt in the treatment period was measured as described above. Data are reported as % inhibition of thrombus formation in the treatment period versus in control period. Three doses of compound <b>16b</b> were tested: 0.1 mg/kg + 0.16 mg kg<sup>–1</sup> h<sup>–1</sup>, 0.5 mg/kg + 0.8 mg kg<sup>–1</sup> h<sup>–1</sup>, 2.5 mg/kg + 4 mg kg<sup>–1</sup> h<sup>–1</sup> using a dosing vehicle of saline. The saline vehicle did not significantly alter the AV-shunt-induced thrombus formation. A total of three rabbits were used for each dose of <b>16b</b>. The ID<sub>50</sub> represents the dose that produced 50% inhibition of thrombus formation and was estimated by linear regression.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Preparation of Compounds <b>11a</b>–<b>s</b></h3><div class="NLM_p last">Compounds <b>11a</b>–<b>s</b> were prepared by application of the methods described for the preparation of <b>11a</b>. <b>11i</b>–<b>s</b> required additional functional group transformations as described.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (<i>S</i>)-<i>tert</i>-Butyl (2-Phenyl-1-(4-phenyl-1<i>H</i>-imidazol-2-yl)ethyl)carbamate (<b>9a</b>)</h3><div class="NLM_p last">To a solution of <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-phenylalanine (<b>7</b>) (750 mg, 3.7 mmol) in 1:1 EtOH/H<sub>2</sub>O (7.4 mL) was added Cs<sub>2</sub>CO<sub>3</sub> (650 mg, 1.89 mmol). The reaction mixture was stirred at rt for 1 h. The solvent was removed under vacuum, and the solids were suspended in DMF (4.7 mL). 2-Bromoacetophenone (1.0 g, 3.77 mmol) was added in a single portion, and the reaction mixture was stirred at rt for 1.5 h. The mixture was filtered to remove solids. The solids were washed with DMF. The combined washings and filtrate were concentrated in vacuo to yield (<i>S</i>)-2-oxo-2-phenylethyl 2-((<i>tert</i>-butoxycarbonyl)amino)-3-phenylpropanoate (<b>I-1</b>) (650 mg). <b>I-1</b> was placed in a flask fitted with a Dean–Stark trap and dissolved in xylenes (10 mL). NH<sub>4</sub>OAc (2.64 g, 30 mmol) was added to the flask, and the mixture was heated to reflux for 3 h. The reaction mixture was cooled to rt and the solvent removed in vacuo. The residue was redissolved in EtOAc, washed with saturated aq NaHCO<sub>3</sub> and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated in vacuo to provide <b>9a</b> (780 mg, 57%). <i>m</i>/<i>z</i> 364 [M + H]<sup>+</sup>. Alternatively, <b>I-1</b> and 10 equiv of NH<sub>4</sub>OAc were dissolved in ethanol and heated to 160 °C in a sealed tube for 30 min using microwave irradiation. The reaction was cooled to rt, the ethanol was evaporated in vacuo, and the residue was redissolved in EtOAc. The organic layer was washed with brine, dried over MgSO<sub>4</sub>, and evaporated to dryness. The product thus formed was sufficiently pure to carry onto the next step.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>tert</i>-Butyl ((<i>trans</i>-4-(((<i>S</i>)-2-Phenyl-1-(4-phenyl-1<i>H</i>-imidazol-2-yl)ethyl)carbamoyl)cyclohexyl)methyl)carbamate (<b>10a</b>)</h3><div class="NLM_p last">To a solution of <b>9a</b> (100 mg, 0.28 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2.8 mL) was added neat TFA (0.2 mL). The reaction mixture was stirred at rt for 16 h. The solvent and TFA were removed in vacuo. The residue was twice redissolved in CH<sub>3</sub>OH and the solvent removed in vacuo to provide (<i>S</i>)-2-phenyl-1-(4-phenyl-1<i>H</i>-imidazol-2-yl)ethanamine, bis-trifluoroacetic acid salt (<b>I-2</b>) (124 mg, 92%), which was carried onto the next step without purification. <i>m</i>/<i>z</i> 262 (M – H)<sup>−</sup>. To a solution of <b>I-2</b> (75 mg, 0.15 mmol) and <i>N</i>-Boc-tranexamic acid (75 mg, 0.29 mmol) in pyridine (1.7 mL) was added BOP reagent (152 mg, 0.34 mmol). The reaction mixture was stirred at rt for 12 h. The mixture was diluted with H<sub>2</sub>O and extracted with EtOAc. The combined organic extracts were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated in vacuo to give <b>10a</b> (100 mg, 71%). <b>10a</b> was carried onto the next step without purification. <i>m</i>/<i>z</i> 503 [M + H]<sup>+</sup>. Alternatively, <b>I-2</b> was coupled with 1.0 equiv of <i>N</i>-Boc-tranexamic acid, 1.2 equiv of HOAt, 5.0 equiv of <i>N</i>-methylmorpholine, and 1.2 equiv of EDC.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>trans</i>-4-(Aminomethyl)-<i>N</i>-((<i>S</i>)-2-phenyl-1-(4-phenyl-1<i>H</i>-imidazol-2-yl)ethyl)cyclohexanecarboxamide, Bis-trifluoroacetic Acid Salt (<b>11a</b>)</h3><div class="NLM_p last"><b>10a</b> (100 mg, 0.20 mmol) was dissolved in 30% TFA in CH<sub>2</sub>Cl<sub>2</sub> (2.0 mL). The reaction mixture was stirred at rt for 3 h. The mixture was twice dissolved in toluene and dried in vacuo. <b>11a</b> was isolated by preparative HPLC (46 mg, 49%). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.02–1.11 (m, 2H), 1.32–1.45 (m, 2H), 1.54–1.61 (m, 1H), 1.80 (br d, <i>J</i> = 12 Hz, 1H), 1.86 (br d, <i>J</i> = 12 Hz, 3H), 2.28 (dt, <i>J</i> = 12, 3.3 Hz, 1H), 2.77 (d, <i>J</i> = 7.1 Hz, 2H), 3.31 (dd, 1H, overlap with C<u class="uu">H</u><sub>3</sub>OH), 3.38 (dd, <i>J</i> = 13, 8.0 Hz), 5.31 (t, <i>J</i> = 8.2 Hz, 1H), 7.18 (d, <i>J</i> = 7.1 Hz, 2H), 7.22–7.30 (m, 3H), 7.43–7.50 (m, 3H), 7.62 (d, <i>J</i> = 6.6 Hz, 2H), 7.75 (s, 1H). <i>m</i>/<i>z</i> 403 [M + H]<sup>+</sup>.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>trans</i>-4-(Aminomethyl)-<i>N</i>-((<i>S</i>)-1-(4-(4-cyanophenyl)-1<i>H</i>-imidazol-2-yl)-2-phenylethyl)cyclohexanecarboxamide, Bis-trifluoroacetic Acid Salt (<b>11b</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.02–1.12 (m, 2H), 1.30–1.46 (m, 2H), 1.53–1.61 (m, 1H), 1.80 (d, <i>J =</i> 12 Hz, 1H), 1.86 (d, <i>J =</i> 11 Hz, 3H), 2.23–2.32 (m, 1H), 2.64 (d, <i>J =</i> 9.4 Hz, 1H), 2.78 (d, <i>J =</i> 6.6 Hz, 2H), 3.32 (dd, <i>J</i> = 8.2 Hz, 1 H, overlap with C<u class="uu">H</u><sub>3</sub>OH), 3.38 (dd, <i>J =</i> 13, 8.2 Hz, 1H), 5.33 (t, <i>J =</i> 8.2 Hz, 1H), 7.19 (d, <i>J =</i> 6.6 Hz, 2H), 7.22–7.26 (m, 1H), 7.26–7.32 (m, 2H), 7.85 (s, 4H), 7.94 (s, 1H). HRMS calcd for C<sub>26</sub>H<sub>29</sub>N<sub>5</sub>O [M + H]<sup>+</sup> 428.2450, found 428.2443.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Methyl 4-(2-((<i>S</i>)-1-(<i>trans</i>-4-(Aminomethyl)cyclohexanecarboxamido)-2-phenylethyl)-1<i>H</i>-imidazol-4-yl)benzoate, Bis-trifluoroacetic Acid Salt (<b>11c</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.00–1.14 (m, 2H), 1.30–1.47 (m, 2H), 1.51–1.64 (m, 1H), 1.80 (d, <i>J =</i> 12 Hz, 1H), 1.86 (d, <i>J =</i> 12 Hz, 3H), 2.23–2.34 (m, 1H), 2.78 (d, <i>J =</i> 6.6 Hz, 2H), 3.32 (dd, <i>J</i> = 8.2 Hz, 1 H, overlap with C<u class="uu">H</u><sub>3</sub>OH), 3.39 (dd, <i>J =</i> 13, 8.2 Hz, 1H), 3.93 (s, 3H), 5.33 (t, <i>J =</i> 8.2 Hz, 1H), 7.19 (d, <i>J =</i> 7.2 Hz, 2H), 7.22–7.26 (m, 1H), 7.27–7.32 (m, 2H), 7.78 (d, <i>J =</i> 8.8 Hz, 2H), 7.90 (s, 1H), 8.12 (d, <i>J =</i> 8.8 Hz, 2H). HRMS calcd for C<sub>27</sub>H<sub>32</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 461.2553, found 461.2570.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Ethyl 2-(4-(2-((<i>S</i>)-1-(<i>trans</i>-4-(Aminomethyl)cyclohexanecarboxamido)-2-phenylethyl)-1<i>H</i>-imidazol-4-yl)phenyl)acetate, Bis-trifluoroacetic Acid Salt (<b>11d</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.01–1.13 (m, 2H), 1.24 (t, <i>J =</i> 7.1 Hz, 3H), 1.33–1.44 (m, 2H), 1.51–1.64 (m, 1H), 1.80 (d, <i>J =</i> 13 Hz, 1H), 1.86 (d, <i>J =</i> 11 Hz, 4H), 2.23–2.32 (m, 1H), 2.77 (d, <i>J =</i> 7.1 Hz, 2H), 3.32–3.38 (dd, 1H, overlap with C<u class="uu">H</u><sub>3</sub>OH), 3.38 (dd, <i>J =</i> 13, 8.2, 1H), 3.70 (s, 2H), 4.15 (q, <i>J =</i> 7.2 Hz, 2H), 5.31 (t, <i>J =</i> 8.5 Hz, 1H), 7.17 (d, <i>J =</i> 7.2 Hz, 2H), 7.21–7.26 (m, 1H), 7.27–7.32 (m, 2H), 7.41 (d, <i>J =</i> 8.2 Hz, 2H), 7.59 (d, <i>J =</i> 8.2 Hz, 2H), 7.74 (s, 1H). HRMS for calcd for C<sub>29</sub>H<sub>36</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 489.2866, found 489.2861.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>trans</i>-4-(Aminomethyl)-<i>N</i>-((<i>S</i>)-1-(4-(3-cyanophenyl)-1<i>H</i>-imidazol-2-yl)-2-phenylethyl)cyclohexanecarboxamide, Bis-trifluoroacetic Acid Salt (<b>11e</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 0.99–1.13 (m, 2H), 1.26–1.47 (m, 2H), 1.52–1.63 (m, 1H), 1.79 (d, <i>J =</i> 12 Hz, 1H), 1.85 (d, <i>J =</i> 12 Hz, 3H), 2.21–2.34 (m, 1H), 2.77 (d, <i>J =</i> 7.1 Hz, 2H), 3.32 (dd, <i>J</i> = 8.0 Hz, 1 H, overlap with C<u class="uu">H</u><sub>3</sub>OH), 3.38 (m, <i>J =</i> 13, 8.2 Hz, 1H), 5.34 (t, <i>J =</i> 8.2 Hz, 1H), 7.19 (d, <i>J =</i> 7.1 Hz, 2H), 7.22–7.26 (m, 1H), 7.27–7.32 (m, 2H), 7.68 (t, <i>J =</i> 8.0 Hz, 1H), 7.81 (d, <i>J =</i> 7.7 Hz, 1H), 7.91 (s, 1H), 7.97 (d, <i>J =</i> 7.7 Hz, 1H), 8.07 (s, 1H). <i>m</i>/<i>z</i> 428 [M + H]<sup>+</sup>.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Ethyl 2-(3-(2-((<i>S</i>)-1-(<i>trans</i>-4-(Aminomethyl)cyclohexanecarboxamido)-2-phenylethyl)-1<i>H</i>-imidazol-4-yl)phenyl)acetate, Bis-trifluoroacetic Acid Salt (<b>11f</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.02–1.12 (m, 2H), 1.25 (t, <i>J =</i> 7.2 Hz, 3H), 1.33–1.46 (m, 2H), 1.57 (m, 1H), 1.80 (d, <i>J =</i> 12 Hz, 1H), 1.86 (d, <i>J =</i> 12 Hz, 3H), 2.23–2.32 (m, 1H), 2.77 (d, 2H), 3.30 (dd, 1H, overlap with C<u class="uu">H</u><sub>3</sub>OH), 3.38 (dd, <i>J =</i> 13, 8.2 Hz,1H), 3.72 (s, 2H), 4.15 (q, <i>J =</i> 7.2 Hz, 2H), 5.31 (t, <i>J =</i> 8.2 Hz, 1H), 7.16–7.21 (m, 2H), 7.25 (d, <i>J =</i> 5.5 Hz, 1H), 7.26–7.32 (m, 2H), 7.37–7.41 (m, 1H), 7.46 (t, <i>J =</i> 7.7 Hz, 1H), 7.52–7.58 (m, 2H), 7.76 (s, 1H). <i>m</i>/<i>z</i> 489 [M + H]<sup>+</sup>.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>trans</i>-4-(Aminomethyl)-<i>N</i>-((<i>S</i>)-2-phenyl-1-(4-(4-sulfamoylphenyl)-1<i>H</i>-imidazol-2-yl)ethyl)cyclohexanecarboxamide, Bis-trifluoroacetic Acid Salt (<b>11g</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.00–1.12 (m, 2H), 1.30–1.47 (m, 2H), 1.51–1.63 (m, 1H), 1.79 (d, <i>J =</i> 12 Hz, 1H), 1.86 (d, <i>J =</i> 10 Hz, 3H), 2.21–2.33 (m, 1H), 2.77 (d, <i>J =</i> 7.2 Hz, 2H), 3.31 (dd, <i>J</i> = 8.25 Hz, 1H, overlap with C<u class="uu">H</u><sub>3</sub>OH), 3.38 (dd, <i>J</i> = 13, 8.2 Hz, 1H), 5.32 (t, <i>J =</i> 8.2 Hz, 1H), 7.19 (d, <i>J =</i> 7.2 Hz, 2H), 7.21–7.26 (m, 1H), 7.26–7.32 (m, 2H), 7.82 (d, <i>J =</i> 8.2 Hz, 2H), 7.89 (s, 1H), 7.99 (d, <i>J =</i> 8.8 Hz, 2H). <i>m</i>/<i>z</i> 482 [M + H]<sup>+</sup>.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>tert</i>-Butyl ((<i>trans</i>-4-(((<i>S</i>)-1-(4-(4-Carbamoylphenyl)-1<i>H</i>-imidazol-2-yl)-2-phenylethyl)carbamoyl)cyclohexyl)methyl)carbamate (<b>10h</b>)</h3><div class="NLM_p last"><b>10b</b> (117 mg, 0. 22 mmol) was dissolved in DMSO (2 mL) and treated with K<sub>2</sub>CO<sub>3</sub> (90.0 mg, 0.65 mmol) under Ar. 30% aq H<sub>2</sub>O<sub>2</sub> (0.8 mL, 2.4 mmol) and MgO (44 mg, 1.11 mmol) were added sequentially. The reaction mixture was stirred at rt for 4 h. The reaction mixture was diluted with EtOAc, washed with 1 N aq HCl and brine, dried over MgSO<sub>4</sub>, filtered, and evaporated to dryness in vacuo to provide <b>10h</b> (109 mg, 90%) as a yellow solid. <b>10h</b> was carried onto the next step without purification. <i>m</i>/<i>z</i> 546 [M + H]<sup>+</sup>.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 4-(2-((<i>S</i>)-1-(<i>trans</i>-4-(Aminomethyl)cyclohexanecarboxamido)-2-phenylethyl)-1<i>H</i>-imidazol-4-yl)benzamide, Bis-trifluoroacetic Acid Salt (<b>11h</b>)</h3><div class="NLM_p last"><b>10h</b> was treated with TFA according to the procedure described for the conversion of compound <b>10a</b> to <b>11a</b> to provide <b>11h</b> (17.3 mg, 20%). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.00–1.13 (m, 2H), 1.30–1.47 (m, 2H), 1.52–1.63 (m, 1H), 1.80 (d, <i>J =</i> 12 Hz, 1H), 1.86 (d, <i>J =</i> 11 Hz, 3H), 2.28 (t, <i>J =</i> 12 Hz, 1H), 2.77 (d, <i>J =</i> 6.6 Hz, 2H), 3.31 (dd, <i>J</i> = 8.8 Hz, 1H, overlap with C<u class="uu">H</u><sub>3</sub>OH), 3.38 (dd, <i>J =</i> 13, 8.2 Hz, 1H), 5.33 (t, <i>J =</i> 8.2 Hz, 1H), 7.19 (d, <i>J =</i> 7.2 Hz, 2H), 7.21–7.26 (m, 1H), 7.26–7.32 (m, 2H), 7.76 (d, <i>J =</i> 8.8 Hz, 2H), 7.88 (s, 1H), 7.99 (d, <i>J =</i> 8.2 Hz, 2H). HRMS calcd for C<sub>26</sub>H<sub>30</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup> 446.2556, found 446.2561.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>tert</i>-Butyl ((<i>trans</i>-4-(((<i>S</i>)-1-(5-Bromo-4-(4-carbamoylphenyl)-1<i>H</i>-imidazol-2-yl)-2-phenylethyl)carbamoyl)cyclohexyl)methyl)carbamate (<b>10i</b>)</h3><div class="NLM_p last">To a solution of <b>10h</b> (70 mg, 0.13 mmol) in CHCl<sub>3</sub> (10 mL) was added bromine (21 mg, 0.13 mmol). The reaction mixture was stirred at rt for 16 h. The reaction mixture was evaporated to dryness in vacuo to yield <b>10i</b> (93 mg, 100%), which was carried onto the next step without purification. <i>m</i>/<i>z</i> 622/624 (1:1) [M – H]<sup>−</sup>.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 4-(2-((<i>S</i>)-1-(<i>trans</i>-4-(Aminomethyl)cyclohexanecarboxamido)-2-phenylethyl)-5-bromo-1<i>H</i>-imidazol-4-yl)benzamide, Bis-trifluoroacetic Acid Salt (<b>11i</b>)</h3><div class="NLM_p last"><b>10i</b> was converted to <b>11i</b> (35.8 mg, 36%) using the method described for the conversion of compound <b>10a</b> to <b>11a</b>. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 0.99–1.11 (m, 2H), 1.29–1.48 (m, 2H), 1.55–1.63 (m, 1H), 1.75 (d, 1H), 1.85 (d, <i>J =</i> 9.9 Hz, 3H), 2.16–2.27 (m, 1H), 2.77 (d, <i>J =</i> 6.6 Hz, 2H), 3.17 (dd, <i>J =</i> 13, 8.2 Hz, 1H), 3.25 (dd, <i>J</i> = 13, 7.7 Hz, 1H), 3.98 (s, 1H), 5.22 (t, <i>J =</i> 7.7 Hz, 1H), 7.17 (d, <i>J =</i> 7.2 Hz, 2H), 7.20 (d, <i>J =</i> 7.2 Hz, 1H), 7.23–7.28 (m, 2H), 7.75 (d, <i>J =</i> 8.2 Hz, 2H), 7.94 (d, <i>J =</i> 8.2 Hz, 2H). HRMS calcd for C<sub>26</sub>H<sub>30</sub>BrN<sub>5</sub>O<sub>2</sub> 524.1661 [M + H]<sup>+</sup>, found 524.1653.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 4-(2-((<i>S</i>)-1-(<i>trans</i>-4-(Aminomethyl)cyclohexanecarboxamido)-2-phenylethyl)-5-chloro-1<i>H</i>-imidazol-4-yl)benzamide, Bis-trifluoroacetic Acid Salt (<b>11j</b>)</h3><div class="NLM_p last"><b>9b</b> was converted to <b>11j</b> by sequentially applying the procedures used to convert <b>10b</b> to <b>10h</b>, <b>14a</b> to <b>14b</b>, and <b>9a</b> to <b>11a</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 0.94–1.13 (m, 2H), 1.30–1.49 (m, 2H), 1.51–1.64 (m, 1H), 1.75 (d, <i>J =</i> 13 Hz, 1H), 1.86 (d, <i>J =</i> 11 Hz, 3H), 2.16–2.27 (m, 1H), 2.77 (d, <i>J =</i> 7.0 Hz, 2H), 3.14 (dd, <i>J =</i> 13, 7.2 Hz, 1H), 3.24 (dd, <i>J =</i> 13, 7.5 Hz, 1H), 5.21 (t, <i>J =</i> 7.9 Hz, 1H), 7.14–7.22 (m, 3H), 7.22–7.29 (m, 2H), 7.74 (d, <i>J =</i> 8.8 Hz, 2H), 7.93 (d, <i>J =</i> 8.8 Hz, 2H). <i>m</i>/<i>z</i> 480 [M + H]<sup>+</sup>.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 4-(2-((<i>S</i>)-1-(<i>trans</i>-4-(Aminomethyl)cyclohexanecarboxamido)-2-phenylethyl)-5-fluoro-1<i>H</i>-imidazol-4-yl)benzamide, Bis-trifluoroacetic Acid Salt (<b>11k</b>)</h3><div class="NLM_p last"><b>10h</b> was converted to <b>11k</b> by sequential application of the methods descibed for the conversion of <b>14a</b> to <b>14c</b> and <b>10a</b> to <b>11a</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.90 (d, <i>J</i> = 8.2 Hz, 2H), 7.58 (d, <i>J</i> = 8.2 Hz, 2H), 7.27–7.20 (m, 2H), 7.20–7.14 (m, 3H), 5.17 (t, <i>J</i> = 7.7 Hz, 1H), 3.20 (dd, <i>J</i> = 13.2, 7.7 Hz, 1H), 3.12 (dd, <i>J</i> = 13.2, 7.7 Hz, 1H), 2.77 (d, <i>J</i> = 7.1 Hz, 2H), 2.26–2.16 (m, 1H), 1.89–1.80 (m, 3H), 1.78–1.70 (m, 1H), 1.64–1.51 (m, 1H), 1.49–1.29 (m, 2H), 1.12–0.98 (m, 2H). <sup>19</sup>F NMR (376 MHz, CD<sub>3</sub>OD) δ −77.47 (s), −133.62 (s). <i>m</i>/<i>z</i> 464 [M + H]<sup>+</sup>.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 4-(2-((<i>S</i>)-1-(<i>trans</i>-4-((<i>tert</i>-Butoxycarbonylamino)methyl)cyclohexanecarboxamido)-2-phenylethyl)-1<i>H</i>-imidazol-4-yl)benzoic Acid (<b>10l</b>)</h3><div class="NLM_p last">To a solution of <b>10c</b> (162 mg, 0.28 mmol) in CH<sub>3</sub>OH (5 mL) and EtOAc (1 mL) were added 1 N aq NaOH (2 mL) and MgO (112 mg, 2.8 mmol). The reaction mixture was stirred for 5 h at rt. The solvent was evaporated to dryness in vacuo. The residue was diluted with water and treated with 1 N aq HCl. The aqueous solution was diluted with EtOAc, washed with brine, dried over MgSO<sub>4</sub>, filtered, and evaporated in vacuo to yield <b>10l</b> (75 mg, 60%), which was carried onto the next step without purification. <i>m</i>/<i>z</i> 548 [M + H]<sup>+</sup>.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 4-(2-((<i>S</i>)-1-(<i>trans</i>-4-(Aminomethyl)cyclohexanecarboxamido)-2-phenylethyl)-1<i>H</i>-imidazol-4-yl)benzoic Acid, Bis-trifluoroacetic Acid Salt (<b>11l</b>)</h3><div class="NLM_p last"><b>10l</b> was treated according to the method described for compound the conversion of compound <b>10a</b> to <b>11a</b> to provide <b>11l</b> (34 mg, 18%). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.02–1.11 (m, 2H), 1.32–1.46 (m, 2H), 1.53–1.62 (m, 1H), 1.80 (d, <i>J</i> = 12 Hz, 1H), 1.86 (d, <i>J</i> = 12 Hz, 3H), 2.28 (tt, <i>J</i> = 12, 3.3 Hz, 1H), 2.77 (d, <i>J</i> = 7.1 Hz, 2H), 3.33 (d, <i>J</i> = 8.2 Hz, 1 H, overlap with C<u class="uu">H</u><sub>3</sub>OH), 3.39 (dd, <i>J</i> = 13, 8.2 Hz, 1H), 5.33 (t, <i>J</i> = 8.2 Hz, 1H), 7.19 (d, <i>J</i> = 7.1 Hz, 2H), 7.24 (t, <i>J</i> = 7.1 Hz, 1H), 7.29 (t, <i>J</i> = 7.1 Hz, 2H), 7.76 (d, <i>J</i> = 8.2 Hz, 2H), 7.89 (s, 1H), 8.12 (d, <i>J</i> = 8.8 Hz, 2H). HRMS calcd for C<sub>26</sub>H<sub>29</sub>N<sub>4</sub>O<sub>3</sub> 447.2396 [M + H]<sup>+</sup>, found 447.2397.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>tert</i>-Butyl ((<i>trans</i>-4-(((<i>S</i>)-1-(4-(4-(Methylcarbamoyl)phenyl)-1<i>H</i>-imidazol-2-yl)-2-phenylethyl)carbamoyl)cyclohexyl)methyl)carbamate (<b>10m</b>)</h3><div class="NLM_p last"><b>10l</b> (45 mg, 0.08 mmol) and methylamine (0.2 mL, 0.09 mmol) were converted to <b>10m</b> (44.0. mg, 93%) using the alternative procedure described for conversion of <b>I-2</b> to <b>10a</b>. <b>10m</b> was carried to the next step without purification. <i>m</i>/<i>z</i> 560 [M + H]<sup>+</sup>.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 4-(2-((<i>S</i>)-1-(<i>trans</i>-4-(Aminomethyl)cyclohexanecarboxamido)-2-phenylethyl)-1<i>H</i>-imidazol-4-yl)-<i>N</i>-methylbenzamide, Bis-trifluoroacetic Acid Salt (<b>11m</b>)</h3><div class="NLM_p last"><b>10m</b> was converted to <b>11m</b> (1.0 mg, 3%) according to the method for the conversion of <b>10a</b> to <b>11a</b>. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.02–1.11 (m, 1H), 1.32–1.46 (m, 1H), 1.53–1.62 (m, 1H), 1.79 (d, <i>J =</i> 13 Hz, 1H), 1.86 (d, <i>J</i> = 11 Hz, 1H), 2.30–2.65 (m, 1H), 2.77 (d, <i>J</i> = 7.2 Hz, 1H), 2.92 (s, 3H), 3.38 (dd, <i>J =</i> 13, 8.2 Hz, 2H, overlap with C<u class="uu">H</u><sub>3</sub>OH), 5.29 (t, <i>J =</i> 8.2 Hz, 1H), 7.16 (d, <i>J =</i> 7.2 Hz, 1H), 7.23 (t, <i>J =</i> 7.2 Hz, 1H), 7.28 (t, <i>J</i> = 7.2 Hz, 1H), 7.72 (d, <i>J</i> = 8.2 Hz, 1H), 7.86 (s, 1H), 7.92 (d, <i>J</i> = 8.8 Hz, 1H). HRMS calcd for C<sub>27</sub>H<sub>32</sub>N<sub>5</sub>O<sub>2</sub> 460.2713 [M + H]<sup>+</sup>, found 460.2735.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 4-(2-((<i>S</i>)-1-(<i>trans</i>-4-(Aminomethyl)cyclohexanecarboxamido)-2-phenylethyl)-1<i>H</i>-imidazol-4-yl)-<i>N</i>,<i>N</i>-dimethylbenzamide, Bis-trifluoroacetic Acid Salt (<b>11n</b>)</h3><div class="NLM_p last"><b>11n</b> was prepared from <b>10l</b> according to the method for <b>11m</b> from <b>10l</b> by substituting dimethylamine for methylamine. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.03–1.11 (m, 2H), 1.32–1.46 (m, 2H), 1.54–1.61 (m, 1H), 1.81 (d, <i>J</i> = 15 Hz, 1H), 1.86 (d, <i>J</i> = 10 Hz, 3H), 2.28 (tt, <i>J</i> = 12, 3.3 Hz, 1H), 2.77 (d, <i>J</i> = 7.1 Hz, 2H), 3.01 (s, 3H), 3.12 (s, 3H), 3.31 (dd, 1 H, overlap with C<u class="uu">H</u><sub>3</sub>OH), 3.39 (dd, <i>J</i> = 13, 8.2 Hz, 1H), 5.31 (t, <i>J</i> = 8.2 Hz, 1H), 7.18 (d, <i>J</i> = 7.2 Hz, 2H), 7.24 (t, <i>J</i> = 7.2 Hz, 1H), 7.29 (t, <i>J</i> = 7.4 Hz, 2H), 7.55 (d, <i>J</i> = 8.2 Hz, 2H), 7.72 (d, <i>J</i> = 8.2 Hz, 2H), 7.85 (s, 1H) ppm. HRMS calcd for C<sub>28</sub>H<sub>34</sub>N<sub>5</sub>O<sub>2</sub> 474.2870 [M + H]<sup>+</sup>, found 474.2875.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 2-(4-(2-((<i>S</i>)-1-(<i>trans</i>-4-((<i>tert</i>-Butoxycarbonylamino)methyl)cyclohexanecarboxamido)-2-phenylethyl)-1<i>H</i>-imidazol-4-yl)phenyl)acetic Acid (<b>10o</b>)</h3><div class="NLM_p last"><b>10d</b> (200 mg, 0.34 mmol) was dissolved in CH<sub>3</sub>OH (3 mL) and treated with 1 N aq NaOH (0.34 mL, 0.34 mmol). The reaction mixture was stirred at rt for 16 h. The solvent was removed in vacuo. The residue purified by preperative HPLC to provide <b>10o</b> (90 mg, 47%). <i>m</i>/<i>z</i> 561 [M + H]<sup>+</sup>.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 2-(4-(2-((<i>S</i>)-1-(<i>trans</i>-4-(Aminomethyl)cyclohexanecarboxamido)-2-phenylethyl)-1<i>H</i>-imidazol-4-yl)phenyl)acetic Acid, Bis-trifluoroacetic Acid Salt (<b>11o</b>)</h3><div class="NLM_p last"><b>10o</b> was treated according to the method described for conversion of <b>10a</b> to <b>11a</b> to provide <b>11o</b> (15 mg, 81%). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 0.99–1.13 (m, 2H), 1.52–1.63 (m, 1H), 1.80 (d, <i>J =</i> 12 Hz, 1H), 1.86 (d, <i>J =</i> 10 Hz, 3H), 2.22–2.33 (m, 1H), 2.77 (d, <i>J =</i> 7.2 Hz, 2H), 3.31 (dd, 1 H, overlap with C<u class="uu">H</u><sub>3</sub>OH), 3.38 (dd, <i>J</i> = 13, 8.2 Hz, 1H), 3.67 (s, 2H), 5.31 (t, <i>J =</i> 8.2 Hz, 1H), 7.18 (d, <i>J =</i> 6.6 Hz, 2H), 7.21–7.26 (m, 1H), 7.26–7.32 (m, 2H), 7.42 (d, <i>J =</i> 8.2 Hz, 2H), 7.59 (d, <i>J =</i> 8.2 Hz, 2H), 7.74 (s, 1H). HRMS calcd for C<sub>27</sub>H<sub>32</sub>N<sub>4</sub>O<sub>3</sub> 461.2553 [M + H]<sup>+</sup>, found 461.2572.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> <i>tert</i>-Butyl (<i>trans</i>-4-(((<i>S</i>)-1-(4-(4-(2-Amino-2-oxoethyl)phenyl)-1<i>H</i>-imidazol-2-yl)-2-phenylethyl)carbamoyl)cyclohexyl)carbamate (<b>10p</b>)</h3><div class="NLM_p last">To a solution of <b>10o</b> (33 mg, 0.060 mmol) and HOAt (9.7 mg, 0.071 mmol) in DMF (1 mL) were added sequentially <i>N</i>-methylmorpholine (18.2 mg, 0.18 mmol) and EDC (13.6 mg, 0.071 mmol). The reaction mixture was stirred for 30 min at rt. Concentrated aq NH<sub>3</sub> (5 drops from a Pasteur pipet) was added, and the reaction mixture was stirred at rt for 16 h. The mixture was diluted with EtOAc and washed with a 1:1 mixture of H<sub>2</sub>O and brine, 1 N aq HCl, and brine, dried over MgSO<sub>4</sub>, filtered, and dried in vacuo. The product was isolated by preparative HPLC to provide <b>10p</b> (9 mg, 22%). <i>m</i>/<i>z</i> 560 [M + H]<sup>+</sup>.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> <i>trans</i>-<i>N</i>-((<i>S</i>)-1-(4-(4-(2-Amino-2-oxoethyl)phenyl)-1<i>H</i>-imidazol-2-yl)-2-phenylethyl)-4-(aminomethyl)cyclohexanecarboxamide, Bis-trifluoroacetic Acid Salt (<b>11p</b>)</h3><div class="NLM_p last"><b>10p</b> (9 mg, 0.016 mmol) was converted to <b>11p</b> (11 mg, 99%) according the method described for the conversion of compound <b>10a</b> to <b>11a</b>. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.02–1.11 (m, 2H), 1.32–1.44 (m, 2H), 1.53–1.61 (m, 1H), 1.79 (d, <i>J</i> = 13 Hz, 1H), 1.85 (d, <i>J</i> = 11 Hz, 3H), 2.28 (tt, <i>J</i> = 3.0, 12 Hz, 1H), 2.77 (d, <i>J</i> = 7.2 Hz, 2H), 3.31 (dd, 1 H, overlap with C<u class="uu">H</u><sub>3</sub>OH), 3.38 (dd, <i>J</i> = 13, 8.0 Hz, 1H), 3.57 (s, 2H), 5.31 (t, <i>J</i> = 8.2 Hz, 1H), 7.17 (d, <i>J</i> = 7.2 Hz, 2H), 7.22–7.25 (m, 1H), 7.27–7.30 (m, 2H), 7.43 (d, <i>J</i> = 8.2 Hz, 2H), 7.59 (d, <i>J</i> = 8.2 Hz, 2H), 7.74 (s, 1H). HRMS calcd for C<sub>27</sub>H<sub>33</sub>N<sub>5</sub>O<sub>2</sub> 460.2713 [M + H]<sup>+</sup>, found 460.2714.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 3-(2-((<i>S</i>)-1-(<i>trans</i>-4-(Aminomethyl)cyclohexanecarboxamido)-2-phenylethyl)-1<i>H</i>-imidazol-4-yl)benzamide, Bis-trifluoroacetic Acid Salt (<b>11q</b>)</h3><div class="NLM_p last"><b>11q</b> was prepared from <b>10e</b> according to the method used for conversion of <b>10b</b> to <b>11h</b>. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.00–1.13 (m, 2H), 1.30–1.47 (m, 2H), 1.52–1.64 (m, 1H), 1.80 (d, <i>J =</i> 12 Hz, 1H), 1.86 (d, <i>J =</i> 12 Hz, 3H), 2.28 (t, <i>J =</i> 12 Hz, 1H), 2.77 (d, <i>J =</i> 7.2 Hz, 2H), 3.32 (dd, <i>J</i> = 8.2 Hz, overlap with C<u class="uu">H</u><sub>3</sub>OH), 3.39 (dd, J = 13, 8.2 Hz, 1H), 5.34 (t, <i>J =</i> 8.2 Hz, 1H), 7.19 (d, <i>J =</i> 6.6 Hz, 2H), 7.22–7.26 (m, 1H), 7.27–7.32 (m, 2H), 7.60 (t, <i>J =</i> 7.7 Hz, 1H), 7.83 (s, 1H), 7.93 (d, <i>J =</i> 8.2 Hz, 1H), 8.18 (s, 1H). HRMS calcd for C<sub>26</sub>H<sub>31</sub>N<sub>5</sub>O<sub>2</sub> 446.2556 [M + H]<sup>+</sup>, found 446.2535.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 2-(3-(2-((<i>S</i>)-1-(<i>trans</i>-4-(Aminomethyl)cyclohexanecarboxamido)-2-phenylethyl)-1<i>H</i>-imidazol-4-yl)phenyl)acetic Acid, Bis-trifluoroacetic Acid Salt (<b>11r</b>)</h3><div class="NLM_p last"><b>11r</b> was synthesized from <b>10f</b> using the methods for the conversion of <b>10d</b> to <b>11o</b>. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.01–1.13 (m, 2H), 1.29–1.47 (m, 2H), 1.52–1.63 (m, 1H), 1.80 (d, <i>J =</i> 12 Hz, 1H), 1.86 (d, <i>J =</i> 10 Hz, 4H), 2.23–2.32 (m, <i>J =</i> 12, 12, 3.1, 3.0 Hz, 1H), 2.77 (d, <i>J =</i> 7.2 Hz, 2H), 3.31 (dd, 1H, overlap with C<u class="uu">H</u><sub>3</sub>OH), 3.38 (dd, <i>J</i> = 13, 8.2 Hz, 1H), 5.31 (t, <i>J =</i> 8.2 Hz, 1H), 7.18 (d, <i>J =</i> 7.2 Hz, 2H), 7.22–7.27 (m, 1H), 7.27–7.32 (m, 2H), 7.39 (d, <i>J =</i> 7.7 Hz, 1H), 7.45 (t, <i>J =</i> 7.7 Hz, 1H), 7.53 (d, <i>J =</i> 7.7 Hz, 1H), 7.56 (s, 1H), 7.76 (s, 1H). <i>m</i>/<i>z</i> 461 [M + H]<sup>+</sup>.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> <i>trans</i>-<i>N</i>-((<i>S</i>)-1-(4-(3-(2-Amino-2-oxoethyl)phenyl)-1<i>H</i>-imidazol-2-yl)-2-phenylethyl)-4-(aminomethyl)cyclohexanecarboxamide, Bis-trifluoroacetic Acid Salt (<b>11s</b>)</h3><div class="NLM_p last"><b>11s</b> was synthesized from <b>10f</b> using the methods for the conversion of <b>10d</b> to <b>11p</b>. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 0.99–1.13 (m, 2H), 1.29–1.48 (m, 2H), 1.53–1.62 (m, 1H), 1.80 (d, 1H), 1.86 (d, <i>J =</i> 10 Hz, 3H), 2.21–2.33 (m, 1H), 2.77 (d, <i>J =</i> 7.2 Hz, 2H), 3.33 (dd, 1H, overlap with C<u class="uu">H</u><sub>3</sub>OH), 3.38 (dd, <i>J</i> = 13, 8.2 Hz, 1H), 3.59 (s, 2H), 5.32 (t, <i>J =</i> 8.2 Hz, 1H), 7.18 (d, <i>J =</i> 7.15 Hz, 2H), 7.22–7.26 (m, 1H), 7.26–7.32 (m, 2H), 7.37–7.41 (m, 1H), 7.45 (t, <i>J =</i> 7.7 Hz, 1H), 7.52 (d, 1H), 7.57 (s, 1H), 7.75 (s, 1H). <i>m</i>/<i>z</i> 460 [M + H]<sup>+</sup>.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 4-(2-Bromoacetyl)-2-fluorobenzonitrile (<b>13</b>)</h3><div class="NLM_p last">4-Bromo-3-fluorobenzoic acid (<b>12</b>) (7.5 g, 34 mmol), Zn(CN)<sub>2</sub> (4.0 g, 34 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (3.95 g, 34 mmol) were combined in 60 mL of DMF that had been sparged with N<sub>2</sub>. The reaction mixture was heated at 90 °C under N<sub>2</sub> for 3 h. The mixture was cooled to rt and filtered. The filtrate was diluted with water and extracted with EtOAc. The combined organic layers were washed with H<sub>2</sub>O, brine, dried over MgSO<sub>4</sub>, and concentrated in vacuo to yield 4-cyano-3-fluorobenzoic acid (<b>I-3</b>) (4.0 g, 20 mmol). To a solution of <b>I-3</b> in CH<sub>2</sub>Cl<sub>2</sub> (50 mL) was added oxalyl chloride (2.3 mL, 26 mmol) dropwise over 15 min. The reaction mixture was stirred at rt for 1 h, then heated at reflux for 1 h under N<sub>2</sub>. The solvent was removed and the residue dissolved in CH<sub>3</sub>CN (50 mL). This solution was cooled to −15 °C. TMSCH<sub>2</sub>N<sub>2</sub> (2.0 M in hexane; 11 mL, 22 mmol) was added dropwise over 20 min. The reaction mixture was stirred at −15 °C for 1 h under N<sub>2</sub>. A solution of HBr in HOAc (33% by mass; 4.25 mL) was added dropwise over 20 min, and the reaction mixture was stirred at −15 °C for an additional 20 min. The solvent was removed, and the residue dissolved in EtOAc, washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated to provide <b>13</b> (3.2 g, 39% yield over two steps), which was used in the next step without purification. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 2.42 (s, 2H), 7.76–7.85 (m, 3H). <i>m</i>/<i>z</i> 240, 242 (1:1) [M + H]<sup>+</sup>.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (<i>S</i>)-<i>tert</i>-Butyl 1-(4-(4-Cyano-3-fluorophenyl)-1<i>H</i>-imidazol-2-yl)-2-phenylethylcarbamate (<b>14a</b>)</h3><div class="NLM_p last">To a solution of <b>13</b> (3.2 g, 13 mmol) and <b>7</b> (3.5 g, 13 mmol) in DMF (20 mL) was added Cs<sub>2</sub>CO<sub>3</sub> (2.6 g, 8 mmol). The reaction mixture was stirred at 15 °C for 1 h under N<sub>2</sub>. The mixture was diluted with 100 mL of EtOAc, washed with H<sub>2</sub>O, brine, dried over MgSO<sub>4</sub>, concentrated in vacuo, and purified by flash chromatography (240 g silica, 10–55% EtOAc in hexane) to yield (<i>S</i>)-2-(4-cyano-3-fluorophenyl)-2-oxoethyl 2-(<i>tert</i>-butoxycarbonylamino)-3-phenylpropanoate (<b>I-4</b>) (3.5 g, 63%). <i>m</i>/<i>z</i> 425 [H + H<sup>+</sup>]<sup>+</sup>. <b>I-4</b> was combined with NH<sub>4</sub>OAc (12 g, 155 mmol) and suspended in xylenes (100 mL). The mixture was heated under N<sub>2</sub> at 150 °C for 2.5 h in a flask equipped with a Dean–Stark trap. The xylenes were removed in vacuo. The residue was dissolved in EtOAc, washed with H<sub>2</sub>O and brine, dried over MgSO<sub>4</sub>, concentrated in vacuo, and purified by flash chromatography (240 g silica, 15–70% EtOAc in hexane) to give <b>14a</b> (2.2 g, 41%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.39 (s, 9H), 3.30 (m, 2H), 4.86 (d, <i>J</i> = 6.6 Hz, 1H), 5.32 (d, <i>J</i> = 7.5 Hz, 1H), 7.14–7.24 (m, 6H), 7.53–7.61 (m, 3H). <i>m</i>/<i>z</i> 407 [M + H]<sup>+</sup>.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> (<i>S</i>)-<i>tert</i>-Butyl (1-(5-Chloro-4-(4-cyano-3-fluorophenyl)-1<i>H</i>-imidazol-2-yl)-2-phenylethyl)carbamate (<b>14b</b>)</h3><div class="NLM_p last">To a solution of <b>14a</b> (2.2 g, 5.4 mmol) in CH<sub>3</sub>CN (100 mL) was added NCS (0.80 g, 6.7 mmol). The reaction mixture was heated at reflux for 7 h under N<sub>2</sub>. The solvent was removed in vacuo. The residue was dissolved in EtOAc, washed with H<sub>2</sub>O, saturated aq NaHCO<sub>3</sub>, and brine, dried over MgSO<sub>4</sub>, and concentrated in vacuo to give <b>14b</b> (2.4 g, 99%). <b>14b</b> was used without purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.27 (s, 9H), 3.23 (m, 2H), 4.89 (m, 1H), 5.46 (d, <i>J</i> = 7.0 Hz, 1H), 7.07 (d, <i>J</i> = 6.2 Hz, 2H), 7.25–7.26 (m, 5H), 7.54 (m, 1H). <i>m</i>/<i>z</i> 441 [M + H]<sup>+</sup>.</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> (<i>S</i>)-<i>tert</i>-Butyl 1-(4-(4-Cyano-3-fluorophenyl)-5-fluoro-1<i>H</i>-imidazol-2-yl)-2-phenylethylcarbamate (<b>14c</b>)</h3><div class="NLM_p last">To a solution of <b>14a</b> (406 mg, 1 mmol) in DMF (10 mL) and H<sub>2</sub>O (1 mL) was added Selecfluor (390 mg, 1.1 mmol). The reaction mixture was stirred at rt for 2 h, then diluted with H<sub>2</sub>O and extracted with EtOAc. The combined organic extracts were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated in vacuo. Purification by silica gel chromatography (40 g silica gel; EtOAc in hexanes) provided <b>14c</b> (113 mg, 27%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.37 (s, 9H), 3.10–3.30 (m, 2H), 4.81–4.89 (m, 1H), 5.42 (d, <i>J</i> = 7.1 Hz, 1H), 6.90–7.00 (m, 2H), 7.08 (m, 2H), 7.21–7.27 (m, 3H), 7.45–7.52 (m, 1H), 11.01 (s, 1H). <i>m</i>/<i>z</i> 425 [M + H]<sup>+</sup>.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> (<i>S</i>)-4-(2-(1-Amino-2-phenylethyl)-5-chloro-1<i>H</i>-imidazol-4-yl)-2-fluorobenzonitrile, Bis-trifluoroacetic Acid Salt (<b>I-5</b>)</h3><div class="NLM_p last"><b>14b</b> (0.20 g, 0.45 mmol) was stirred with CH<sub>2</sub>Cl<sub>2</sub> (6 mL) and TFA (1.5 mL) under N<sub>2</sub> for 0.5 h. The solvent and TFA were removed in vacuo to give <b>I-5</b> (0.26 g, 99%). <b>I-5</b> was used without purification. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 3.33 (m, 2H), 4.56 (dd, <i>J</i> = 8.6, 6.4 Hz, 1H), 7.12 (d, <i>J</i> = 6.6 Hz, 2H), 7.25–7.30 (m, 3H), 7.67 (m, 2H), 7.81 (m, 1H). <i>m</i>/<i>z</i> 341 [M + H]<sup>+</sup>.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> <i>tert</i>-Butyl (<i>trans</i>-4-(((<i>S</i>)-1-(5-Chloro-4-(4-cyano-3-fluorophenyl)-1<i>H</i>-imidazol-2-yl)-2-phenylethyl)carbamoyl)cyclohexyl)carbamate (<b>I-6</b>)</h3><div class="NLM_p last"><i>N-</i>Boc-tranexamic acid (0.14 g, 0.54 mmol), BOP reagent (0.24 g, 0.54 mmol), and TEA (0.38 mL, 2.7 mmol) were combined in THF (10 mL). The reaction mixture was stirred at rt for 15 min under N<sub>2,</sub> followed by the addition of <b>I-5</b> (0.26 g, 0.45 mmol). The resulting mixture was heated at 75 °C for 15 min under N<sub>2</sub>. The mixture was cooled to rt and the solvent removed in vacuo. The residue was dissolved in EtOAc. The solution was washed with H<sub>2</sub>O and brine, dried over MgSO<sub>4</sub>, concentrated in vacuo, and purified by flash chromatography (40 g silica, 10–100% EtOAc in hexane) to give intermediate <b>I-6</b> (0.21 g, 67%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 0.94 (m, 2H), 1.25–1.37 (m, 4H), 1.42 (s, 9H), 1.76–1.79 (m, 3H), 2.15 (m, 1H), 2.85 (m, 2H), 3.20–3.30 (m, 2H), 5.17 (m, 1H), 7.16–7.23 (m, 5H), 7.67–7.80 (m, 3H). <i>m</i>/<i>z</i> 580 [M + H]<sup>+</sup>.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> <i>trans</i>-4-(Aminomethyl)-<i>N</i>-((<i>S</i>)-1-(5-chloro-4-(4-cyano-3-fluorophenyl)-1<i>H</i>-imidazol-2-yl)-2-phenylethyl)cyclohexanecarboxamide, Bis-trifluoroacetic Acid Salt (<b>15b</b>)</h3><div class="NLM_p last"><b>I-6</b> (0.21 g, 0.36 mmol) was stirred with CH<sub>2</sub>Cl<sub>2</sub> (8 mL) and TFA (2 mL) under N<sub>2</sub> for 0.5 h. The solvent and TFA were removed in vacuo to give <b>15b</b> (0.25 g, >100%). <b>15b</b> was carried onto the next step without purification. <i>m</i>/<i>z</i> 480 [M + H]<sup>+</sup>.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> <i>trans</i>-<i>N</i>-((<i>S</i>)-1-(4-(3-Amino-1<i>H</i>-indazol-6-yl)-5-chloro-1<i>H</i>-imidazol-2-yl)-2-phenylethyl)-4-(aminomethyl)cyclohexanecarboxamide, Bis-trifluoroacetic Acid Salt (<b>16b-2TFA</b>)</h3><div class="NLM_p last"><b>15b</b> (0.21 g, 0.36 mmol) and hydrazine monohydrate (0.69 mL) were combined in <i>n</i>-BuOH (8 mL). The reaction mixture was heated at 120 °C under N<sub>2</sub> for 1 h. The solvent was removed in vacuo and the product was purified by preperative HPLC to give <b>16b-2TFA</b> (0.14 g, 54%). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 0.98–1.12 (m, 2H), 1.30–1.49 (m, 2H), 1.53–1.63 (m, 1H), 1.75 (d, <i>J =</i> 12 Hz, 1H), 1.85 (d, <i>J =</i> 12 Hz, 3H), 2.18–2.27 (m, 1H), 2.77 (d, <i>J =</i> 7.2 Hz, 2H), 3.16 (dd, <i>J</i> = 13, 7.7 Hz, 1H), 3.25 (dd, <i>J</i> = 13, 7.7 Hz, 1H), 5.21 (t, <i>J =</i> 8.0 Hz, 1H), 7.15–7.21 (m, 3H), 7.23–7.28 (m, 2H), 7.53 (dd, <i>J =</i> 8.5, 1.4 Hz, 1H), 7.71 (s, 1H), 7.98 (d, <i>J =</i> 8.8 Hz, 1H). HRMS calcd for C<sub>26</sub>H<sub>30</sub>ClN<sub>7</sub>O 491.2200 [M + H]<sup>+</sup>, found 492.2283.</div></div><div id="sec4_46_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Alternative Synthesis of Compound <b>16b</b> Leading to the Bis-hydrochloric Acid Salt. <i>tert</i>-Butyl (<i>trans</i>-4-((<i>S</i>)-1-(4-(3-Amino-1<i>H</i>-indazol-6-yl)-5-chloro-1<i>H</i>-imidazol-2-yl)-2-phenylethylcarbamoyl)cyclohexyl)methylcarbamate (<b>I-7</b>)</h3><div class="NLM_p last">To a slurrry of <b>I-6</b> (4.4 g, 7.8 mmol) in <i>n</i>-BuOH (45 mL) was added hydrazine (14.5 mL, 462 mmol). The reaction mixture was heated to 120 °C under Ar for 1 h. The solvent and excess hydrazine were removed in vacuo. The solids were washed with Et<sub>2</sub>O, collected by filtration, and rinsed with additional Et<sub>2</sub>O and then dried in vacuo to provide <b>I-7</b> (4.57 g, 99%). <b>I-7</b> was carried onto the next step without purification. <i>m</i>/<i>z</i> 592 [M + H]<sup>+</sup>.</div></div><div id="sec4_46_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> <i>trans</i>-<i>N</i>-((<i>S</i>)-1-(4-(3-Amino-1<i>H</i>-indazol-6-yl)-5-chloro-1<i>H</i>-imidazol-2-yl)-2-phenylethyl)-4-(aminomethyl)cyclohexanecarboxamide, Bis-hydrochloric Acid Salt (<b>16b-2HCl</b>)</h3><div class="NLM_p last">Intermediate <b>I-7</b> (4.55 g, 7.7 mmol) was suspended in 4 N HCl in dioxane (45 mL). The reaction mixture was stirred at rt for 1.5 h. The mixture was dried in vacuo and the product purified by prep HPLC using buffer containing 0.05% HCl to afford <b>16b-2HCl</b> (1.88 g, 43%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.01–1.15 (m, 2H), 1.29–1.50 (m, 2H), 1.53–1.65 (m, 1H), 1.76–1.92 (m, 4H), 2.32 (tt, <i>J =</i> 12, 3.3 Hz, 1H), 2.78 (d, <i>J =</i> 7.0 Hz, 2H), 3.35 (dd, <i>J =</i> 8.1, 2.9 Hz, 2H), 5.26 (t, <i>J =</i> 8.1 Hz, 1H), 7.21–7.27 (m, 3H), 7.27–7.33 (m, 2H), 7.55 (dd, <i>J =</i> 8.8, 1.3 Hz, 1H), 7.80 (s, 1H), 8.10 (d, <i>J =</i> 8.8 Hz, 1H). <i>m</i>/<i>z</i> 492 [M + H]<sup>+</sup>.</div></div><div id="sec4_46_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> <i>trans</i>-<i>N</i>-((<i>S</i>)-1-(4-(3-Amino-1<i>H</i>-indazol-6-yl)-1<i>H</i>-imidazol-2-yl)-2-phenylethyl)-4-(aminomethyl)cyclohexanecarboxamide, Bis-trifluoroacetic Acid Salt (<b>16a</b>)</h3><div class="NLM_p last">Intermediate <b>14a</b> was converted to compound <b>16a</b> by using the methods used to convert <b>14b</b> to <b>16b</b>. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.00–1.13 (m, 2H), 1.30–1.47 (m, 2H), 1.51–1.64 (m, 1H), 1.80 (d, <i>J =</i> 13 Hz, 1H), 1.86 (d, <i>J =</i> 12 Hz, 3H), 2.29 (tt, <i>J =</i> 12, 3.3 Hz, 1H), 2.77 (d, <i>J =</i> 7.2 Hz, 2H), 3.33 (dd, <i>J</i> = 8.8 Hz, 1 H, overlap with C<u class="uu">H</u><sub>3</sub>OH), 3.38 (dd, <i>J =</i> 13, 8.2 Hz, 1H), 5.35 (t, <i>J =</i> 8.2 Hz, 1H), 7.20 (d, <i>J =</i> 7.2 Hz, 2H), 7.22–7.27 (m, 1H), 7.27–7.32 (m, 2H), 7.45 (d, <i>J =</i> 8.8 Hz, 1H), 7.72 (s, 1H), 7.91 (s, 1H), 7.98 (d, <i>J =</i> 8.8 Hz, 1H). HRMS calcd for C<sub>26</sub>H<sub>31</sub>N<sub>7</sub>O 458.2650 [M + H]<sup>+</sup>, found 458.2700.</div></div><div id="sec4_46_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> <i>trans</i>-<i>N</i>-((<i>S</i>)-1-(4-(3-Amino-1<i>H</i>-indazol-6-yl)-5-fluoro-1<i>H</i>-imidazol-2-yl)-2-phenylethyl)-4-(aminomethyl)cyclohexanecarboxamide, Bis-trifluoroacetic Acid Salt (<b>16c</b>)</h3><div class="NLM_p last">Intermediate <b>14c</b> was converted to compound <b>16c</b> using the methods used to convert <b>14b</b> to <b>16b</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.94 (d, <i>J</i> = 8.2 Hz, 1H), 7.51 (s, 1H), 7.44 (d, <i>J</i> = 8.2 Hz, 1H), 7.28–7.21 (m, 2H), 7.21–7.14 (m, 3H), 5.18 (t, <i>J</i> = 8.0 Hz, 1H), 3.23 (dd, <i>J</i> = 13.7, 7.7 Hz, 1H), 3.14 (dd, <i>J</i> = 13.2, 8.2 Hz, 1H), 2.77 (d, <i>J</i> = 7.1 Hz, 2H), 2.28–2.17 (m, 1H), 1.91–1.79 (m, 3H), 1.79–1.70 (m, 1H), 1.65–1.51 (m, 1H), 1.50–1.29 (m, 2H), 1.13–0.98 (m, 2H). <sup>19</sup>F NMR (471 MHz, CD<sub>3</sub>OD) δ −77.15 (s), −131.90 (s). <i>m</i>/<i>z</i> 476 [M + H]<sup>+</sup>.</div></div><div id="sec4_46_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> (<i>S</i>)-2-(2-Phenyl-1-(5-phenyloxazol-2-yl)ethyl)isoindoline-1,3-dione (<b>19</b>)</h3><div class="NLM_p last">To a solution of (<i>S</i>)-2-(1,3-dioxoisoindolin-2-yl)-3-phenylpropanoic acid (<b>17</b>) (290 mg, 1 mmol) and 2-amino-1-phenylethanone (<b>18</b>) (171 mg, 1 mmol) in anhydrous pyridine (8 mL) was added BOP reagent (996 mg, 2.2 mmol). The reaction was stirred at rt for 16 h. The reaction was diluted with water and extracted with EtOAc. The combined organic extracts were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to dryness in vacuo to yield 412 mg (100%) of crude (<i>S</i>)-2-(1,3-dioxoisoindolin-2-yl)-<i>N</i>-(2-oxo-2-phenylethyl)-3-phenylpropanamide (<b>I-8</b>). <i>m</i>/<i>z</i> 413 [M + H]<sup>+</sup>. To a solution of <b>I-8</b> (412 mg, 1 mmol) in anhydrous DMF (1.7 mL) was added phosphorus oxychloride (460 mg, 3 mmol). The solution was heated to 90 °C for 20 min, cooled to rt, and poured onto ice. The resulting slurry was stirred for 30 min, then added to saturated aq NaHCO<sub>3</sub> and extracted with EtOAc. The combined organic extracts were washed with H<sub>2</sub>O and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and dried in vacuo. The product was purified by flash chromatography to yield <b>19</b> (160 mg, 41%). <i>m</i>/<i>z</i> 395 [M + H]<sup>+</sup>.</div></div><div id="sec4_46_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> <i>trans</i>-4-(Aminomethyl)-<i>N</i>-((<i>S</i>)-2-phenyl-1-(5-phenyloxazol-2-yl)ethyl)cyclohexanecarboxamide, Bis-trifluoroacetic Acid Salt, Trifluoroacetic Acid Salt (<b>20</b>)</h3><div class="NLM_p last">To a solution of compound <b>19</b> (160 mg, 0.4 mmol) in ethanol (10 mL) was added hydrazine (39 mg, 1.2 mmol). The reaction mixture was heated to reflux for 2 h. After cooling to rt, the solvent was removed in vacuo. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub>, and insoluble solids were removed by filtration. The clear filtrate was concentrated to yield 95 mg (90%) of (<i>S</i>)-2-phenyl-1-(5-phenyloxazol-2-yl)ethanamine (<b>I-9</b>). <i>m</i>/<i>z</i> 265 [M + H]<sup>+</sup>. <b>I-9</b> (95 mg, 0.5 mmol) was converted to compound <b>20</b> (48 mg, 26%) using the procedures described for the conversion of compound <b>I-2</b> to <b>11a</b>. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.04–1.10 (m, 2H), 1.29–1.42 (m, 2H), 1.56 (m, 1H), 1.75 (m, 1H), 1.83–1.86 (m, 3H), 2.22 (m, 1H), 2.77 (d, <i>J</i> = 7.2 Hz, 2H), 3.20 (m, 1H), 3.33 (m, 1H), 5.41 (m, 1H), 7.22–7.27 (m, 5H), 7.34 (t, <i>J</i> = 7.2 Hz, 1H), 7.42 (m, 3H), 7.63- 7.65 (d, <i>J</i> = 8.2 Hz, 2H). <i>m</i>/<i>z</i> 404 [M + H]<sup>+</sup>.</div></div><div id="sec4_46_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> (<i>S</i>)-<i>tert</i>-Butyl (2-Phenyl-1-(3-phenyl-1<i>H</i>-1,2,4-triazol-5-yl)ethyl)carbamate (<b>21</b>)</h3><div class="NLM_p last">Compound <b>7</b> (265 mg, 1 mmol) and hydrazine (64 mg, 2 mmol) were combined using the conditions describe to convert <b>I-2</b> to <b>10a</b> and substituting hydrazine for <i>N</i>-Boc-tranexamic acid to give (<i>S</i>)-<i>tert</i>-butyl (1-hydrazinyl-1-oxo-3-phenylpropan-2-yl)carbamate (<b>I-10</b>) (279 mg, 100%). <i>m</i>/<i>z</i> 280 [M + H]<sup>+</sup>. To a solution of <b>I-10</b> (279 mg, 1.0 mmol) and Et<sub>3</sub>N (161 mg, 1.6 mmol) in ACN (10 mL) was added ethyl benzimidate hydrochloride (278 mg, 1.5 mmol). The reaction was heated to reflux for 24 h, cooled to rt, and diluted with EtOAc. The mixture was washed with H<sub>2</sub>O and brine, dried over Na<sub>2</sub>SO<sub>4,</sub> filtered, and evaporated to dryness in vacuo. The product was purified by preparative HPLC to yield <b>21</b> (154 mg, 42%). <i>m</i>/<i>z</i> 365 [M + H]<sup>+</sup>.</div></div><div id="sec4_46_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> <i>trans</i>-4-(Aminomethyl)-<i>N</i>-((<i>S</i>)-2-phenyl-1-(3-phenyl-1<i>H</i>-1,2,4-triazol-5-yl)ethyl)-cyclohexanecarboxamide, Bis-trifluoroacetic Acid Salt (<b>22</b>)</h3><div class="NLM_p last">Compound <b>21</b> (154 mg, 0.42 mmol) was converted to compound <b>22</b> (75 mg, 28%) using the methods described for the conversion of compound <b>9a</b> to compound <b>11a</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.02–1.06 (m, 2H), 1.29–1.42 (m, 2H), 1.56 (m, 1H), 1.75 (m, 1H), 1.83–1.86 (m, 3H), 2.21 (m, 1H), 2.77 (d, <i>J</i> = 7.0 Hz, 2H), 3.18–3.21 (m, 1H), 3.31 (m, 1H), 5.42 (t, <i>J</i> = 8.1 Hz, 1H), 7.22–7.26 (m, 5H), 7.51–7.52 (m, 3H), 7.96–7.98 (m, 2H). <i>m</i>/<i>z</i> 404 [M + H]<sup>+</sup>.</div></div><div id="sec4_46_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> (<i>S</i>)-Benzyl (3,5-Dioxo-1,5-diphenylpentan-2-yl)carbamate (<b>25</b>)</h3><div class="NLM_p last">To a solution of ethyl benzolyacetate (<b>23</b>) (2.88 g, 15 mmol) in EtOH (30 mL) was added 1 N aq NaOH (30 mL). The reaction mixture was stirred at rt for 72 h. The mixture was cooled to 0 °C and acidified with 1 N aq HCl. The EtOH was removed under reduced pressure. The aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic extracts were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to give 3-oxo-3-phenylpropanoic acid (<b>I-11</b>) (600 mg, 24%). <i>m</i>/<i>z</i> 165 [M + H]<sup>+</sup>. To a solution of <b>I-11</b> (600 mg, 3.65 mmol) in THF (20 mL) and CH<sub>3</sub>OH (20 mL) was added magnesium ethoxide (417 mg, 3.65 mmol). The mixture was stirred at rt for 4 h. The solvents were removed in vacuo. The residue was dissolved in DMF (2 mL) and added to a mixture of <i>N</i>-CBz-<span class="smallcaps smallerCapital">l</span>-phenylalanine (<b>24</b>) (800 mg, 2.68 mmol) and 1,1′-carbonyldiimidazole (520 mg, 3.21 mmol) in DMF (4 mL), which had been stirred at rt for 2 h. The combined reaction mixture was stirred at rt for 16 h, diluted with EtOAc, washed with dilute aq HCl, water, and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The product was isolated by prep HPLC to give <b>25</b> (140 mg, 13%). <i>m</i>/<i>z</i> 402 [M + H]<sup>+</sup>.</div></div><div id="sec4_46_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> (<i>S</i>)-Benzyl (2-Phenyl-1-(3-phenyl-1<i>H</i>-pyrazol-5-yl)ethyl)carbamate (<b>26</b>)</h3><div class="NLM_p last">To a solution of compound <b>25</b> (32 mg, 0.08 mmol) in EtOH (3 mL) was added hydrazine hydrate (3 mg, 0.09 mmol). The reaction mixture was heated at 60 °C for 3 h. EtOH was removed in vacuo to give compound <b>26</b> (32 mg, 100%). <i>m</i>/<i>z</i> 398 [M + H]<sup>+</sup>.</div></div><div id="sec4_46_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> <i>trans</i>-4-(Aminomethyl)-<i>N</i>-((<i>S</i>)-2-phenyl-1-(3-phenyl-1<i>H</i>-pyrazol-5-yl)ethyl)cyclohexanecarboxamide, Bis-trifluoroacetic Acid Salt (<b>27</b>)</h3><div class="NLM_p last">To a solution of compound <b>26</b> (32 mg, 0.06 mmol) in CH<sub>3</sub>OH (3 mL) was added 10% Pd/C (5 mg). The reaction mixture was stirred under 1 atm of H<sub>2</sub> at rt for 4 h. The catalyst was removed by filtration. The product was isolated by preparative HPLC to give (<i>S</i>)-2-phenyl-1-(3-phenyl-1<i>H</i>-pyrazol-5-yl)ethanamine (<b>I-12</b>) (12 mg, 76%). <i>m</i>/<i>z</i> 262 [M – H]<sup>−</sup>. <b>I-12</b> (12 mg, 0.046 mmol) was converted to compound <b>27</b> (11 mg, 46%) using the procedures described for the conversion of intermediate <b>I-2</b> to <b>11a</b>. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.02–1.06 (m, 2H), 1.30–1.33 (m, 1H),1.43–1.46 (m, 1H), 1.56 (m, 1H), 1.64 (m, 1H), 1.83 (m, 3H), 2.16–2.18 (m, 1H), 2.75 (d, <i>J</i> = 7.0 Hz, 2H), 3.08–3.10 (m,1H), 3.27 (m, 1H), 5.35 (t, <i>J</i> = 8.1 Hz, 1H), 6.61 (s, 1H), 7.22 (m, 1H), 7.23 (m, 4H), 7.35–7.36 (t, <i>J</i> = 7.2 Hz, 1H), 7.41–7.44 (t, <i>J</i> = 7.7 Hz, 2H), 7.69–7.71 (d, <i>J</i> = 7.2 Hz, 2H). <i>m</i>/<i>z</i> 403 [M + H]<sup>+</sup>.</div></div><div id="sec4_46_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> (<i>S</i>)-Benzyl (1-(5-Oxo-1-phenyl-4,5-dihydro-1<i>H</i>-1,2,4-triazol-3-yl)-2-phenylethyl)carbamate (<b>29</b>)</h3><div class="NLM_p last">A solution of (<i>S</i>)-benzyl (1-cyano-2-phenylethyl)carbamate (<b>28</b>) (140 mg, 0.5 mmol) and sodium methoxide (13 mg, 0.24 mmol) in CH<sub>3</sub>OH (4 mL) was stirred at 30 °C for 3 h. Acetic acid (14 mg, 0.24 mmol) was added followed by phenylhydrazine (108 mg, 1 mmol). The reaction mixture was stirred at rt for 18 h. The mixture was cooled to 0 °C, and solids were removed by filtration. The product was isolated by flash chromatograph to give (<i>S</i>)-benzyl (1-imino-3-phenyl-1-(2-phenylhydrazinyl)propan-2-yl)carbamate (<b>I-13)</b> (55 mg, 28%). <i>m</i>/<i>z</i> 389 [M + H]<sup>+</sup>. A solution of <b>I-13</b> (55 mg, 0.14 mmol) and 1,1′-carbonyldiimidazole (68 mg, 0.42 mmol) in THF (6 mL) was heated to reflux for 48 h. The reaction was cooled to rt, diluted with CH<sub>2</sub>Cl<sub>2</sub>, washed with water and brine, dried over Na<sub>2</sub>SO<sub>4,</sub> filtered, and concentrated in vacuo to give <b>29</b> (38 mg, 66%). <b>29</b> was carried onto the next step without purification. <i>m</i>/<i>z</i> 413 [M – H]<sup>−</sup>.</div></div><div id="sec4_46_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> <i>trans</i>-4-(Aminomethyl)-<i>N</i>-((<i>S</i>)-1-(5-oxo-1-phenyl-4,5-dihydro-1<i>H</i>-1,2,4-triazol-3-yl)-2-phenylethyl)cyclohexanecarboxamide, Trifluoroacetic Acid Salt (<b>30</b>)</h3><div class="NLM_p last">Compound <b>29</b> (38 mg, 0.09 mmol) was converted to <b>30</b> (8 mg, 17%) by using the procedures described for the conversion of compound <b>26</b> to <b>27</b>. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.02–1.06 (m, 2H), 1.30–1.33 (m, 1H), 1.43–1.46 (m, 1H), 1.56 (m, 1H), 1.67 (m, 1H), 1.81- 1.86 (m, 3H), 2.16–2.18 (m, 1H), 2.75 (d, <i>J</i> = 7.2 Hz, 2H), 3.08–3.10 (m, 1H), 3.31 (m, 1H), 5.15–5.17 (m, 1H), 7.19–7.21 (m, 2H), 7.27–7.28 (m, 4H), 7.40–7.43 (t, <i>J</i> = 8.0 Hz, 2H), 7.85–7.87 (d, <i>J</i> = 7.7 Hz, 2H). <i>m</i>/<i>z</i> 420.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_46_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> (<i>S</i>)-Benzyl (2-Phenyl-1-(2-phenyl-1<i>H</i>-imidazol-4-yl)ethyl)carbamate (<b>32</b>)</h3><div class="NLM_p last">A solution of (<i>S</i>)-benzyl-(4-bromo-3-oxo-1-phenylbutan-2-yl) carbamate (<b>31</b>) (376 mg, 1.0 mmol) and sodium formate (68 mg, 1.0 mmol) in EtOH (15 mL) was heated to reflux for 14 h. Benzamidine (240 mg, 1.5 mmol) and sodium bicarbonate (400 mg, 4.7 mmol) were added to the mixture. The reaction mixture was heated to reflux for an additional 24 h. The mixture was cooled to rt and concentrated in vacuo. The residue was dissolved in EtOAc, washed with H<sub>2</sub>O and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The product was isolated by flash chromatography to give <b>32</b> (33 mg, 8%). <i>m</i>/<i>z</i> 398 [M + H]<sup>+</sup>.</div></div><div id="sec4_46_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> <i>trans</i>-4-(Aminomethyl)-<i>N</i>-((<i>S</i>)-2-phenyl-1-(2-phenyl-1<i>H</i>-imidazol-4-yl)ethyl)cyclohexanecarboxamide, Bis-trifluoroacetic Acid Salt (<b>33</b>)</h3><div class="NLM_p last">Compound <b>32</b> (33 mg, 0.08 mmol) was converted to compound <b>33</b> (5 mg, 12%) using the procedures described for the conversion of compound <b>26</b> to <b>27</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.02–1.06 (m, 2H), 1.30–1.33 (m, 1H), 1.43–1.46 (m, 1H), 1.56 (m, 1H), 1.67 (m, 1H), 1.83 (m, 3H), 2.16–2.18 (m, 1H), 2.75 (d, <i>J</i> = 7.0 Hz, 2H), 3.08–3.10 (m,1H), 3.31 (m, 1H), 5.34–5.36 (m, 1H), 7.22–7.29 (m, 5H), 7.51 (s, 1H), 7.62–7.68 (m, 3H), 7.87–7.89 (m, 2H). <i>m</i>/<i>z</i> 403 [M + H]<sup>+</sup>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79"><a href="/doi/suppl/10.1021/jm5010607">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46664" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46664" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Crystallographic data and refinement statistics. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5010607/suppl_file/jm5010607_si_001.pdf">jm5010607_si_001.pdf (140.13 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm5010607" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35861" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35861" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jon J. Hangeland</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb,
P.O. Box 5400, Princeton, New Jersey 08543, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2d47424303454c434a48414c43496d4f405e034e4240"><span class="__cf_email__" data-cfemail="53393c3d7d3b323d34363f323d3713313e207d303c3e">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Todd J. Friends</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb,
P.O. Box 5400, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karen A. Rossi</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb,
P.O. Box 5400, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joanne M. Smallheer</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb,
P.O. Box 5400, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cailan Wang</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb,
P.O. Box 5400, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhong Sun</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb,
P.O. Box 5400, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James R. Corte</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb,
P.O. Box 5400, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tianan Fang</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb,
P.O. Box 5400, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pancras C. Wong</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb,
P.O. Box 5400, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan R. Rendina</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb,
P.O. Box 5400, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frank A. Barbera</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb,
P.O. Box 5400, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey M. Bozarth</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb,
P.O. Box 5400, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph M. Luettgen</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb,
P.O. Box 5400, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carol A. Watson</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb,
P.O. Box 5400, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ge Zhang</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb,
P.O. Box 5400, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anzhi Wei</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb,
P.O. Box 5400, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vidhyashankar Ramamurthy</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb,
P.O. Box 5400, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul E. Morin</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb,
P.O. Box 5400, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregory S. Bisacchi</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb,
P.O. Box 5400, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Srinath Subramaniam</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb,
P.O. Box 5400, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Piramanayagam Arunachalam</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb,
P.O. Box 5400, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arvind Mathur</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb,
P.O. Box 5400, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dietmar A. Seiffert</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb,
P.O. Box 5400, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruth R. Wexler</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb,
P.O. Box 5400, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mimi L. Quan</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb,
P.O. Box 5400, Princeton, New Jersey 08543, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d472e6898-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i80">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85188" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85188" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Use of the IMCA-CAT beamline 17-ID at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with the Illinois Institute of Technology. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.  We thank Dr. Steven Sheriff for final refinement of the X-ray crystal structures for the FXIa/11h and FXIa/16b complexes and for depositing the coordinates and X-ray data in the Protein Data Bank, Dr. William R. Ewing and Dr. R. Michael Lawrence for assistance editing the manuscript, and Jergen Bauman, Dr. Eileen Bird, Dr. Baomin Xin, and Gang Luo for obtaining the rabbit pharmacokinetic data.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i81" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i81"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i82" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i82"> Abbreviations Used</h2><tr><td class="NLM_term">aPTT</td><td class="NLM_def"><p class="first last">activated partial thromboplastin time</p></td></tr><tr><td class="NLM_term">AV</td><td class="NLM_def"><p class="first last">arterovenous</p></td></tr><tr><td class="NLM_term">ECAT</td><td class="NLM_def"><p class="first last">electrically mediated carotid arterial thrombosis</p></td></tr><tr><td class="NLM_term">FVIIa</td><td class="NLM_def"><p class="first last">activated coagulation factor VII</p></td></tr><tr><td class="NLM_term">FVIIIa</td><td class="NLM_def"><p class="first last">activated coagulation factor VIII</p></td></tr><tr><td class="NLM_term">FIXa</td><td class="NLM_def"><p class="first last">activated coagulation factor IX</p></td></tr><tr><td class="NLM_term">FXa</td><td class="NLM_def"><p class="first last">activated coagulation factor X</p></td></tr><tr><td class="NLM_term">FXIa</td><td class="NLM_def"><p class="first last">activated coagulation factor XI</p></td></tr><tr><td class="NLM_term">FXIIa</td><td class="NLM_def"><p class="first last">activated coagulation factor XII</p></td></tr><tr><td class="NLM_term">IPTG</td><td class="NLM_def"><p class="first last">isopropyl β-<span class="smallcaps smallerCapital">d</span>-1-thiogalactopyranoside</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">plasma kallikrein</p></td></tr><tr><td class="NLM_term">PT</td><td class="NLM_def"><p class="first last">prothrombin time</p></td></tr><tr><td class="NLM_term">TAFI</td><td class="NLM_def"><p class="first last">thrombin-activatable fibrinolysis inhibitor</p></td></tr><tr><td class="NLM_term">TF</td><td class="NLM_def"><p class="first last">tissue factor</p></td></tr><tr><td class="NLM_term">TT</td><td class="NLM_def"><p class="first last">thrombin time</p></td></tr><tr><td class="NLM_term">VT</td><td class="NLM_def"><p class="first last">venous thombosis</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i83">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02551" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02551" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 24 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jackson, S. P.</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1423</span><span class="NLM_x">–</span> <span class="NLM_lpage">1436</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1038%2Fnm.2515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=22064432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOisL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Jackson%2C+S.+P.Nat.+Med.+2011%2C+17%2C+1423%E2%80%931436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Arterial thrombosis-insidious, unpredictable and deadly</span></div><div class="casAuthors">Jackson, Shaun P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1423-1436</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The formation of blood clots-thrombosis-at sites of atherosclerotic plaque rupture is a major clin. problem despite ongoing improvements in antithrombotic therapy.  Progress in identifying the pathogenic mechanisms regulating arterial thrombosis has led to the development of newer therapeutics, and there is general anticipation that these treatments will have greater efficacy and improved safety.  However, major advances in this field require the identification of specific risk factors for arterial thrombosis in affected individuals and a rethink of the 'one size fits all' approach to antithrombotic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou9_kt5O0PGbVg90H21EOLACvtfcHk0lis6Is4DhEkZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOisL3E&md5=86c00e091a7225bbc0278d921bc77451</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2Fnm.2515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2515%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DS.%2BP.%26jtitle%3DNat.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D1423%26epage%3D1436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span> </span><span class="NLM_article-title">Global Status Report on Noncommunicable Diseases 2010</span>. <span class="NLM_publisher-name">WHO Press</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Global+Status+Report+on+Noncommunicable+Diseases+2010.+WHO+Press%3A+Geneva%2C+Switzerland%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DGlobal%2520Status%2520Report%2520on%2520Noncommunicable%2520Diseases%25202010%26pub%3DWHO%2520Press%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span> </span><span class="NLM_article-title">WHO Fact Sheet No. 310</span>. <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>, June<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+WHO+Fact+Sheet+No.+310.+World+Health+Organization%3A+Geneva%2C+Switzerland%2C+June+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DWHO%2520Fact%2520Sheet%2520No.%2520310%26pub%3DWorld%2520Health%2520Organization%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mcfarlane, R.</span><span> </span><span class="NLM_article-title">An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">499</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=1964&pages=498-499&author=R.+Mcfarlane&title=An+enzyme+cascade+in+the+blood+clotting+mechanism%2C+and+its+function+as+a+biochemical+amplifier"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcfarlane%26aufirst%3DR.%26atitle%3DAn%2520enzyme%2520cascade%2520in%2520the%2520blood%2520clotting%2520mechanism%252C%2520and%2520its%2520function%2520as%2520a%2520biochemical%2520amplifier%26jtitle%3DNature%26date%3D1964%26volume%3D202%26spage%3D498%26epage%3D499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Davie, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnoff, O.</span><span> </span><span class="NLM_article-title">Waterfall sequence for intrinsic clotting</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">1310</span><span class="NLM_x">–</span> <span class="NLM_lpage">1313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=1964&pages=1310-1313&author=E.+W.+Davieauthor=O.+Ratnoff&title=Waterfall+sequence+for+intrinsic+clotting"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavie%26aufirst%3DE.%2BW.%26aulast%3DRatnoff%26aufirst%3DO.%26atitle%3DWaterfall%2520sequence%2520for%2520intrinsic%2520clotting%26jtitle%3DScience%26date%3D1964%26volume%3D145%26spage%3D1310%26epage%3D1313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Davie, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisiel, W.</span><span> </span><span class="NLM_article-title">The coagulation cascade: initiation, maintenance and regulation</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">10363</span><span class="NLM_x">–</span> <span class="NLM_lpage">10370</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00107a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1991&pages=10363-10370&author=E.+W.+Davieauthor=K.+Fujikawaauthor=W.+Kisiel&title=The+coagulation+cascade%3A+initiation%2C+maintenance+and+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1021%2Fbi00107a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00107a001%26sid%3Dliteratum%253Aachs%26aulast%3DDavie%26aufirst%3DE.%2BW.%26aulast%3DFujikawa%26aufirst%3DK.%26aulast%3DKisiel%26aufirst%3DW.%26atitle%3DThe%2520coagulation%2520cascade%253A%2520initiation%252C%2520maintenance%2520and%2520regulation%26jtitle%3DBiochemistry%26date%3D1991%26volume%3D30%26spage%3D10363%26epage%3D10370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Gailani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broze, G.</span><span> </span><span class="NLM_article-title">Factor XI activation in a revised model of blood coagulation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">253</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">912</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1126%2Fscience.1652157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=1652157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADyaK3MXlvVShtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1991&pages=909-912&author=D.+Gailaniauthor=G.+Broze&title=Factor+XI+activation+in+a+revised+model+of+blood+coagulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2dR"><div class="casContent"><span class="casTitleNuber">2d</span><div class="casTitle"><span class="NLM_cas:atitle">Factor XI activation in a revised model of blood coagulation</span></div><div class="casAuthors">Gailani, David; Broze, George J., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">253</span>
        (<span class="NLM_cas:issue">5022</span>),
    <span class="NLM_cas:pages">909-12</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Coagulation factor XI is activated in vitro by factor XIIa in the presence of high-mol.-wt. kininogen (HMWK) and a neg. charged surface.  Factor XII deficiency is not assocd. with bleeding, which suggests that another mechanism for factor XI activation exists in vivo.  A revised model of coagulation is proposed in which factor XI is activated by thrombin.  In the absence of cofactors, thrombin is more effective (kcat/Km = 1.6 × 105) than factor XIIa (1.7 × 104) in activating factor XI.  Dextran sulfate enhances activation of factor XI by thrombin 2000-fold; part of this effect is due to autoactivation of factor XI by activated factor XI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrM9Iw-blL8N7Vg90H21EOLACvtfcHk0ljXZj7KAMVKow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlvVShtr8%253D&md5=acd04c34f4b36eb87a368b765ffe9cc8</span></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=10.1126%2Fscience.1652157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1652157%26sid%3Dliteratum%253Aachs%26aulast%3DGailani%26aufirst%3DD.%26aulast%3DBroze%26aufirst%3DG.%26atitle%3DFactor%2520XI%2520activation%2520in%2520a%2520revised%2520model%2520of%2520blood%2520coagulation%26jtitle%3DScience%26date%3D1991%26volume%3D253%26spage%3D909%26epage%3D912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Müller, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutch, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esterl, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spronk, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidbauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gahl, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrissey, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renné, T.</span><span> </span><span class="NLM_article-title">Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">1143</span><span class="NLM_x">–</span> <span class="NLM_lpage">1156</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2009&pages=1143-1156&author=F.+M%C3%BCllerauthor=N.+J.+Mutchauthor=W.+A.+Schenkauthor=S.+A.+Smithauthor=L.+Esterlauthor=H.+M.+Spronkauthor=S.+Schmidbauerauthor=W.+A.+Gahlauthor=J.+H.+Morrisseyauthor=T.+Renn%C3%A9&title=Platelet+polyphosphates+are+proinflammatory+and+procoagulant+mediators+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DF.%26aulast%3DMutch%26aufirst%3DN.%2BJ.%26aulast%3DSchenk%26aufirst%3DW.%2BA.%26aulast%3DSmith%26aufirst%3DS.%2BA.%26aulast%3DEsterl%26aufirst%3DL.%26aulast%3DSpronk%26aufirst%3DH.%2BM.%26aulast%3DSchmidbauer%26aufirst%3DS.%26aulast%3DGahl%26aufirst%3DW.%2BA.%26aulast%3DMorrissey%26aufirst%3DJ.%2BH.%26aulast%3DRenn%25C3%25A9%26aufirst%3DT.%26atitle%3DPlatelet%2520polyphosphates%2520are%2520proinflammatory%2520and%2520procoagulant%2520mediators%2520in%2520vivo%26jtitle%3DCell%26date%3D2009%26volume%3D139%26spage%3D1143%26epage%3D1156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Chatterjee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogler, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siedlecki, C. A.</span><span> </span><span class="NLM_article-title">Contributions of contact activation pathways of coagulation factor XII in plasma</span> <span class="citation_source-journal">J. Biomed. Mater. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">90A</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90A&publication_year=2009&pages=27-34&author=K.+Chatterjeeauthor=Z.+Guoauthor=E.+A.+Voglerauthor=C.+A.+Siedlecki&title=Contributions+of+contact+activation+pathways+of+coagulation+factor+XII+in+plasma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChatterjee%26aufirst%3DK.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DVogler%26aufirst%3DE.%2BA.%26aulast%3DSiedlecki%26aufirst%3DC.%2BA.%26atitle%3DContributions%2520of%2520contact%2520activation%2520pathways%2520of%2520coagulation%2520factor%2520XII%2520in%2520plasma%26jtitle%3DJ.%2520Biomed.%2520Mater.%2520Res.%26date%3D2009%26volume%3D90A%26spage%3D27%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Asakai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davie, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seligsohn, U.</span><span> </span><span class="NLM_article-title">Factor XI deficiency in Ashkenazi Jews in Israel</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1056%2FNEJM199107183250303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=2052060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A280%3ADyaK3M3ntVehtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=1991&pages=153-158&author=R.+Asakaiauthor=D.+Chungauthor=E.+Davieauthor=U.+Seligsohn&title=Factor+XI+deficiency+in+Ashkenazi+Jews+in+Israel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Factor XI deficiency in Ashkenazi Jews in Israel</span></div><div class="casAuthors">Asakai R; Chung D W; Davie E W; Seligsohn U</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">153-8</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND AND METHODS:  Severe factor XI deficiency, which is relatively common among Ashkenazi Jews, is associated with injury-related bleeding of considerable severity.  Three point mutations--a splice-junction abnormality (Type I), Glu117----Stop (Type II), and Phe283----Leu (Type III)--have been described in six patients with factor XI deficiency.  Clinical correlations with these mutations have not been carried out.  We determined the relative frequency of the mutations and their association with plasma levels of factor XI clotting activity and bleeding, analyzing the mutations with the polymerase chain reaction and restriction-enzyme digestion.  RESULTS:  The Type II and Type III mutations had similar frequencies among 43 Ashkenazi Jewish probands with severe factor XI deficiency; these two mutations accounted for 49 percent and 47 percent, respectively, of a total of 86 analyzed alleles.  Among 40 of the probands and 12 of their relatives with severe factor XI deficiency, patients homozygous for Type III mutation had a significantly higher level of factor XI clotting activity (mean [+/- SD] percentage of normal values, 9.7 +/- 3.8 percent; n = 13) than those homozygous for Type II mutation (1.2 +/- 0.5 percent, n = 16) or compound heterozygotes with Type II/III mutation (3.3 +/- 1.6 percent, n = 23), as well as significantly fewer episodes of injury-related bleeding.  Each of these three groups had a similarly increased proportion of episodes of bleeding complications after surgery at sites with enhanced local fibrinolysis, such as the urinary tract, or during tooth extraction.  CONCLUSIONS:  Type II and Type III mutations are the predominant causes of factor XI deficiency among Ashkenazi Jews.  Genotypic analysis, assay for factor XI, and consideration of the type and location of surgery can be helpful in planning operations in patients with this disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQVeX6-t8nFPty3lHz94U-GfW6udTcc2eZ-CM1IAVLpRrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M3ntVehtQ%253D%253D&md5=25973c99d4f25e1f5ec74bb56b156b33</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1056%2FNEJM199107183250303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199107183250303%26sid%3Dliteratum%253Aachs%26aulast%3DAsakai%26aufirst%3DR.%26aulast%3DChung%26aufirst%3DD.%26aulast%3DDavie%26aufirst%3DE.%26aulast%3DSeligsohn%26aufirst%3DU.%26atitle%3DFactor%2520XI%2520deficiency%2520in%2520Ashkenazi%2520Jews%2520in%2520Israel%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1991%26volume%3D325%26spage%3D153%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gailani, D.; Broze, G. J.</span><span> </span><span class="NLM_article-title">Factor XI and the Contact System</span>. In  <span class="citation_source-book">The Metabolic and Molecular Basis of Inherited Disease</span>, <span class="NLM_edition">8</span>th ed.; <span class="NLM_contrib-group">Scriver, C. R.; Beaudet, A. L.; Sly, W. S.; Valle, D.; Childs, B.; Kinzler, K. W.; Vogelstein, B.</span>, Eds.; <span class="NLM_publisher-name">McGraw-Hill</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2001</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">4433</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=4433&author=D.+Gailani&author=G.+J.+Brozeauthor=C.+R.+Scriver&author=A.+L.+Beaudet&author=W.+S.+Sly&author=D.+Valle&author=B.+Childs&author=K.+W.+Kinzler&author=B.+Vogelstein&title=The+Metabolic+and+Molecular+Basis+of+Inherited+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DGailani%26aufirst%3DD.%26atitle%3DFactor%2520XI%2520and%2520the%2520Contact%2520System%26btitle%3DThe%2520Metabolic%2520and%2520Molecular%2520Basis%2520of%2520Inherited%2520Disease%26aulast%3DScriver%26aufirst%3DC.%2BR.%26pub%3DMcGraw-Hill%26date%3D2001%26spage%3D4433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Gailani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renné, T.</span><span> </span><span class="NLM_article-title">The intrinsic pathway for coagulation: A target for treating thromboembolic disease?</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1106</span><span class="NLM_x">–</span> <span class="NLM_lpage">1112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1111%2Fj.1538-7836.2007.02446.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=17388803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntl2ksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=1106-1112&author=D.+Gailaniauthor=T.+Renn%C3%A9&title=The+intrinsic+pathway+for+coagulation%3A+A+target+for+treating+thromboembolic+disease%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">The intrinsic pathway of coagulation: a target for treating thromboembolic disease?</span></div><div class="casAuthors">Gailani, D.; Renne, T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1106-1112</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">A review.  The classic intrinsic pathway of coagulation is triggered by contact activation of the plasma protease factor (F)XII, followed by sequential proteolytic activation of FXI and FIX.  While a key mechanism for initiating coagulation in some clin. useful in vitro assays, the absence of abnormal bleeding assocd. with congenital FXII deficiency indicates that the intrinsic pathway is not important for normal blood coagulation in vivo.  However, recent work with mice lacking FXII or FXI suggest that these proteases make important contributions to formation of pathol. intravascular thrombi.  In models of arterial injury, FXII or FXI null mice are protected from formation of platelet rich occlusive thrombi to a degree similar to that seen in FIX deficient mice (a model for the severe bleeding disorder hemophilia B) or to wild type mice treated with high dose heparin.  FXII or FXI deficiency does not appear to prevent the initiation of thrombus formation in these models, but instead causes significant thrombus instability that prevents occlusion of the vessel.  These findings raise the possibility that a pathway similar or identical to the intrinsic pathway may operate in vivo under some circumstances.  Furthermore, the disproportionate importance of FXII and FXI to occlusive thrombus formation compared to normal hemostasis makes these proteases attractive candidates for therapeutic inhibitors to treat or prevent thromboembolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjkZhGskIyXrVg90H21EOLACvtfcHk0lj9-5U4tPrpOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntl2ksLo%253D&md5=07d82612a7c5dd32a756f17739818eeb</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2007.02446.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2007.02446.x%26sid%3Dliteratum%253Aachs%26aulast%3DGailani%26aufirst%3DD.%26aulast%3DRenn%25C3%25A9%26aufirst%3DT.%26atitle%3DThe%2520intrinsic%2520pathway%2520for%2520coagulation%253A%2520A%2520target%2520for%2520treating%2520thromboembolic%2520disease%253F%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2007%26volume%3D5%26spage%3D1106%26epage%3D1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Schumacher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luettgen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiffert, D.</span><span> </span><span class="NLM_article-title">Inhibition of factor XIa as a new approach to anticoagulant</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">388</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1161%2FATVBAHA.109.197178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=20139363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlSgt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=388-392&author=W.+Schumacherauthor=J.+Luettgenauthor=M.+L.+Quanauthor=D.+Seiffert&title=Inhibition+of+factor+XIa+as+a+new+approach+to+anticoagulant"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3dR"><div class="casContent"><span class="casTitleNuber">3d</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Factor XIa as a New Approach to Anticoagulation</span></div><div class="casAuthors">Schumacher, William A.; Luettgen, Joseph M.; Quan, Mimi L.; Seiffert, Dietmar A.</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">388-392</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  The dose-limiting issue with available anticoagulant therapies is bleeding.  Is there an approach that could provide antithrombotic protection with reduced bleeding One hypothesis is that targeting proteases upstream from the common pathway provides a redn. in thrombin sufficient to impede occlusive thrombosis yet allows enough thrombin generation to support hemostasis.  The impairment of intrinsic coagulation by selective inhibition of factor XI (FXI) leaves the extrinsic and common pathways of coagulation intact, making FXI a drug target.  This concept is supported by the observation that human deficiency in FXI results in a mild bleeding disorder compared with other coagulation factor deficiencies, and that elevated levels of FXI are a risk factor for thromboembolic disease.  Moreover, FXI knockout mice have reduced thrombosis with little effect on hemostasis.  The results from genetic models have been supported by studies using neutralizing antibodies, peptide inhibitors, and small-mol. inhibitors.  These agents impede thrombosis without affecting bleeding time in a variety of exptl. animals, including primates.  Together, these data strongly support FXIa inhibition as a viable method to increase the ratio of benefit to risk in an antithrombotic drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEpUMDMvRdj7Vg90H21EOLACvtfcHk0lj9-5U4tPrpOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlSgt7k%253D&md5=6a34271f438b91dd5978bf5b7c02cca1</span></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.109.197178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.109.197178%26sid%3Dliteratum%253Aachs%26aulast%3DSchumacher%26aufirst%3DW.%26aulast%3DLuettgen%26aufirst%3DJ.%26aulast%3DQuan%26aufirst%3DM.%2BL.%26aulast%3DSeiffert%26aufirst%3DD.%26atitle%3DInhibition%2520of%2520factor%2520XIa%2520as%2520a%2520new%2520approach%2520to%2520anticoagulant%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2010%26volume%3D30%26spage%3D388%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Bolton-Maggs, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wensley, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuddenham, E. G.</span><span> </span><span class="NLM_article-title">Definition of the bleeding tendency in factor XI-deficient kindreds—a clinical and laboratory study</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">194</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=7792729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADyaK2MXjsl2hsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1995&pages=194-202&author=P.+H.+Bolton-Maggsauthor=D.+A.+Pattersonauthor=R.+T.+Wensleyauthor=E.+G.+Tuddenham&title=Definition+of+the+bleeding+tendency+in+factor+XI-deficient+kindreds%E2%80%94a+clinical+and+laboratory+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Definition of the bleeding tendency in factor XI-deficient kindreds - a clinical and laboratory study</span></div><div class="casAuthors">Bolton-Maggs, P. H. B.; Patterson, D. A.; Wensley, R. T.; Tuddenham, E. G. D.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">194-202</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer</span>)
        </div><div class="casAbstract">Individuals with severe factor XI deficiency are prone to excessive bleeding after injury or surgery, but the existence of a haemorrhagic tendency in partial factor XI deficiency is controversial.  In this study, 172 members of 30 kindreds (20 non-Jewish) transmitting factor XI deficiency in North West England were interviewed and a bleeding history questionnaire completed.  Blood was taken for coagulation assays.  The questionnaires were categorized independently by two assessors to det. presence or absence of a bleeding tendency, in the absence of information about the factor XI level of family history.  Anal. shows that 48% of heterozygotes have a bleeding tendency.  Eighteen (60%) families came to attention because of bleeding probalems in heterozygotes.  Comparison of histories between partially deficient and non-deficient individuals demonstrated a higher incidence of menstrual problems, an increased in significant burising, and an increased likelihood of excessive bleeding after tonsillectomy and dental extns.  The incidence of von Willebrand's disease was not increased, but individuals with heterozygous factor XI deficiency who were bleeders tended to have lower levels of factor VIIIc and von Willebrand factor, and were more commonly of blood group 0.  These features may contribute to the bleeding tendency.  There was no evidence of alteration in factor VII activity (as defined by the ratio of activity to antigen) between the bleeders and non-bleeders.  This is convincing evidence for abnormal bleeding in factor XI deficiency which is not confined to severly deficient patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooGoCqeaOT6bVg90H21EOLACvtfcHk0lj9-5U4tPrpOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjsl2hsro%253D&md5=c1e8d8bc24105f60460f7654d8c0306f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBolton-Maggs%26aufirst%3DP.%2BH.%26aulast%3DPatterson%26aufirst%3DD.%2BA.%26aulast%3DWensley%26aufirst%3DR.%2BT.%26aulast%3DTuddenham%26aufirst%3DE.%2BG.%26atitle%3DDefinition%2520of%2520the%2520bleeding%2520tendency%2520in%2520factor%2520XI-deficient%2520kindreds%25E2%2580%2594a%2520clinical%2520and%2520laboratory%2520study%26jtitle%3DThromb.%2520Haemostasis%26date%3D1995%26volume%3D73%26spage%3D194%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Lozier, J. N.; Kessler, C. M.</span><span> </span><span class="NLM_article-title">Clinical Aspects and Therapy of Hemophilia</span>. In  <span class="citation_source-book">Hematology: Basic Principles and Practice</span>, <span class="NLM_edition">4</span>th ed.; <span class="NLM_contrib-group">Hoffman, R.; Benz, E.; Shattil, S.; Furie, B.; Cohen, H.; Silberstein, L.; McGlave, P.</span>, Eds.; <span class="NLM_publisher-name">Churchill Livingstone</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">2047</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=2047&author=J.+N.+Lozier&author=C.+M.+Kesslerauthor=R.+Hoffman&author=E.+Benz&author=S.+Shattil&author=B.+Furie&author=H.+Cohen&author=L.+Silberstein&author=P.+McGlave&title=Hematology%3A+Basic+Principles+and+Practice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLozier%26aufirst%3DJ.%2BN.%26atitle%3DClinical%2520Aspects%2520and%2520Therapy%2520of%2520Hemophilia%26btitle%3DHematology%253A%2520Basic%2520Principles%2520and%2520Practice%26aulast%3DHoffman%26aufirst%3DR.%26pub%3DChurchill%2520Livingstone%26date%3D2005%26spage%3D2047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gailani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogletree, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiffert, D. A.</span><span> </span><span class="NLM_article-title">Effects of factor XI deficiency on ferric chloride-induced vena cava thrombosis in mice</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1982</span><span class="NLM_x">–</span> <span class="NLM_lpage">1988</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1111%2Fj.1538-7836.2006.02093.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=16961605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A280%3ADC%252BD28rjvVakuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=1982-1988&author=X.+Wangauthor=P.+L.+Smithauthor=M.-Y.+Hsuauthor=D.+Gailaniauthor=W.+A.+Schumacherauthor=M.+L.+Ogletreeauthor=D.+A.+Seiffert&title=Effects+of+factor+XI+deficiency+on+ferric+chloride-induced+vena+cava+thrombosis+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of factor XI deficiency on ferric chloride-induced vena cava thrombosis in mice</span></div><div class="casAuthors">Wang X; Smith P L; Hsu M-Y; Gailani D; Schumacher W A; Ogletree M L; Seiffert D A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of thrombosis and haemostasis : JTH</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1982-8</span>
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    </div><div class="casAbstract">BACKGROUND:  Increased plasma levels of coagulation factor (F) XI are a risk factor for venous thrombosis.  OBJECTIVE:  To further explore the relationship between FXI and venous thrombosis, we evaluated FXI-deficient and wild-type mice in a ferric chloride (FeCl(3))-induced vena cava thrombosis model.  METHODS AND RESULTS:  Thrombosis was induced by 3-min topical application of filter papers containing increasing concentrations of FeCl(3) and the thrombus was measured at 30 min.  In contrast to wild-type mice, FXI-deficient mice failed to form a thrombus with 5% FeCl(3,) and were partially protected against 7.5% and 10% FeCl(3,) respectively.  The protective effect was substantially stronger than a high dose of heparin (1,000 units kg(-1), i.v.), clopidogrel (30 mg kg(-1), p.o.) or argatroban (30 mg kg(-1), i.p.).  These antithrombotic agents resulted in off-scale bleeding in a tail bleeding time assay, whereas the bleeding time of FXI-deficient mice was unchanged compared to wild-type mice.  In addition to its known effect on the coagulation cascade, enhanced clot lysis was demonstrated in FXI-deficient mouse and human plasma compared to those supplemented with FXIa.  CONCLUSION:  Given the strong antithrombotic efficacy (possibly contributed by strong anticoagulant activity associated with increased fibrinolytic activity) and mild bleeding diathesis associated with FXI deficiency, therapeutic inhibition of FXI may be a reasonable therapeutic strategy to treat or prevent venous thrombosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSh8DUHIk-VfIxhnOQkIHOxfW6udTcc2eZamOmQ79Fw2Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rjvVakuw%253D%253D&md5=e9e52e88908920ee2e72434a470a1961</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2006.02093.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2006.02093.x%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DP.%2BL.%26aulast%3DHsu%26aufirst%3DM.-Y.%26aulast%3DGailani%26aufirst%3DD.%26aulast%3DSchumacher%26aufirst%3DW.%2BA.%26aulast%3DOgletree%26aufirst%3DM.%2BL.%26aulast%3DSeiffert%26aufirst%3DD.%2BA.%26atitle%3DEffects%2520of%2520factor%2520XI%2520deficiency%2520on%2520ferric%2520chloride-induced%2520vena%2520cava%2520thrombosis%2520in%2520mice%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2006%26volume%3D4%26spage%3D1982%26epage%3D1988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yang, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flanders, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, G. M.</span><span> </span><span class="NLM_article-title">Elevated factor XIa activity levels are associated with an increased odds ratio for cerebrovascular events</span> <span class="citation_source-journal">Am. J. Clin. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1309%2FQC259F09UNMKVP0R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=16880142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVGmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2006&pages=411-415&author=D.+T.+Yangauthor=M.+M.+Flandersauthor=H.+Kimauthor=G.+M.+Rodgers&title=Elevated+factor+XIa+activity+levels+are+associated+with+an+increased+odds+ratio+for+cerebrovascular+events"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events</span></div><div class="casAuthors">Yang, David T.; Flanders, Michele M.; Kim, Hyunhee; Rodgers, George M.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Clinical Pathology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">411-415</span>CODEN:
                <span class="NLM_cas:coden">AJCPAI</span>;
        ISSN:<span class="NLM_cas:issn">0002-9173</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Pathology</span>)
        </div><div class="casAbstract">High levels of factor XI have been implicated as a risk factor for deep venous thrombosis and possibly cardiovascular disease; however, the relationship between elevated factor XI activity and stroke has yet to be established.  We retrospectively evaluated factor XI activity, factor XI antigen, and high-sensitivity C-reactive protein (hs-CRP) values in samples from 65 patients with stroke, 13 with transient ischemic attack (TIA), and 17 with venous thrombosis, younger than 55 years with normal prothrombin and partial thromboplastin times who underwent evaluation for a hypercoagulable state.  Factor XI activity levels were more than normal in 22% of patients with stroke or TIA and 18% of patients with venous thrombosis, producing odds ratios of 5.3 and 4.1 for stroke or TIA and venous thrombosis, resp.  Factor XI activity levels correlate with factor XI antigen levels by Deming regression anal. (slope, 1.3; R = 0.667), and a lack of correlation of both with hs-CRP suggests that factor XI is not an acute phase reactant.  Our findings suggest an assocn. between elevated factor XI activity and stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsES1G-_EdgbVg90H21EOLACvtfcHk0lha6EtWs9uOiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVGmsA%253D%253D&md5=f0b7fd080dab27c44302eb4ac745b56c</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1309%2FQC259F09UNMKVP0R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1309%252FQC259F09UNMKVP0R%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DD.%2BT.%26aulast%3DFlanders%26aufirst%3DM.%2BM.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DRodgers%26aufirst%3DG.%2BM.%26atitle%3DElevated%2520factor%2520XIa%2520activity%2520levels%2520are%2520associated%2520with%2520an%2520increased%2520odds%2520ratio%2520for%2520cerebrovascular%2520events%26jtitle%3DAm.%2520J.%2520Clin.%2520Pathol.%26date%3D2006%26volume%3D126%26spage%3D411%26epage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Butenas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Undas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gissel, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szuldrzynski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zmudka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, K. G.</span><span> </span><span class="NLM_article-title">Factor XIa and tissue factor activity in patients with coronary artery disease</span> <span class="citation_source-journal">Thomb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">142</span><span class="NLM_x">–</span> <span class="NLM_lpage">149</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=18217146" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=142-149&author=S.+Butenasauthor=A.+Undasauthor=M.+T.+Gisselauthor=K.+Szuldrzynskiauthor=K.+Zmudkaauthor=K.+G.+Mann&title=Factor+XIa+and+tissue+factor+activity+in+patients+with+coronary+artery+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DButenas%26aufirst%3DS.%26aulast%3DUndas%26aufirst%3DA.%26aulast%3DGissel%26aufirst%3DM.%2BT.%26aulast%3DSzuldrzynski%26aufirst%3DK.%26aulast%3DZmudka%26aufirst%3DK.%26aulast%3DMann%26aufirst%3DK.%2BG.%26atitle%3DFactor%2520XIa%2520and%2520tissue%2520factor%2520activity%2520in%2520patients%2520with%2520coronary%2520artery%2520disease%26jtitle%3DThomb.%2520Haemostasis%26date%3D2008%26volume%3D99%26spage%3D142%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Salomon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koren-Morag, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanne, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seligsohn, U.</span><span> </span><span class="NLM_article-title">Reduced incidence of ischemic stroke in patients with severe factor XI deficiency</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">4113</span><span class="NLM_x">–</span> <span class="NLM_lpage">4117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1182%2Fblood-2007-10-120139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=18268095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvFeis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=4113-4117&author=O.+Salomonauthor=D.+M.+Steinbergauthor=N.+Koren-Moragauthor=D.+Tanneauthor=U.+Seligsohn&title=Reduced+incidence+of+ischemic+stroke+in+patients+with+severe+factor+XI+deficiency"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced incidence of ischemic stroke in patients with severe factor XI deficiency</span></div><div class="casAuthors">Salomon, Ophira; Steinberg, David M.; Koren-Morag, Nira; Tanne, David; Seligsohn, Uri</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4113-4117</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Inherited disorders of hemostasis are natural models for investigating mechanisms of thrombosis and development of antithrombotic therapy.  Because mice with total factor XI deficiency are protected against ischemic stroke and do not manifest excessive bleeding, we investigated the incidence of ischemic stroke in patients with severe inherited factor XI deficiency.  Incidence of ischemic stroke in 115 patients aged 45 years or more with severe factor XI deficiency (activity less than 15 U/dL) was compared with incidence in the Israeli population as estd. from a stroke survey of 1528 patients.  Adjustment for major risk factors of stroke (hypertension, diabetes mellitus, hypercholesterolemia, current smoking) was based on comparison of their prevalence in the stroke survey to an Israeli health survey of 9509 subjects.  Incidence of myocardial infarction in the factor XI cohort was also recorded.  After adjustment for the 4 major risk factors of ischemic stroke, the expected incidence of ischemic stroke was 8.56 compared with one obsd.  The reduced 1:115 incidence of ischemic stroke contrasted with a 19:115 incidence of myocardial infarction, similar to the expected incidence.  Thus, severe factor XI deficiency probably is protective against ischemic stroke but not against acute myocardial infarction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr47o3PkQqcu7Vg90H21EOLACvtfcHk0lhaKzBix6x2ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvFeis7k%253D&md5=5441715115d43fb53dbb011fd7e742ba</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1182%2Fblood-2007-10-120139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2007-10-120139%26sid%3Dliteratum%253Aachs%26aulast%3DSalomon%26aufirst%3DO.%26aulast%3DSteinberg%26aufirst%3DD.%2BM.%26aulast%3DKoren-Morag%26aufirst%3DN.%26aulast%3DTanne%26aufirst%3DD.%26aulast%3DSeligsohn%26aufirst%3DU.%26atitle%3DReduced%2520incidence%2520of%2520ischemic%2520stroke%2520in%2520patients%2520with%2520severe%2520factor%2520XI%2520deficiency%26jtitle%3DBlood%26date%3D2008%26volume%3D111%26spage%3D4113%26epage%3D4117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rynkiewicz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorga, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibbins, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celatka, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagafuji, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannister, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babine, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayward, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benjamin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stassen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Meguid, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickler, J. E.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Evaluation of Peptidimimetic Inhibitors of Factor XIa as Novel Anticoagulants</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7781</span><span class="NLM_x">–</span> <span class="NLM_lpage">7791</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060978s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7781-7791&author=J.+Linauthor=H.+Dengauthor=L.+Jinauthor=P.+Pandeyauthor=J.+Quinnauthor=S.+Cantinauthor=M.+J.+Rynkiewiczauthor=J.+C.+Gorgaauthor=F.+Bibbinsauthor=C.+A.+Celatkaauthor=P.+Nagafujiauthor=T.+D.+Bannisterauthor=H.+V.+Meyersauthor=R.+E.+Babineauthor=N.+J.+Haywardauthor=D.+Weaverauthor=H.+Benjaminauthor=F.+Stassenauthor=S.+S.+Abdel-Meguidauthor=J.+E.+Strickler&title=Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Peptidimimetic+Inhibitors+of+Factor+XIa+as+Novel+Anticoagulants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Fjm060978s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060978s%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DPandey%26aufirst%3DP.%26aulast%3DQuinn%26aufirst%3DJ.%26aulast%3DCantin%26aufirst%3DS.%26aulast%3DRynkiewicz%26aufirst%3DM.%2BJ.%26aulast%3DGorga%26aufirst%3DJ.%2BC.%26aulast%3DBibbins%26aufirst%3DF.%26aulast%3DCelatka%26aufirst%3DC.%2BA.%26aulast%3DNagafuji%26aufirst%3DP.%26aulast%3DBannister%26aufirst%3DT.%2BD.%26aulast%3DMeyers%26aufirst%3DH.%2BV.%26aulast%3DBabine%26aufirst%3DR.%2BE.%26aulast%3DHayward%26aufirst%3DN.%2BJ.%26aulast%3DWeaver%26aufirst%3DD.%26aulast%3DBenjamin%26aufirst%3DH.%26aulast%3DStassen%26aufirst%3DF.%26aulast%3DAbdel-Meguid%26aufirst%3DS.%2BS.%26aulast%3DStrickler%26aufirst%3DJ.%2BE.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Peptidimimetic%2520Inhibitors%2520of%2520Factor%2520XIa%2520as%2520Novel%2520Anticoagulants%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7781%26epage%3D7791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Deng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannister, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babine, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagafuji, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celatka, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarova, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rynkiewice, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibbins, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Meguid, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickler, J. E.</span><span> </span><span class="NLM_article-title">Synthesis, SAR exploration, and X-ray crystal structures of factor XIa inhibitors containing an α-ketothiazole arginine</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3049</span><span class="NLM_x">–</span> <span class="NLM_lpage">3054</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3049-3054&author=H.+Dengauthor=T.+D.+Bannisterauthor=L.+Jinauthor=R.+E.+Babineauthor=J.+Quinnauthor=P.+Nagafujiauthor=C.+A.+Celatkaauthor=J.+Linauthor=T.+I.+Lazarovaauthor=M.+J.+Rynkiewiceauthor=F.+Bibbinsauthor=P.+Pandeyauthor=J.+Gotgaauthor=H.+V.+Meyersauthor=S.+S.+Abdel-Meguidauthor=J.+E.+Strickler&title=Synthesis%2C+SAR+exploration%2C+and+X-ray+crystal+structures+of+factor+XIa+inhibitors+containing+an+%CE%B1-ketothiazole+arginine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DH.%26aulast%3DBannister%26aufirst%3DT.%2BD.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DBabine%26aufirst%3DR.%2BE.%26aulast%3DQuinn%26aufirst%3DJ.%26aulast%3DNagafuji%26aufirst%3DP.%26aulast%3DCelatka%26aufirst%3DC.%2BA.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DLazarova%26aufirst%3DT.%2BI.%26aulast%3DRynkiewice%26aufirst%3DM.%2BJ.%26aulast%3DBibbins%26aufirst%3DF.%26aulast%3DPandey%26aufirst%3DP.%26aulast%3DGotga%26aufirst%3DJ.%26aulast%3DMeyers%26aufirst%3DH.%2BV.%26aulast%3DAbdel-Meguid%26aufirst%3DS.%2BS.%26aulast%3DStrickler%26aufirst%3DJ.%2BE.%26atitle%3DSynthesis%252C%2520SAR%2520exploration%252C%2520and%2520X-ray%2520crystal%2520structures%2520of%2520factor%2520XIa%2520inhibitors%2520containing%2520an%2520%25CE%25B1-ketothiazole%2520arginine%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3049%26epage%3D3054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Schumacher, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiler, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbacher, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bostwick, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartl, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogletree, M. L.</span><span> </span><span class="NLM_article-title">Antithrombotic and hemostatic effects of a small molecule factor XIa inhibitor in rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">570</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1016%2Fj.ejphar.2007.05.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=17597608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1Sjsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=570&publication_year=2007&pages=167-174&author=W.+A.+Schumacherauthor=S.+E.+Seilerauthor=T.+E.+Steinbacherauthor=A.+B.+Stewartauthor=J.+B.+Bostwickauthor=K.+S.+Hartlauthor=E.+C.+Liuauthor=M.+L.+Ogletree&title=Antithrombotic+and+hemostatic+effects+of+a+small+molecule+factor+XIa+inhibitor+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Antithrombotic and hemostatic effects of a small molecule factor XIa inhibitor in rats</span></div><div class="casAuthors">Schumacher, William A.; Seiler, Steven E.; Steinbacher, Thomas E.; Stewart, Anne B.; Bostwick, Jeffrey S.; Hartl, Karen S.; Liu, Eddie C.; Ogletree, Martin L.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">570</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">167-174</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The effect of inhibiting activated blood coagulation factor XIa was detd. in rat models of thrombosis and hemostasis.  BMS-262084 is an irreversible and selective small mol. inhibitor of factor XIa with an IC50 of 2.8 nM against human factor XIa.  BMS-262084 doubled the activated thromboplastin time in human and rat plasma at 0.14 and 2.2 μM, resp.  Consistent with factor XIa inhibition, the prothrombin time was unaffected at up to 100 μM.  BMS-262084 administered as an i.v. loading plus sustaining infusion was effective against FeCl2-induced thrombosis in both the vena cava and carotid artery.  Maximum thrombus wt. redns. of 97 and 73%, resp. (P < 0.05), were achieved at a pretreatment dose of 12 mg/kg + 12 mg/kg/h which increased the ex vivo activated thromboplastin time to 3.0 times control.  This dose level also arrested growth of venous and arterial thrombi when administered after partial thrombus formation.  BMS-262084 was most potent in FeCl2-induced venous thrombosis, decreasing thrombus wt. 38% (P < 0.05) at a threshold dose of 0.2 mg/kg + 0.2 mg/kg/h.  In contrast, doses of up to 24 mg/kg + 24 mg/kg/h had no effect on either tissue factor-induced venous thrombosis or the ex vivo prothrombin time.  Doses of up to 24 mg/kg + 24 mg/kg/h also did not significantly prolong bleeding time provoked by either puncture of small mesenteric blood vessels, template incision of the renal cortex, or cuticle incision.  These results demonstrate that pharmacol. inhibition of factor XIa achieves antithrombotic efficacy with minimal effects on provoked bleeding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0mp5Jl7II4rVg90H21EOLACvtfcHk0lhaKzBix6x2ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1Sjsbc%253D&md5=69442ef81346e93e9ee5c7272cc6fdaa</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2007.05.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2007.05.043%26sid%3Dliteratum%253Aachs%26aulast%3DSchumacher%26aufirst%3DW.%2BA.%26aulast%3DSeiler%26aufirst%3DS.%2BE.%26aulast%3DSteinbacher%26aufirst%3DT.%2BE.%26aulast%3DStewart%26aufirst%3DA.%2BB.%26aulast%3DBostwick%26aufirst%3DJ.%2BB.%26aulast%3DHartl%26aufirst%3DK.%2BS.%26aulast%3DLiu%26aufirst%3DE.%2BC.%26aulast%3DOgletree%26aufirst%3DM.%2BL.%26atitle%3DAntithrombotic%2520and%2520hemostatic%2520effects%2520of%2520a%2520small%2520molecule%2520factor%2520XIa%2520inhibitor%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D570%26spage%3D167%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crain, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, W. A.</span><span> </span><span class="NLM_article-title">A small-molecule factor XIa inhibitor produces antithrombotic efficacy with minimal bleeding time prolongation in rabbits</span> <span class="citation_source-journal">J. Thromb. Thrombolysis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1007%2Fs11239-011-0599-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=21614454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptVOgt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=129-137&author=P.+C.+Wongauthor=E.+J.+Crainauthor=C.+A.+Watsonauthor=W.+A.+Schumacher&title=A+small-molecule+factor+XIa+inhibitor+produces+antithrombotic+efficacy+with+minimal+bleeding+time+prolongation+in+rabbits"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">A small-molecule factor XIa inhibitor produces antithrombotic efficacy with minimal bleeding time prolongation in rabbits</span></div><div class="casAuthors">Wong, Pancras C.; Crain, Earl J.; Watson, Carol A.; Schumacher, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Thrombolysis</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">129-137</span>CODEN:
                <span class="NLM_cas:coden">JTTHFF</span>;
        ISSN:<span class="NLM_cas:issn">0929-5305</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">BMS-262084 is a 4-carboxy-2-azetidinone-contg. irreversible inhibitor of FXIa, which is selective over other coagulation proteases.  We evaluated the in vitro and in vivo properties of BMS-262084 in rabbits.  Studies were conducted in arteriovenous-shunt thrombosis (AVST), venous thrombosis (VT), electrolytic-mediated carotid arterial thrombosis (ECAT) and cuticle bleeding time (BT) models.  BMS-262084 was infused IV from 1 h before thrombus induction or cuticle transection to the end of the expt.  In vitro, BMS-262084 prolonged activated partial thromboplastin time (aPTT) with EC2x (concn. required to double aPTT) of 10.6 μM in rabbit plasma, and did not prolong prothrombin time (PT), thrombin time (TT) and HepTest.  In vivo, BMS-262084 produced dose-dependent antithrombotic effects in rabbits with antithrombotic ED50 (dose that reduced thrombus wt. or increased blood flow by 50% of the control) in AVST, VT and ECAT of 0.4, 0.7 and 1.5 mg/kg/h IV, resp.  BMS-262084 increased ex vivo aPTT dose-dependently without changes in PT and TT.  The antithrombotic effect of BMS-262084 was significantly correlated with its ex vivo aPTT, supporting the use of ex vivo aPTT as a pharmacodynamic biomarker.  BMS-262084 did not alter ex vivo rabbit platelet aggregation to ADP and collagen.  BT (fold-increase) detd. at 3 and 10 mg/kg/h of BMS-262084 were 1.17 ± 0.04 and 1.52 ± 0.07*, resp. (*P < 0.05 vs. control).  This study demonstrated that BMS-262084 prevented exptl. thrombosis at doses with low BT effects in rabbits, and suggests that a small mol. FXIa inhibitor may represent a promising antithrombotic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowBWA5CF6An7Vg90H21EOLACvtfcHk0lhgPrtaq806zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptVOgt7s%253D&md5=b66ac86fc92f96363968720fe2bfbd54</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1007%2Fs11239-011-0599-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11239-011-0599-0%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DCrain%26aufirst%3DE.%2BJ.%26aulast%3DWatson%26aufirst%3DC.%2BA.%26aulast%3DSchumacher%26aufirst%3DW.%2BA.%26atitle%3DA%2520small-molecule%2520factor%2520XIa%2520inhibitor%2520produces%2520antithrombotic%2520efficacy%2520with%2520minimal%2520bleeding%2520time%2520prolongation%2520in%2520rabbits%26jtitle%3DJ.%2520Thromb.%2520Thrombolysis%26date%3D2011%26volume%3D32%26spage%3D129%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Sutton, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolton, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartl, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogletree, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiler, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slusarchyk, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treuner, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhaler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basicchi, G. S.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3229</span><span class="NLM_x">–</span> <span class="NLM_lpage">3233</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3229-3233&author=J.+C.+Suttonauthor=S.+A.+Boltonauthor=K.+S.+Hartlauthor=M.-H.+Huangauthor=G.+Jacobsauthor=W.+Mengauthor=M.+L.+Ogletreeauthor=Z.+Piauthor=W.+A.+Schumacherauthor=S.+M.+Seilerauthor=W.+A.+Slusarchykauthor=U.+Treunerauthor=R.+Zhalerauthor=G.+Zhaoauthor=G.+S.+Basicchi&title=Synthesis+and+SAR+of+4-carboxy-2-azetidinone+mechanism-based+tryptase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSutton%26aufirst%3DJ.%2BC.%26aulast%3DBolton%26aufirst%3DS.%2BA.%26aulast%3DHartl%26aufirst%3DK.%2BS.%26aulast%3DHuang%26aufirst%3DM.-H.%26aulast%3DJacobs%26aufirst%3DG.%26aulast%3DMeng%26aufirst%3DW.%26aulast%3DOgletree%26aufirst%3DM.%2BL.%26aulast%3DPi%26aufirst%3DZ.%26aulast%3DSchumacher%26aufirst%3DW.%2BA.%26aulast%3DSeiler%26aufirst%3DS.%2BM.%26aulast%3DSlusarchyk%26aufirst%3DW.%2BA.%26aulast%3DTreuner%26aufirst%3DU.%26aulast%3DZhaler%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DBasicchi%26aufirst%3DG.%2BS.%26atitle%3DSynthesis%2520and%2520SAR%2520of%25204-carboxy-2-azetidinone%2520mechanism-based%2520tryptase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3229%26epage%3D3233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Quan, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woerner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smallheer, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbera, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bozarth, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harpel, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luettgen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramamurthy, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rendina, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiffert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">955</span><span class="NLM_x">–</span> <span class="NLM_lpage">969</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401670x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Quan%2C+M.+L.%3B+Wong%2C+P.+C.%3B+Wang%2C+C.%3B+Woerner%2C+F.%3B+Smallheer%2C+J.+M.%3B+Barbera%2C+F.+A.%3B+Bozarth%2C+J.+M.%3B+Brown%2C+R.+L.%3B+Harpel%2C+M.+R.%3B+Luettgen%2C+J.+M.%3B+Morin%2C+P.+E.%3B+Peterson%2C+T.%3B+Ramamurthy%2C+V.%3B+Rendina%2C+A.+R.%3B+Rossi%2C+K.+A.%3B+Watson%2C+C.+A.%3B+Wei%2C+A.%3B+Zhang%2C+G.%3B+Seiffert%2C+D.%3B+Wexler%2C+R.+R.J.+Med.+Chem.+2014%2C+57%2C+955%E2%80%93969"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm401670x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401670x%26sid%3Dliteratum%253Aachs%26aulast%3DQuan%26aufirst%3DM.%2BL.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWoerner%26aufirst%3DF.%26aulast%3DSmallheer%26aufirst%3DJ.%2BM.%26aulast%3DBarbera%26aufirst%3DF.%2BA.%26aulast%3DBozarth%26aufirst%3DJ.%2BM.%26aulast%3DBrown%26aufirst%3DR.%2BL.%26aulast%3DHarpel%26aufirst%3DM.%2BR.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DMorin%26aufirst%3DP.%2BE.%26aulast%3DPeterson%26aufirst%3DT.%26aulast%3DRamamurthy%26aufirst%3DV.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DRossi%26aufirst%3DK.%2BA.%26aulast%3DWatson%26aufirst%3DC.%2BA.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DSeiffert%26aufirst%3DD.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D955%26epage%3D969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Wong, P. C.; Quan, M. L.; Watson, C.; Crain, E.; Wexler, R. R.; Seiffert, D.</span><span> </span><span class="NLM_article-title">Potent Antithrombotic Effect of a Small-Molecule, Reversible and Direct Inhibitor of Factor XIa with Minimum Bleeding Time Effect in Rabbit Models of Arterial Thrombosis and Hemostasis</span>. Presented at the American Heart Association Scientific Sessions, November<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>APS.709.03, Poster 7050.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=P.+C.+Wong&author=M.+L.+Quan&author=C.+Watson&author=E.+Crain&author=R.+R.+Wexler&author=D.+Seiffert&title=Potent+Antithrombotic+Effect+of+a+Small-Molecule%2C+Reversible+and+Direct+Inhibitor+of+Factor+XIa+with+Minimum+Bleeding+Time+Effect+in+Rabbit+Models+of+Arterial+Thrombosis+and+Hemostasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DP.%2BC.%26atitle%3DPotent%2520Antithrombotic%2520Effect%2520of%2520a%2520Small-Molecule%252C%2520Reversible%2520and%2520Direct%2520Inhibitor%2520of%2520Factor%2520XIa%2520with%2520Minimum%2520Bleeding%2520Time%2520Effect%2520in%2520Rabbit%2520Models%2520of%2520Arterial%2520Thrombosis%2520and%2520Hemostasis%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Buchanan, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wessling, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jobling, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zue, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fex, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deinum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooper, J. N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, R. J.</span><span> </span><span class="NLM_article-title">Clavatadine A, a natural product with selective recognition and irreversible inhibition of factor XIa</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3583</span><span class="NLM_x">–</span> <span class="NLM_lpage">3587</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800314b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3583-3587&author=M.+S.+Buchananauthor=A.+R.+Carrollauthor=D.+Wesslingauthor=M.+Joblingauthor=V.+M.+Averyauthor=R.+A.+Davisauthor=Y.+Fengauthor=Y.+Zueauthor=T.+Fexauthor=J.+Deinumauthor=J.+N.+A.+Hooperauthor=R.+J.+Quinn&title=Clavatadine+A%2C+a+natural+product+with+selective+recognition+and+irreversible+inhibition+of+factor+XIa"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm800314b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800314b%26sid%3Dliteratum%253Aachs%26aulast%3DBuchanan%26aufirst%3DM.%2BS.%26aulast%3DCarroll%26aufirst%3DA.%2BR.%26aulast%3DWessling%26aufirst%3DD.%26aulast%3DJobling%26aufirst%3DM.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DDavis%26aufirst%3DR.%2BA.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DZue%26aufirst%3DY.%26aulast%3DFex%26aufirst%3DT.%26aulast%3DDeinum%26aufirst%3DJ.%26aulast%3DHooper%26aufirst%3DJ.%2BN.%2BA.%26aulast%3DQuinn%26aufirst%3DR.%2BJ.%26atitle%3DClavatadine%2520A%252C%2520a%2520natural%2520product%2520with%2520selective%2520recognition%2520and%2520irreversible%2520inhibition%2520of%2520factor%2520XIa%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3583%26epage%3D3587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Lazarova, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rynkiewicz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorga, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibbins, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babine, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickler, J.</span><span> </span><span class="NLM_article-title">Synthesis and in vitro biological evaluation or aryl boronic acids as potential inhibitors of factor XIa</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5022</span><span class="NLM_x">–</span> <span class="NLM_lpage">5027</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5022-5027&author=T.+I.+Lazarovaauthor=L.+Jinauthor=M.+Rynkiewiczauthor=J.+C.+Gorgaauthor=F.+Bibbinsauthor=H.+V.+Meyersauthor=R.+Babineauthor=J.+Strickler&title=Synthesis+and+in+vitro+biological+evaluation+or+aryl+boronic+acids+as+potential+inhibitors+of+factor+XIa"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLazarova%26aufirst%3DT.%2BI.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DRynkiewicz%26aufirst%3DM.%26aulast%3DGorga%26aufirst%3DJ.%2BC.%26aulast%3DBibbins%26aufirst%3DF.%26aulast%3DMeyers%26aufirst%3DH.%2BV.%26aulast%3DBabine%26aufirst%3DR.%26aulast%3DStrickler%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520biological%2520evaluation%2520or%2520aryl%2520boronic%2520acids%2520as%2520potential%2520inhibitors%2520of%2520factor%2520XIa%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5022%26epage%3D5027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Smallheer, J. M.; Wang, S.; Rossi, K. A.; Rendina, A.; Morin, P. E.; Wei, A.; Zhang, G.; Wong, P. C.; Seiffert, D.; Wexler, R. R.; Quan, M. L.</span> <span class="citation_source-book">Abstracts of Papers</span>, 245th National Meeting of the American Chemical Society, New Orleans, LA, U.S., April 7–11, 2013; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>MEDI-415.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=J.+M.+Smallheer&author=S.+Wang&author=K.+A.+Rossi&author=A.+Rendina&author=P.+E.+Morin&author=A.+Wei&author=G.+Zhang&author=P.+C.+Wong&author=D.+Seiffert&author=R.+R.+Wexler&author=M.+L.+Quan&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSmallheer%26aufirst%3DJ.%2BM.%26btitle%3DAbstracts%2520of%2520Papers%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sinha, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badellina, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcinkiewicz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, P. N.</span><span> </span><span class="NLM_article-title">Allosteric modification of factor XIa functional activity upon binding to polyanions</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">7593</span><span class="NLM_x">–</span> <span class="NLM_lpage">7600</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi049808c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=7593-7600&author=D.+Sinhaauthor=K.+O.+Badellinaauthor=M.+Marcinkiewiczauthor=P.+N.+Walsh&title=Allosteric+modification+of+factor+XIa+functional+activity+upon+binding+to+polyanions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Fbi049808c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi049808c%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DD.%26aulast%3DBadellina%26aufirst%3DK.%2BO.%26aulast%3DMarcinkiewicz%26aufirst%3DM.%26aulast%3DWalsh%26aufirst%3DP.%2BN.%26atitle%3DAllosteric%2520modification%2520of%2520factor%2520XIa%2520functional%2520activity%2520upon%2520binding%2520to%2520polyanions%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D7593%26epage%3D7600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Argade, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">Allosteric inhibition of human factor XIa: discovery of monosulfated benzofurans as a class of promising inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">3559</span><span class="NLM_x">–</span> <span class="NLM_lpage">3569</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm5002698" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkvVCku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3559-3569&author=M.+D.+Argadeauthor=A.+Y.+Mehtaauthor=A.+Sarkarauthor=U.+R.+Desai&title=Allosteric+inhibition+of+human+factor+XIa%3A+discovery+of+monosulfated+benzofurans+as+a+class+of+promising+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Inhibition of Human Factor XIa: Discovery of Monosulfated Benzofurans as a Class of Promising Inhibitors</span></div><div class="casAuthors">Argade, Malaika D.; Mehta, Akul Y.; Sarkar, Aurijit; Desai, Umesh R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3559-3569</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Factor XIa (fXIa) is being recognized as a prime target for developing safer anticoagulants.  To discover synthetic, small, allosteric inhibitors of fXIa, we screened an inhouse, unique library of 65 mols. displaying many distinct scaffolds and varying levels of sulfation.  Of these, monosulfated benzofurans were the only group of mols. found to inhibit fXIa (∼100% efficacy) and led to the identification of monosulfated trimer 24 (IC50 0.82 μM) as the most potent inhibitor.  Michaelis-Menten kinetics studies revealed a classic noncompetitive mechanism of action for 24.  Although monosulfated, the inhibitors did not compete with unfractionated heparin alluding to a novel site of interaction.  Fluorescence quenching studies indicated that trimer 24 induces major conformational changes in the active site of fXIa.  Docking studies identified a site near Lys255 on the A3 domain of fXIa as the most probable site of binding for 24.  Factor XIa devoid of the A3 domain displayed a major defect in the inhibition potency of 24 supporting the docking prediction.  Our work presents the sulfated benzofuran scaffold as a promising framework to develop allosteric fXIa inhibitors that likely function through the A3 domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAfSbW5eFY5LVg90H21EOLACvtfcHk0lieHG0wcrxKHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkvVCku7Y%253D&md5=674dc4a2305c9f95a54b2a9fc2365706</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Fjm5002698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5002698%26sid%3Dliteratum%253Aachs%26aulast%3DArgade%26aufirst%3DM.%2BD.%26aulast%3DMehta%26aufirst%3DA.%2BY.%26aulast%3DSarkar%26aufirst%3DA.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DAllosteric%2520inhibition%2520of%2520human%2520factor%2520XIa%253A%2520discovery%2520of%2520monosulfated%2520benzofurans%2520as%2520a%2520class%2520of%2520promising%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3559%26epage%3D3569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Al-Horani, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">Designing allosteric inhibitors of factor XIa. Lessons from the interactions of sulfated pentagalloylglucopyranosides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4805</span><span class="NLM_x">–</span> <span class="NLM_lpage">4818</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500311e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosVSqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4805-4818&author=R.+A.+Al-Horaniauthor=U.+R.+Desai&title=Designing+allosteric+inhibitors+of+factor+XIa.+Lessons+from+the+interactions+of+sulfated+pentagalloylglucopyranosides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17cR"><div class="casContent"><span class="casTitleNuber">17c</span><div class="casTitle"><span class="NLM_cas:atitle">Designing Allosteric Inhibitors of Factor XIa. Lessons from the Interactions of Sulfated Pentagalloylglucopyranosides</span></div><div class="casAuthors">Al-Horani, Rami A.; Desai, Umesh R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4805-4818</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We recently introduced sulfated pentagalloylglucopyranoside (SPGG) as an allosteric inhibitor of factor XIa (FXIa) (Al-Horani et al., J.  Med Chem. 2013, 56, 867-878).  To better understand the SPGG-FXIa interaction, we utilized eight SPGG variants and a range of biochem. techniques.  The results reveal that SPGG's sulfation level moderately affected FXIa inhibition potency and selectivity over thrombin and factor Xa.  Variation in the anomeric configuration did not affect potency.  Interestingly, zymogen factor XI bound SPGG with high affinity, suggesting its possible use as an antidote.  Acrylamide quenching expts. suggested that SPGG induced significant conformational changes in the active site of FXIa.  Inhibition studies in the presence of heparin showed marginal competition with highly sulfated SPGG variants but robust competition with less sulfated variants.  Resoln. of energetic contributions revealed that nonionic forces contribute nearly 87% of binding energy suggesting a strong possibility of specific interaction.  Overall, the results indicate that SPGG may recognize more than one anion-binding, allosteric site on FXIa.  An SPGG mol. contg. approx. 10 sulfate groups on positions 2 through 6 of the pentagalloylglucopyranosyl scaffold may be the optimal FXIa inhibitor for further preclin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIW7O9ciTuRLVg90H21EOLACvtfcHk0ljB3OoN1PSeng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosVSqtbs%253D&md5=8d6cc598c8ddc9765184231e4dfe794b</span></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=10.1021%2Fjm500311e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500311e%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Horani%26aufirst%3DR.%2BA.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DDesigning%2520allosteric%2520inhibitors%2520of%2520factor%2520XIa.%2520Lessons%2520from%2520the%2520interactions%2520of%2520sulfated%2520pentagalloylglucopyranosides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4805%26epage%3D4818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Al-Horani, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponnusamy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gailani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">Sulfated pentagalloylglucoside is a potent, allosteric, and selective inhibitor of factor XIa</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">867</span><span class="NLM_x">–</span> <span class="NLM_lpage">878</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301338q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVWgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=867-878&author=R.+A.+Al-Horaniauthor=P.+Ponnusamyauthor=A.+Y.+Mehtaauthor=D.+Gailaniauthor=U.+R.+Desai&title=Sulfated+pentagalloylglucoside+is+a+potent%2C+allosteric%2C+and+selective+inhibitor+of+factor+XIa"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17dR"><div class="casContent"><span class="casTitleNuber">17d</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfated Pentagalloylglucoside Is a Potent, Allosteric, and Selective Inhibitor of Factor XIa</span></div><div class="casAuthors">Al-Horani, Rami A.; Ponnusamy, Pooja; Mehta, Akul Y.; Gailani, David; Desai, Umesh R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">867-878</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of factor XIa (FXIa) is a novel paradigm for developing anticoagulants without major bleeding consequences.  We present the discovery of sulfated pentagalloylglucoside (6) as a highly selective inhibitor of human FXIa.  Biochem. screening of a focused library led to the identification of 6, a sulfated arom. mimetic of heparin.  Inhibitor 6 displayed a potency of 551 nM against FXIa, which was at least 200-fold more selective than other relevant enzymes.  It also prevented activation of factor IX and prolonged human plasma and whole blood clotting.  Inhibitor 6 reduced VMAX of FXIa hydrolysis of chromogenic substrate without affecting the KM, suggesting an allosteric mechanism.  Competitive studies showed that 6 bound in the heparin-binding site of FXIa.  No allosteric small mol. has been discovered to date that exhibits equiv. potency against FXIa.  Inhibitor 6 is expected to open up a major route to allosteric FXIa anticoagulants with clin. relevance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGKg_oDquc3LVg90H21EOLACvtfcHk0ljB3OoN1PSeng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVWgsQ%253D%253D&md5=ee6eb18186f2cbe58d954f8d3dea0290</span></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=10.1021%2Fjm301338q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301338q%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Horani%26aufirst%3DR.%2BA.%26aulast%3DPonnusamy%26aufirst%3DP.%26aulast%3DMehta%26aufirst%3DA.%2BY.%26aulast%3DGailani%26aufirst%3DD.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DSulfated%2520pentagalloylglucoside%2520is%2520a%2520potent%252C%2520allosteric%252C%2520and%2520selective%2520inhibitor%2520of%2520factor%2520XIa%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D867%26epage%3D878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Karuturi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Horani, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gailani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">Discovery of allosteric modulators of factor XIa by targeting the hydrophobic domains adjacent to its heparin-binding site</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2415</span><span class="NLM_x">–</span> <span class="NLM_lpage">2428</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301757v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2415-2428&author=R.+Karuturiauthor=R.+A.+Al-Horaniauthor=S.+C.+Mehtaauthor=D.+Gailaniauthor=U.+R.+Desai&title=Discovery+of+allosteric+modulators+of+factor+XIa+by+targeting+the+hydrophobic+domains+adjacent+to+its+heparin-binding+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17e&amp;dbid=16384&amp;doi=10.1021%2Fjm301757v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301757v%26sid%3Dliteratum%253Aachs%26aulast%3DKaruturi%26aufirst%3DR.%26aulast%3DAl-Horani%26aufirst%3DR.%2BA.%26aulast%3DMehta%26aufirst%3DS.%2BC.%26aulast%3DGailani%26aufirst%3DD.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DDiscovery%2520of%2520allosteric%2520modulators%2520of%2520factor%2520XIa%2520by%2520targeting%2520the%2520hydrophobic%2520domains%2520adjacent%2520to%2520its%2520heparin-binding%2520site%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2415%26epage%3D2428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Ma, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizurini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assumpcao, T. C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotsyfakis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro, J. M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteiro, R. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francischetti, I. M. B.</span><span> </span><span class="NLM_article-title">Desmolaris, a novel factor XIa anticoagulant from the salivary gland of the vampire bat (<i>Desmodus rotundus</i>) inhibits inflammation and thrombosis in vivo</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">4094</span><span class="NLM_x">–</span> <span class="NLM_lpage">4106</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2013&pages=4094-4106&author=D.+Maauthor=D.+M.+Mizuriniauthor=T.+C.+F.+Assumpcaoauthor=Y.+Liauthor=Y.+Qiauthor=M.+Kotsyfakisauthor=J.+M.+C.+Ribeiroauthor=R.+Q.+Monteiroauthor=I.+M.+B.+Francischetti&title=Desmolaris%2C+a+novel+factor+XIa+anticoagulant+from+the+salivary+gland+of+the+vampire+bat+%28Desmodus+rotundus%29+inhibits+inflammation+and+thrombosis+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DD.%26aulast%3DMizurini%26aufirst%3DD.%2BM.%26aulast%3DAssumpcao%26aufirst%3DT.%2BC.%2BF.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DQi%26aufirst%3DY.%26aulast%3DKotsyfakis%26aufirst%3DM.%26aulast%3DRibeiro%26aufirst%3DJ.%2BM.%2BC.%26aulast%3DMonteiro%26aufirst%3DR.%2BQ.%26aulast%3DFrancischetti%26aufirst%3DI.%2BM.%2BB.%26atitle%3DDesmolaris%252C%2520a%2520novel%2520factor%2520XIa%2520anticoagulant%2520from%2520the%2520salivary%2520gland%2520of%2520the%2520vampire%2520bat%2520%2528Desmodus%2520rotundus%2529%2520inhibits%2520inflammation%2520and%2520thrombosis%2520in%2520vivo%26jtitle%3DBlood%26date%3D2013%26volume%3D122%26spage%3D4094%26epage%3D4106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crain, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knabb, R. M.</span><span> </span><span class="NLM_article-title">Nonpeptide factor Xa inhibitors: studies with SF303 and SK549, a new class of potent antithrombotics</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">292</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">357</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=10604970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhslGrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2000&pages=351-357&author=P.+C.+Wongauthor=M.+L.+Quanauthor=E.+J.+Crainauthor=C.+A.+Watsonauthor=R.+R.+Wexlerauthor=R.+M.+Knabb&title=Nonpeptide+factor+Xa+inhibitors%3A+studies+with+SF303+and+SK549%2C+a+new+class+of+potent+antithrombotics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Nonpeptide factor Xa inhibitors: I. Studies with SF303 and SK549, a new class of potent antithrombotics</span></div><div class="casAuthors">Wong, Pancras C.; Quan, Mimi L.; Crain, Earl J.; Watson, Carol A.; Wexler, Ruth R.; Knabb, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">351-357</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A series of benzamidine isoxazoline derivs. was evaluated for their inhibitory potency against purified human factor Xa (fXa) and in a rabbit model of arteriovenous shunt thrombosis for their antithrombotic activities, expressed as K1 and IC50, resp.  A highly significant correlation was found between K1 and IC50 (r = 0.93, P < .0001).  The antithrombotic effects of SF303 [mol. wt. 536; K1: fXa, 6.3 nM; thrombin, 3,100 nM; trypsin, 110 nM; tissue plasminogen activator >20,000 nM; plasmin, 2,500 nM] and SK549 [mol. wt. 546; K1: fXa, 0.52 nM; thrombin, 400 nM; trypsin, 45 nM; tissue plasminogen activator >33,000 nM; plasmin, 890 nM] were compared with recombinant tick anticoagulant peptide [K1(fXa) = 0.5 nM], DX-9065a [K1(fXa) = 30 nM], and heparin or low mol. wt. heparin (dalteparin) in a rabbit model of arteriovenous shunt thrombosis.  ID50 values for preventing arteriovenous shunt-induced thrombosis were 0.6 μmol/kg/h for SF303, 0.035 μmol/kg/h for SK549, 0.01 μmol/kg/h for recombinant tick anticoagulant peptide, 0.4 μmol/kg/h for DX-9065a, 21 U/kg/h for heparin, and 23 U/kg/h for low mol. wt. heparin.  SK549 produced a concn.-dependent antithrombotic effect with an IC50 of 0.062 μM.  To evaluate its potential oral efficacy, SK549 was given intraduodenally at a dose of 5 mg/kg; it produced a peak antithrombotic effect of 59 ± 4% with a duration of action greater than 6.7 h.  Therefore, our study suggests that SF303, SK549, and their analogs represent a new class of synthetic fXa inhibitors that may be clin. useful as antithrombotic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquCxWNrZ5Py7Vg90H21EOLACvtfcHk0ljB3OoN1PSeng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhslGrtg%253D%253D&md5=8a93de5d2c71c21af72ba29e96bf6cd9</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DQuan%26aufirst%3DM.%2BL.%26aulast%3DCrain%26aufirst%3DE.%2BJ.%26aulast%3DWatson%26aufirst%3DC.%2BA.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DKnabb%26aufirst%3DR.%2BM.%26atitle%3DNonpeptide%2520factor%2520Xa%2520inhibitors%253A%2520studies%2520with%2520SF303%2520and%2520SK549%252C%2520a%2520new%2520class%2520of%2520potent%2520antithrombotics%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D292%26spage%3D351%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crain, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knabb, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meade, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slee, A. M.</span><span> </span><span class="NLM_article-title">Nonpeptide factor Xa inhibitors II. Antithrombotic evaluation in a rabbit model of electrically induced carotid artery thrombosis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=10991981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1ygu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2000&pages=212-218&author=P.+C.+Wongauthor=E.+J.+Crainauthor=R.+M.+Knabbauthor=R.+P.+Meadeauthor=M.+L.+Quanauthor=C.+A.+Watsonauthor=R.+R.+Wexlerauthor=M.+R.+Wrightauthor=A.+M.+Slee&title=Nonpeptide+factor+Xa+inhibitors+II.+Antithrombotic+evaluation+in+a+rabbit+model+of+electrically+induced+carotid+artery+thrombosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Nonpeptide factor Xa inhibitors. II. Antithrombotic evaluation in a rabbit model of electrically induced carotid artery thrombosis</span></div><div class="casAuthors">Wong, Pancras C.; Crain, Earl J.; Knabb, Robert M.; Meade, Raymond P.; Quan, Mimi L.; Watson, Carol A.; Wexler, Ruth R.; Wright, Matthew R.; Slee, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">212-218</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">SK549 (mol. wt. 546 Da) is a synthetic, selective inhibitor of human coagulation factor Xa (fXa) (Ki = 0.52 nM).  This study compared the antithrombotic effects of SK549 and a series of benzamidine isoxazoline fXa inhibitors with aspirin, DuP 714 (a direct thrombin inhibitor), recombinant tick anticoagulant peptide, or heparin in a rabbit model of elec. induced carotid arterial thrombosis.  Compds. were infused i.v. continuously from 60 min before elec. stimulation to the end of the expt.  Values of ED50 (dose that increases the carotid blood flow to 50% of the control) were 0.12 μmol/kg/h for SK549, 0.56 μmol/kg/h for aspirin, 0.14 μmol/kg/h for DuP 714, 0.06 μmol/kg/h for recombinant tick anticoagulant peptide, and >100 U/kg/h for heparin.  The EC50 (plasma concn. that increased blood flow to 50% of the control) for SK549 was 97 nM.  Unlike aspirin and heparin, SK549 was efficacious and, at 1.5 μmol/kg/h i.v. (n = 9), maintained carotid blood flow at 87±6% of control level for greater than 90 min.  Unlike heparin, SK549 inhibited ex vivo fXa activity but not ex vivo thrombin activity.  There was a highly significant correlation between Ki (fXa) and ED50 of a series of fXa inhibitors (r = 0.85, P <.001).  Therefore, these results suggest that SK549 is a novel, potent, and effective antithrombotic agent in a rabbit model of arterial thrombosis.  It is likely that SK549 exerts its antithrombotic effect through selective inhibition of fXa.  Furthermore, SK549 may be clin. useful for the prevention of arterial thrombosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7m_8Krs2pdrVg90H21EOLACvtfcHk0lhly5krtXV9fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1ygu74%253D&md5=52ed9fac0aeb3b953fd1a5825d03b5af</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DCrain%26aufirst%3DE.%2BJ.%26aulast%3DKnabb%26aufirst%3DR.%2BM.%26aulast%3DMeade%26aufirst%3DR.%2BP.%26aulast%3DQuan%26aufirst%3DM.%2BL.%26aulast%3DWatson%26aufirst%3DC.%2BA.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DWright%26aufirst%3DM.%2BR.%26aulast%3DSlee%26aufirst%3DA.%2BM.%26atitle%3DNonpeptide%2520factor%2520Xa%2520inhibitors%2520II.%2520Antithrombotic%2520evaluation%2520in%2520a%2520rabbit%2520model%2520of%2520electrically%2520induced%2520carotid%2520artery%2520thrombosis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D295%26spage%3D212%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crain, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaspel, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, D. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knabb, R. M.</span><span> </span><span class="NLM_article-title">Nonpeptide factor Xa inhibitors III. Effects of DPC423, an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbits</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1124%2Fjpet.102.040089" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2000&pages=993-1000&author=P.+C.+Wongauthor=E.+J.+Crainauthor=C.+A.+Watsonauthor=A.+M.+Zaspelauthor=M.+R.+Wrightauthor=P.+Y.+Lamauthor=D.+J.+P.+Pintoauthor=R.+R.+Wexlerauthor=R.+M.+Knabb&title=Nonpeptide+factor+Xa+inhibitors+III.+Effects+of+DPC423%2C+an+orally-active+pyrazole+antithrombotic+agent%2C+on+arterial+thrombosis+in+rabbits"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.040089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.040089%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DCrain%26aufirst%3DE.%2BJ.%26aulast%3DWatson%26aufirst%3DC.%2BA.%26aulast%3DZaspel%26aufirst%3DA.%2BM.%26aulast%3DWright%26aufirst%3DM.%2BR.%26aulast%3DLam%26aufirst%3DP.%2BY.%26aulast%3DPinto%26aufirst%3DD.%2BJ.%2BP.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DKnabb%26aufirst%3DR.%2BM.%26atitle%3DNonpeptide%2520factor%2520Xa%2520inhibitors%2520III.%2520Effects%2520of%2520DPC423%252C%2520an%2520orally-active%2520pyrazole%2520antithrombotic%2520agent%252C%2520on%2520arterial%2520thrombosis%2520in%2520rabbits%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D303%26spage%3D993%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Himber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirchhofer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschopp, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, S. P.</span><span> </span><span class="NLM_article-title">Dissociation of antithrombotic effect and bleeding time prolongation in rabbits by inhibiting tissue factor function</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">1142</span><span class="NLM_x">–</span> <span class="NLM_lpage">1149</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18d&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=9308768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18d&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADyaK2sXmtVejsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1997&pages=1142-1149&author=J.+Himberauthor=D.+Kirchhoferauthor=M.+Riedererauthor=T.+B.+Tschoppauthor=B.+Steinerauthor=S.+P.+Roux&title=Dissociation+of+antithrombotic+effect+and+bleeding+time+prolongation+in+rabbits+by+inhibiting+tissue+factor+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18dR"><div class="casContent"><span class="casTitleNuber">18d</span><div class="casTitle"><span class="NLM_cas:atitle">Dissociation of antithrombotic effect and bleeding time prolongation in rabbits by inhibiting tissue factor function</span></div><div class="casAuthors">Himber, Jacques; Kirchhofer, Daniel; Riederer, Markus; Tschopp, Thomas B.; Steiner, Beat; Roux, Sebastien P.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1142-1149</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer</span>)
        </div><div class="casAbstract">The antithrombotic and the antihemostatic effects of a monoclonal anti-TF antibody (AP-1) were compared in a model of arterial thrombosis to those of a direct thrombin inhibitor (napsagatran), and heparin.  In anesthetized rabbits transient arterial thrombi were induced by mech. damage to the subendothelium of a moderately stenosed carotid artery.  Recurrent formation and dislodgement of thrombi resulted in cyclic flow variations (CFVs) which were monitored over 2 h.  Rabbits received i.v. either a placebo (control), a monoclonal anti-rabbit TF antibody (AP-1, 0.05 mg/kg as an i.v. bolus repeated every 15 min), a specific low mol. wt. thrombin inhibitor (napsagatran, 3 μg/kg/min) or heparin (3 and 13 μg/kg/min).  The effect of the inhibitors on the hemostatic system was studied in a sep. set of rabbits by measuring template bleeding times (BT) in the ear arterioles, marginal ear vein, and the nail cuticle of the foreleg.  AP-1 and napsagatran showed a similar antithrombotic activity (78 and 80% abolition of the CFVs, resp.), whereas either low or high dose heparin was poorly effective (43 and 40% inhibition of CFVs, resp.).  At these antithrombotic doses and even at 4-fold higher dosage, AP-1 did not alter the BT, whereas napsagatran and heparin prolonged the ear vessels and cuticle BT in a dose-dependent manner.  Thus, in contrast to direct thrombin inhibition, the blockade of the TF/F.VIIa function did not result in a concomitant prolongation of the bleeding time.  Thus, dissocn. of antithrombotic and antihemostatic effects indicates that inhibition of the coagulation system at its initial stage represents a promising approach for the development of new anticoagulants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbfhcRWuYH4bVg90H21EOLACvtfcHk0lhly5krtXV9fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtVejsbo%253D&md5=6ae2d7e80ee1b6baa3f9a3ef897dc0ca</span></div><a href="/servlet/linkout?suffix=cit18d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHimber%26aufirst%3DJ.%26aulast%3DKirchhofer%26aufirst%3DD.%26aulast%3DRiederer%26aufirst%3DM.%26aulast%3DTschopp%26aufirst%3DT.%2BB.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DRoux%26aufirst%3DS.%2BP.%26atitle%3DDissociation%2520of%2520antithrombotic%2520effect%2520and%2520bleeding%2520time%2520prolongation%2520in%2520rabbits%2520by%2520inhibiting%2520tissue%2520factor%2520function%26jtitle%3DThromb.%2520Haemostasis%26date%3D1997%26volume%3D78%26spage%3D1142%26epage%3D1149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Bird, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbera, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revelli, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiffert, D.</span><span> </span><span class="NLM_article-title">Effects of plasma kallikrein deficiency on haemostasis and thrombosis in mice: murine ortholog of the Fletcher trait</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">1141</span><span class="NLM_x">–</span> <span class="NLM_lpage">1150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1160%2FTH11-10-0682" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=22398951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BC38Xpt1egu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2012&pages=1141-1150&author=J.+E.+Birdauthor=P.+L.+Smithauthor=X.+Wangauthor=W.+A.+Schumacherauthor=F.+Barberaauthor=J.-P.+Revelliauthor=D.+Seiffert&title=Effects+of+plasma+kallikrein+deficiency+on+haemostasis+and+thrombosis+in+mice%3A+murine+ortholog+of+the+Fletcher+trait"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of plasma kallikrein deficiency on haemostasis and thrombosis in mice: murine ortholog of the fletcher trait</span></div><div class="casAuthors">Bird, J. Eileen; Smith, Patricia L.; Wang, Xinkang; Schumacher, William A.; Barbera, Frank; Revelli, Jean-Pierre; Seiffert, Dietmar</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1141-1150</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">Plasma kallikrein is a multifunctional serine protease involved in contact activation of coagulation.  Deficiency in humans is characterised by prolonged activated partial thromboplastin time (aPTT); however, the balance between thrombosis and haemostasis is not fully understood.  A study of plasma kallikrein-deficient mice revealed increased aPTT, without prolonged bleeding time.  Prekallikrein antisense oligonucleotide (ASO) treatment in mice suggested potential for a pos. therapeutic index.  The current goal was to further define the role of plasma kallikrein in coagulation.  Blood pressure and heart rate were normal in plasma kallikrein-deficient mice, and mice were completely protected from occlusion (100 ± 1.3% control flow) in 3.5% FeCl3-induced arterial thrombosis vs. heterozygotes (20 ± 11.4%) and wild-type littermates (8 ± 0%).  Vessels occluded in 8/8 wild-type, 7/8 heterozygotes, and 0/8 knockouts.  Anti-thrombotic protection was less pronounced in 5% FeCl3-induced arterial injury.  Integrated blood flow was 8 ± 0% control in wild-type and heterozygotes, and significantly (p<0.01) improved to 43 ± 14.2% in knockouts.  The no. of vessels occluded was similar in all genotypes.  Thrombus wt. was significantly reduced in knockouts (-47%) and heterozygotes (-23%) vs. wild-type in oxidative venous thrombosis.  Av. tail bleeding time increased modestly in knockout mice compared to wild-type.  Av. renal bleeding times were similar in all genotypes.  These studies confirm and extend studies with prekallikrein ASO, and demonstrate that plasma kallikrein deletion prevents occlusive thrombus formation in mice with a minimal role in provoked bleeding.  Addnl. support for the significance of the intrinsic pathway in the coagulation cascade is provided, as well as for a potential new anti-thrombotic approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFqwTwIoHvLLVg90H21EOLACvtfcHk0libjY8Qnrer2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xpt1egu70%253D&md5=5f3acfb850654d78ac6182717a5cb25c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1160%2FTH11-10-0682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1160%252FTH11-10-0682%26sid%3Dliteratum%253Aachs%26aulast%3DBird%26aufirst%3DJ.%2BE.%26aulast%3DSmith%26aufirst%3DP.%2BL.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSchumacher%26aufirst%3DW.%2BA.%26aulast%3DBarbera%26aufirst%3DF.%26aulast%3DRevelli%26aufirst%3DJ.-P.%26aulast%3DSeiffert%26aufirst%3DD.%26atitle%3DEffects%2520of%2520plasma%2520kallikrein%2520deficiency%2520on%2520haemostasis%2520and%2520thrombosis%2520in%2520mice%253A%2520murine%2520ortholog%2520of%2520the%2520Fletcher%2520trait%26jtitle%3DThromb.%2520Haemostasis%26date%3D2012%26volume%3D107%26spage%3D1141%26epage%3D1150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Contour-Galcera, M.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poitout, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moinet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roubert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurieau, C.</span><span> </span><span class="NLM_article-title">Synthesis of substituted imidazopyrazines as ligands for the human somatostatin receptor subtype 5</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">741</span><span class="NLM_x">–</span> <span class="NLM_lpage">745</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=741-745&author=M.-O.+Contour-Galceraauthor=L.+Poitoutauthor=C.+Moinetauthor=B.+Morganauthor=T.+Gordonauthor=P.+Roubertauthor=C.+Thurieau&title=Synthesis+of+substituted+imidazopyrazines+as+ligands+for+the+human+somatostatin+receptor+subtype+5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DContour-Galcera%26aufirst%3DM.-O.%26aulast%3DPoitout%26aufirst%3DL.%26aulast%3DMoinet%26aufirst%3DC.%26aulast%3DMorgan%26aufirst%3DB.%26aulast%3DGordon%26aufirst%3DT.%26aulast%3DRoubert%26aufirst%3DP.%26aulast%3DThurieau%26aufirst%3DC.%26atitle%3DSynthesis%2520of%2520substituted%2520imidazopyrazines%2520as%2520ligands%2520for%2520the%2520human%2520somatostatin%2520receptor%2520subtype%25205%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D741%26epage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Otwinowski, Z.; Minor, W.</span> <span class="citation_source-book">Macromolecular Crystallography. Part A</span>; Carter, C. W., Sweet, R. M., Eds.; Methods in Enzymology, Vol.  <span class="NLM_volume">276</span>; <span class="NLM_publisher-name">Academic Press, Inc.</span>, <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">1997</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=307-326&author=Z.+Otwinowski&author=W.+Minor&title=Macromolecular+Crystallography.+Part+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26btitle%3DMacromolecular%2520Crystallography.%2520Part%2520A%26volume%3D276%26pub%3DAcademic%2520Press%252C%2520Inc%26date%3D1997%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Blanc, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roversi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vonrhein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flensburg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lea, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bricogne, G.</span><span> </span><span class="NLM_article-title">Refinement of severely incomplete structures with maximum likelihood in BUSTER/TNT</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2210</span><span class="NLM_x">–</span> <span class="NLM_lpage">2221</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2210-2221&author=E.+Blancauthor=P.+Roversiauthor=C.+Vonrheinauthor=C.+Flensburgauthor=S.+M.+Leaauthor=G.+Bricogne&title=Refinement+of+severely+incomplete+structures+with+maximum+likelihood+in+BUSTER%2FTNT"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlanc%26aufirst%3DE.%26aulast%3DRoversi%26aufirst%3DP.%26aulast%3DVonrhein%26aufirst%3DC.%26aulast%3DFlensburg%26aufirst%3DC.%26aulast%3DLea%26aufirst%3DS.%2BM.%26aulast%3DBricogne%26aufirst%3DG.%26atitle%3DRefinement%2520of%2520severely%2520incomplete%2520structures%2520with%2520maximum%2520likelihood%2520in%2520BUSTER%252FTNT%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2210%26epage%3D2221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lokhamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and Development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lokhampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+Development+of+Coot"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0libjY8Qnrer2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLokhamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520Development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Laskowski, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacArthur, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, J. M.</span><span> </span><span class="NLM_article-title">PROCHECK: a program to check the stereochemical quality of protein structures</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1107%2FS0021889892009944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADyaK3sXit12lurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1993&pages=283-291&author=R.+A.+Laskowskiauthor=M.+W.+MacArthurauthor=D.+S.+Mossauthor=J.+M.+Thornton&title=PROCHECK%3A+a+program+to+check+the+stereochemical+quality+of+protein+structures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">PROCHECK: a program to check the stereochemical quality of protein structures</span></div><div class="casAuthors">Laskowski, Roman A.; MacArthur, Malcolm W.; Moss, David S.; Thornton, Janet M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">283-91</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    </div><div class="casAbstract">The PROCHECK suite of programs provides a detailed check on the stereochem. of a protein structure.  Its outputs comprise a no. of plots in PostScript format and a comprehensive residue-by-residue listing.  These give an assessment of the overall quality of the structure as compared with well-refined structures of the same resoln. and also highlight regions that may need further investigation.  The PROCHECK programs are useful for assessing the quality not only of protein structures in the process of being solved but also of existing structures and of those being modeled on known structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCe5FgJf4KH7Vg90H21EOLACvtfcHk0libjY8Qnrer2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXit12lurY%253D&md5=fb69fc4410cd716aaaa7cc0db06b3ed2</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1107%2FS0021889892009944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889892009944%26sid%3Dliteratum%253Aachs%26aulast%3DLaskowski%26aufirst%3DR.%2BA.%26aulast%3DMacArthur%26aufirst%3DM.%2BW.%26aulast%3DMoss%26aufirst%3DD.%2BS.%26aulast%3DThornton%26aufirst%3DJ.%2BM.%26atitle%3DPROCHECK%253A%2520a%2520program%2520to%2520check%2520the%2520stereochemical%2520quality%2520of%2520protein%2520structures%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D1993%26volume%3D26%26spage%3D283%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c'],'ref2':['cit2a','cit2b','cit2c','cit2d','cit2e','cit2f'],'ref3':['cit3a','cit3b','cit3c','cit3d'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7a','cit7b'],'ref8':['cit8'],'ref9':['cit9a','cit9b'],'ref10':['cit10a','cit10b'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17a','cit17b','cit17c','cit17d','cit17e','cit17f'],'ref18':['cit18a','cit18b','cit18c','cit18d'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 28 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Mimi L. Quan, Donald J. P. Pinto, Joanne M. Smallheer, William R. Ewing, Karen A. Rossi, Joseph M. Luettgen, Dietmar A. Seiffert, <span class="NLM_string-name hlFld-ContribAuthor">Ruth R. Wexler</span>. </span><span class="cited-content_cbyCitation_article-title">Factor XIa Inhibitors as New Anticoagulants. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (17)
                                     , 7425-7447. <a href="https://doi.org/10.1021/acs.jmedchem.8b00173" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00173</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00173%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFactor%252BXIa%252BInhibitors%252Bas%252BNew%252BAnticoagulants%26aulast%3DQuan%26aufirst%3DMimi%2BL.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D02022018%26date%3D18052018%26volume%3D61%26issue%3D17%26spage%3D7425%26epage%3D7447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Donald J. P.  Pinto</span>, <span class="hlFld-ContribAuthor ">Michael J.  Orwat</span>, <span class="hlFld-ContribAuthor ">Leon M.  Smith, II</span>, <span class="hlFld-ContribAuthor ">Mimi L.  Quan</span>, <span class="hlFld-ContribAuthor ">Patrick Y. S.  Lam</span>, <span class="hlFld-ContribAuthor ">Karen A.  Rossi</span>, <span class="hlFld-ContribAuthor ">Atsu  Apedo</span>, <span class="hlFld-ContribAuthor ">Jeffrey M.  Bozarth</span>, <span class="hlFld-ContribAuthor ">Yiming  Wu</span>, <span class="hlFld-ContribAuthor ">Joanna J.  Zheng</span>, <span class="hlFld-ContribAuthor ">Baomin  Xin</span>, <span class="hlFld-ContribAuthor ">Nathalie  Toussaint</span>, <span class="hlFld-ContribAuthor ">Paul  Stetsko</span>, <span class="hlFld-ContribAuthor ">Olafur  Gudmundsson</span>, <span class="hlFld-ContribAuthor ">Brad  Maxwell</span>, <span class="hlFld-ContribAuthor ">Earl J.  Crain</span>, <span class="hlFld-ContribAuthor ">Pancras C.  Wong</span>, <span class="hlFld-ContribAuthor ">Zhen  Lou</span>, <span class="hlFld-ContribAuthor ">Timothy W.  Harper</span>, <span class="hlFld-ContribAuthor ">Silvi A.  Chacko</span>, <span class="hlFld-ContribAuthor ">Joseph E.  Myers, Jr.</span>, <span class="hlFld-ContribAuthor ">Steven  Sheriff</span>, <span class="hlFld-ContribAuthor ">Huiping  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaoping  Hou</span>, <span class="hlFld-ContribAuthor ">Arvind  Mathur</span>, <span class="hlFld-ContribAuthor ">Dietmar A.  Seiffert</span>, <span class="hlFld-ContribAuthor ">Ruth R.  Wexler</span>, <span class="hlFld-ContribAuthor ">Joseph M.  Luettgen</span>, and <span class="hlFld-ContribAuthor ">William R.  Ewing</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Parenteral Small Molecule Coagulation Factor XIa Inhibitor Clinical Candidate (BMS-962212). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (23)
                                     , 9703-9723. <a href="https://doi.org/10.1021/acs.jmedchem.7b01171" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01171</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01171%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BParenteral%252BSmall%252BMolecule%252BCoagulation%252BFactor%252BXIa%252BInhibitor%252BClinical%252BCandidate%252B%252528BMS-962212%252529%26aulast%3DPinto%26aufirst%3DDonald%2BJ.%2BP.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D15082017%26date%3D17112017%26date%3D14122017%26date%3D27102017%26volume%3D60%26issue%3D23%26spage%3D9703%26epage%3D9723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James A. D.  Good</span>, <span class="hlFld-ContribAuthor ">Martina  Kulén</span>, <span class="hlFld-ContribAuthor ">Jim  Silver</span>, <span class="hlFld-ContribAuthor ">K. Syam  Krishnan</span>, <span class="hlFld-ContribAuthor ">Wael  Bahnan</span>, <span class="hlFld-ContribAuthor ">Carlos  Núñez-Otero</span>, <span class="hlFld-ContribAuthor ">Ingela  Nilsson</span>, <span class="hlFld-ContribAuthor ">Emma  Wede</span>, <span class="hlFld-ContribAuthor ">Esmee  de Groot</span>, <span class="hlFld-ContribAuthor ">Åsa  Gylfe</span>, <span class="hlFld-ContribAuthor ">Sven  Bergström</span>, and <span class="hlFld-ContribAuthor ">Fredrik  Almqvist</span>  . </span><span class="cited-content_cbyCitation_article-title">Thiazolino 2-Pyridone Amide Isosteres As Inhibitors of Chlamydia trachomatis Infectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (22)
                                     , 9393-9399. <a href="https://doi.org/10.1021/acs.jmedchem.7b00716" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00716</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00716%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThiazolino%252B2-Pyridone%252BAmide%252BIsosteres%252BAs%252BInhibitors%252Bof%252BChlamydia%252Btrachomatis%252BInfectivity%26aulast%3DGood%26aufirst%3DJames%2BA.%2BD.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D15052017%26date%3D03112017%26date%3D22112017%26date%3D20102017%26volume%3D60%26issue%3D22%26spage%3D9393%26epage%3D9399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James R.  Corte</span>, <span class="hlFld-ContribAuthor ">Tianan  Fang</span>, <span class="hlFld-ContribAuthor ">Honey  Osuna</span>, <span class="hlFld-ContribAuthor ">Donald J. P.  Pinto</span>, <span class="hlFld-ContribAuthor ">Karen A.  Rossi</span>, <span class="hlFld-ContribAuthor ">Joseph E.  Myers, Jr.</span>, <span class="hlFld-ContribAuthor ">Steven  Sheriff</span>, <span class="hlFld-ContribAuthor ">Zhen  Lou</span>, <span class="hlFld-ContribAuthor ">Joanna J.  Zheng</span>, <span class="hlFld-ContribAuthor ">Timothy W.  Harper</span>, <span class="hlFld-ContribAuthor ">Jeffrey M.  Bozarth</span>, <span class="hlFld-ContribAuthor ">Yiming  Wu</span>, <span class="hlFld-ContribAuthor ">Joseph M.  Luettgen</span>, <span class="hlFld-ContribAuthor ">Dietmar A.  Seiffert</span>, <span class="hlFld-ContribAuthor ">Carl P.  Decicco</span>, <span class="hlFld-ContribAuthor ">Ruth R.  Wexler</span>, and <span class="hlFld-ContribAuthor ">Mimi L.  Quan</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of Macrocyclic Factor XIa Inhibitors: Discovery of the Macrocyclic Amide Linker. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (3)
                                     , 1060-1075. <a href="https://doi.org/10.1021/acs.jmedchem.6b01460" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01460</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01460%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252BMacrocyclic%252BFactor%252BXIa%252BInhibitors%25253A%252BDiscovery%252Bof%252Bthe%252BMacrocyclic%252BAmide%252BLinker%26aulast%3DCorte%26aufirst%3DJames%2BR.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D04102016%26date%3D31012017%26date%3D09022017%26date%3D13012017%26volume%3D60%26issue%3D3%26spage%3D1060%26epage%3D1075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haya  Jamali</span>, <span class="hlFld-ContribAuthor ">Hasan A.  Khan</span>, <span class="hlFld-ContribAuthor ">Caroline C.  Tjin</span>, and <span class="hlFld-ContribAuthor ">Jonathan A.  Ellman</span>  . </span><span class="cited-content_cbyCitation_article-title">Cellular Activity of New Small Molecule Protein Arginine Deiminase 3 (PAD3) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (9)
                                     , 847-851. <a href="https://doi.org/10.1021/acsmedchemlett.6b00215" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00215</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00215%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCellular%252BActivity%252Bof%252BNew%252BSmall%252BMolecule%252BProtein%252BArginine%252BDeiminase%252B3%252B%252528PAD3%252529%252BInhibitors%26aulast%3DJamali%26aufirst%3DHaya%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D22052016%26date%3D11072016%26date%3D20072016%26date%3D08092016%26volume%3D7%26issue%3D9%26spage%3D847%26epage%3D851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paula F.  Carneiro</span>, <span class="hlFld-ContribAuthor ">Bernhard  Gutmann</span>, <span class="hlFld-ContribAuthor ">Rodrigo O. M. A.  de Souza</span>, and <span class="hlFld-ContribAuthor ">C. Oliver  Kappe</span>  . </span><span class="cited-content_cbyCitation_article-title">Process Intensified Flow Synthesis of 1H-4-Substituted Imidazoles: Toward the Continuous Production of Daclatasvir. </span><span class="cited-content_cbyCitation_journal-name">ACS Sustainable Chemistry & Engineering</span><span> <strong>2015,</strong> <em>3 </em>
                                    (12)
                                     , 3445-3453. <a href="https://doi.org/10.1021/acssuschemeng.5b01191" title="DOI URL">https://doi.org/10.1021/acssuschemeng.5b01191</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acssuschemeng.5b01191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facssuschemeng.5b01191%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Sustainable%2520Chemistry%2520%2526%2520Engineering%26atitle%3DProcess%252BIntensified%252BFlow%252BSynthesis%252Bof%252B1H-4-Substituted%252BImidazoles%25253A%252BToward%252Bthe%252BContinuous%252BProduction%252Bof%252BDaclatasvir%26aulast%3DCarneiro%26aufirst%3DPaula%2BF.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D30092015%26date%3D03112015%26date%3D16112015%26date%3D07122015%26date%3D08112015%26volume%3D3%26issue%3D12%26spage%3D3445%26epage%3D3453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zilun  Hu</span>, <span class="hlFld-ContribAuthor ">Pancras C.  Wong</span>, <span class="hlFld-ContribAuthor ">Paul J.  Gilligan</span>, <span class="hlFld-ContribAuthor ">Wei  Han</span>, <span class="hlFld-ContribAuthor ">Kumar B.  Pabbisetty</span>, <span class="hlFld-ContribAuthor ">Jeffrey M.  Bozarth</span>, <span class="hlFld-ContribAuthor ">Earl J.  Crain</span>, <span class="hlFld-ContribAuthor ">Timothy  Harper</span>, <span class="hlFld-ContribAuthor ">Joseph M.  Luettgen</span>, <span class="hlFld-ContribAuthor ">Joseph E.  Myers, Jr.</span>, <span class="hlFld-ContribAuthor ">Vidhyashankar  Ramamurthy</span>, <span class="hlFld-ContribAuthor ">Karen A.  Rossi</span>, <span class="hlFld-ContribAuthor ">Steven  Sheriff</span>, <span class="hlFld-ContribAuthor ">Carol A.  Watson</span>, <span class="hlFld-ContribAuthor ">Anzi  Wei</span>, <span class="hlFld-ContribAuthor ">Joanna J.  Zheng</span>, <span class="hlFld-ContribAuthor ">Dietmar A.  Seiffert</span>, <span class="hlFld-ContribAuthor ">Ruth R.  Wexler</span>, and <span class="hlFld-ContribAuthor ">Mimi L.  Quan</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent Parenterally Administered Factor XIa Inhibitor with Hydroxyquinolin-2(1H)-one as the P2′ Moiety. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (5)
                                     , 590-595. <a href="https://doi.org/10.1021/acsmedchemlett.5b00066" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00066%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252BParenterally%252BAdministered%252BFactor%252BXIa%252BInhibitor%252Bwith%252BHydroxyquinolin-2%2525281H%252529-one%252Bas%252Bthe%252BP2%2525E2%252580%2525B2%252BMoiety%26aulast%3DHu%26aufirst%3DZilun%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D05022015%26date%3D08042015%26date%3D13042015%26date%3D14052015%26date%3D08042015%26volume%3D6%26issue%3D5%26spage%3D590%26epage%3D595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Lei</span>, <span class="hlFld-ContribAuthor ">Bing  Zhang</span>, <span class="hlFld-ContribAuthor ">Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiwen  Dai</span>, <span class="hlFld-ContribAuthor ">Yulin  Duan</span>, <span class="hlFld-ContribAuthor ">Qing  Mao</span>, <span class="hlFld-ContribAuthor ">Jun  Gao</span>, <span class="hlFld-ContribAuthor ">Yuwei  Yang</span>, <span class="hlFld-ContribAuthor ">Ziyang  Bao</span>, <span class="hlFld-ContribAuthor ">Xuefeng  Fu</span>, <span class="hlFld-ContribAuthor ">Kunqi  Ping</span>, <span class="hlFld-ContribAuthor ">Chengda  Yan</span>, <span class="hlFld-ContribAuthor ">Yanhua  Mou</span>, <span class="hlFld-ContribAuthor ">Shaojie  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel FXIa inhibitors with 2-phenyl-1H-imidazole-5-carboxamide moiety as P1 fragment. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>220 </em>, 113437. <a href="https://doi.org/10.1016/j.ejmech.2021.113437" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113437</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113437%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252BFXIa%252Binhibitors%252Bwith%252B2-phenyl-1H-imidazole-5-carboxamide%252Bmoiety%252Bas%252BP1%252Bfragment%26aulast%3DLei%26aufirst%3DYu%26date%3D2021%26volume%3D220%26spage%3D113437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pancras C.  Wong</span>, <span class="hlFld-ContribAuthor ">Mimi L.  Quan</span>. </span><span class="cited-content_cbyCitation_article-title">Improved efficacy/safety profile of factor XIa inhibitor BMS‐724296 versus factor Xa inhibitor apixaban and thrombin inhibitor dabigatran in cynomolgus monkeys. </span><span class="cited-content_cbyCitation_journal-name">Research and Practice in Thrombosis and Haemostasis</span><span> <strong>2021,</strong> <em>5 </em>
                                    (4)
                                     <a href="https://doi.org/10.1002/rth2.12524" title="DOI URL">https://doi.org/10.1002/rth2.12524</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/rth2.12524&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Frth2.12524%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520and%2520Practice%2520in%2520Thrombosis%2520and%2520Haemostasis%26atitle%3DImproved%252Befficacy%25252Fsafety%252Bprofile%252Bof%252Bfactor%252BXIa%252Binhibitor%252BBMS%2525E2%252580%252590724296%252Bversus%252Bfactor%252BXa%252Binhibitor%252Bapixaban%252Band%252Bthrombin%252Binhibitor%252Bdabigatran%252Bin%252Bcynomolgus%252Bmonkeys%26aulast%3DWong%26aufirst%3DPancras%2BC.%26date%3D2021%26date%3D2021%26volume%3D5%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mimi L.  Quan</span>, <span class="hlFld-ContribAuthor ">Peter W.  Glunz</span>, <span class="hlFld-ContribAuthor ">Joseph M.  Luettgen</span>. </span><span class="cited-content_cbyCitation_article-title">Anticoagulants. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-45. <a href="https://doi.org/10.1002/0471266949.bmc182.pub2" title="DOI URL">https://doi.org/10.1002/0471266949.bmc182.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc182.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc182.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DAnticoagulants%26aulast%3DQuan%26aufirst%3DMimi%2BL.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D45%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuko  Tsuda</span>, <span class="hlFld-ContribAuthor ">Koushi  Hidaka</span>, <span class="hlFld-ContribAuthor ">Keiko  Hojo</span>, <span class="hlFld-ContribAuthor ">Yoshio  Okada</span>. </span><span class="cited-content_cbyCitation_article-title">Exploration of Active Site-Directed Plasmin Inhibitors: Beyond Tranexamic Acid. </span><span class="cited-content_cbyCitation_journal-name">Processes</span><span> <strong>2021,</strong> <em>9 </em>
                                    (2)
                                     , 329. <a href="https://doi.org/10.3390/pr9020329" title="DOI URL">https://doi.org/10.3390/pr9020329</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pr9020329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpr9020329%26sid%3Dliteratum%253Aachs%26jtitle%3DProcesses%26atitle%3DExploration%252Bof%252BActive%252BSite-Directed%252BPlasmin%252BInhibitors%25253A%252BBeyond%252BTranexamic%252BAcid%26aulast%3DTsuda%26aufirst%3DYuko%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D2%26spage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tianan  Fang</span>, <span class="hlFld-ContribAuthor ">James R.  Corte</span>, <span class="hlFld-ContribAuthor ">Paul J.  Gilligan</span>, <span class="hlFld-ContribAuthor ">Yoon  Jeon</span>, <span class="hlFld-ContribAuthor ">Honey  Osuna</span>, <span class="hlFld-ContribAuthor ">Karen A.  Rossi</span>, <span class="hlFld-ContribAuthor ">Joseph E.  Myers</span>, <span class="hlFld-ContribAuthor ">Steven  Sheriff</span>, <span class="hlFld-ContribAuthor ">Zhen  Lou</span>, <span class="hlFld-ContribAuthor ">Joanna J.  Zheng</span>, <span class="hlFld-ContribAuthor ">Timothy W.  Harper</span>, <span class="hlFld-ContribAuthor ">Jeffrey M.  Bozarth</span>, <span class="hlFld-ContribAuthor ">Yiming  Wu</span>, <span class="hlFld-ContribAuthor ">Joseph M.  Luettgen</span>, <span class="hlFld-ContribAuthor ">Dietmar A.  Seiffert</span>, <span class="hlFld-ContribAuthor ">Ruth R.  Wexler</span>, <span class="hlFld-ContribAuthor ">Patrick Y.S.  Lam</span>. </span><span class="cited-content_cbyCitation_article-title">Orally bioavailable amine-linked macrocyclic inhibitors of factor XIa. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (4)
                                     , 126949. <a href="https://doi.org/10.1016/j.bmcl.2020.126949" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.126949</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.126949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.126949%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DOrally%252Bbioavailable%252Bamine-linked%252Bmacrocyclic%252Binhibitors%252Bof%252Bfactor%252BXIa%26aulast%3DFang%26aufirst%3DTianan%26date%3D2020%26volume%3D30%26issue%3D4%26spage%3D126949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charles G.  Clark</span>, <span class="hlFld-ContribAuthor ">Karen A.  Rossi</span>, <span class="hlFld-ContribAuthor ">James R.  Corte</span>, <span class="hlFld-ContribAuthor ">Tianan  Fang</span>, <span class="hlFld-ContribAuthor ">Joanne M.  Smallheer</span>, <span class="hlFld-ContribAuthor ">Indawati  De Lucca</span>, <span class="hlFld-ContribAuthor ">David S.  Nirschl</span>, <span class="hlFld-ContribAuthor ">Michael J.  Orwat</span>, <span class="hlFld-ContribAuthor ">Donald J.P.  Pinto</span>, <span class="hlFld-ContribAuthor ">Zilun  Hu</span>, <span class="hlFld-ContribAuthor ">Yufeng  Wang</span>, <span class="hlFld-ContribAuthor ">Wu  Yang</span>, <span class="hlFld-ContribAuthor ">Yoon  Jeon</span>, <span class="hlFld-ContribAuthor ">William R.  Ewing</span>, <span class="hlFld-ContribAuthor ">Joseph E.  Myers</span>, <span class="hlFld-ContribAuthor ">Steven  Sheriff</span>, <span class="hlFld-ContribAuthor ">Zhen  Lou</span>, <span class="hlFld-ContribAuthor ">Jeffrey M.  Bozarth</span>, <span class="hlFld-ContribAuthor ">Yiming  Wu</span>, <span class="hlFld-ContribAuthor ">Alan  Rendina</span>, <span class="hlFld-ContribAuthor ">Timothy  Harper</span>, <span class="hlFld-ContribAuthor ">Joanna  Zheng</span>, <span class="hlFld-ContribAuthor ">Baomin  Xin</span>, <span class="hlFld-ContribAuthor ">Qian  Xiang</span>, <span class="hlFld-ContribAuthor ">Joseph M.  Luettgen</span>, <span class="hlFld-ContribAuthor ">Dietmar A.  Seiffert</span>, <span class="hlFld-ContribAuthor ">Ruth R.  Wexler</span>, <span class="hlFld-ContribAuthor ">Patrick Y.S.  Lam</span>. </span><span class="cited-content_cbyCitation_article-title">Structure based design of macrocyclic factor XIa inhibitors: Discovery of cyclic P1 linker moieties with improved oral bioavailability. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (19)
                                     , 126604. <a href="https://doi.org/10.1016/j.bmcl.2019.08.008" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.08.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.08.008%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%252Bbased%252Bdesign%252Bof%252Bmacrocyclic%252Bfactor%252BXIa%252Binhibitors%25253A%252BDiscovery%252Bof%252Bcyclic%252BP1%252Blinker%252Bmoieties%252Bwith%252Bimproved%252Boral%252Bbioavailability%26aulast%3DClark%26aufirst%3DCharles%2BG.%26date%3D2019%26volume%3D29%26issue%3D19%26spage%3D126604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Orsolya  Székely</span>, <span class="hlFld-ContribAuthor ">Marco  Borgi</span>, <span class="hlFld-ContribAuthor ">Gregory Y. H.  Lip</span>. </span><span class="cited-content_cbyCitation_article-title">Factor XI inhibition fulfilling the optimal expectations for ideal anticoagulation. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Emerging Drugs</span><span> <strong>2019,</strong> <em>24 </em>
                                    (1)
                                     , 55-61. <a href="https://doi.org/10.1080/14728214.2019.1591368" title="DOI URL">https://doi.org/10.1080/14728214.2019.1591368</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728214.2019.1591368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728214.2019.1591368%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Emerging%2520Drugs%26atitle%3DFactor%252BXI%252Binhibition%252Bfulfilling%252Bthe%252Boptimal%252Bexpectations%252Bfor%252Bideal%252Banticoagulation%26aulast%3DSz%25C3%25A9kely%26aufirst%3DOrsolya%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D1%26spage%3D55%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rami A.  Al-Horani</span>, <span class="hlFld-ContribAuthor ">Daniel K.  Afosah</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the discovery and development of factor XI/XIa inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2018,</strong> <em>38 </em>
                                    (6)
                                     , 1974-2023. <a href="https://doi.org/10.1002/med.21503" title="DOI URL">https://doi.org/10.1002/med.21503</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21503%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bdiscovery%252Band%252Bdevelopment%252Bof%252Bfactor%252BXI%25252FXIa%252Binhibitors%26aulast%3DAl-Horani%26aufirst%3DRami%2BA.%26date%3D2018%26date%3D2018%26volume%3D38%26issue%3D6%26spage%3D1974%26epage%3D2023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qunchao  Wei</span>, <span class="hlFld-ContribAuthor ">Zhichao  Zheng</span>, <span class="hlFld-ContribAuthor ">Shijun  Zhang</span>, <span class="hlFld-ContribAuthor ">Xuemin  Zheng</span>, <span class="hlFld-ContribAuthor ">Fancui  Meng</span>, <span class="hlFld-ContribAuthor ">Jing  Yuan</span>, <span class="hlFld-ContribAuthor ">Yongnan  Xu</span>, <span class="hlFld-ContribAuthor ">Changjiang  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Lead Generation of 5-Phenyl-1H-pyrazole-3-carboxamide Derivatives as Leads for Potent Factor Xia Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (8)
                                     , 2002. <a href="https://doi.org/10.3390/molecules23082002" title="DOI URL">https://doi.org/10.3390/molecules23082002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23082002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23082002%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DFragment-Based%252BLead%252BGeneration%252Bof%252B5-Phenyl-1H-pyrazole-3-carboxamide%252BDerivatives%252Bas%252BLeads%252Bfor%252BPotent%252BFactor%252BXia%252BInhibitors%26aulast%3DWei%26aufirst%3DQunchao%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D8%26spage%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zilun  Hu</span>, <span class="hlFld-ContribAuthor ">Cailan  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Han</span>, <span class="hlFld-ContribAuthor ">Karen A.  Rossi</span>, <span class="hlFld-ContribAuthor ">Jeffrey M.  Bozarth</span>, <span class="hlFld-ContribAuthor ">Yiming  Wu</span>, <span class="hlFld-ContribAuthor ">Steven  Sheriff</span>, <span class="hlFld-ContribAuthor ">Joseph E.  Myers</span>, <span class="hlFld-ContribAuthor ">Joseph M.  Luettgen</span>, <span class="hlFld-ContribAuthor ">Dietmar A.  Seiffert</span>, <span class="hlFld-ContribAuthor ">Ruth R.  Wexler</span>, <span class="hlFld-ContribAuthor ">Mimi L.  Quan</span>. </span><span class="cited-content_cbyCitation_article-title">Pyridazine and pyridazinone derivatives as potent and selective factor XIa inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (6)
                                     , 987-992. <a href="https://doi.org/10.1016/j.bmcl.2018.02.049" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.02.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.02.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.02.049%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPyridazine%252Band%252Bpyridazinone%252Bderivatives%252Bas%252Bpotent%252Band%252Bselective%252Bfactor%252BXIa%252Binhibitors%26aulast%3DHu%26aufirst%3DZilun%26date%3D2018%26volume%3D28%26issue%3D6%26spage%3D987%26epage%3D992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cailan  Wang</span>, <span class="hlFld-ContribAuthor ">James R.  Corte</span>, <span class="hlFld-ContribAuthor ">Karen A.  Rossi</span>, <span class="hlFld-ContribAuthor ">Jeffrey M.  Bozarth</span>, <span class="hlFld-ContribAuthor ">Yiming  Wu</span>, <span class="hlFld-ContribAuthor ">Steven  Sheriff</span>, <span class="hlFld-ContribAuthor ">Joseph E.  Myers</span>, <span class="hlFld-ContribAuthor ">Joseph M.  Luettgen</span>, <span class="hlFld-ContribAuthor ">Dietmar A.  Seiffert</span>, <span class="hlFld-ContribAuthor ">Ruth R.  Wexler</span>, <span class="hlFld-ContribAuthor ">Mimi L.  Quan</span>. </span><span class="cited-content_cbyCitation_article-title">Macrocyclic factor XIa inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (17)
                                     , 4056-4060. <a href="https://doi.org/10.1016/j.bmcl.2017.07.048" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.07.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.07.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.07.048%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DMacrocyclic%252Bfactor%252BXIa%252Binhibitors%26aulast%3DWang%26aufirst%3DCailan%26date%3D2017%26volume%3D27%26issue%3D17%26spage%3D4056%26epage%3D4060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James R.  Corte</span>, <span class="hlFld-ContribAuthor ">Wu  Yang</span>, <span class="hlFld-ContribAuthor ">Tianan  Fang</span>, <span class="hlFld-ContribAuthor ">Yufeng  Wang</span>, <span class="hlFld-ContribAuthor ">Honey  Osuna</span>, <span class="hlFld-ContribAuthor ">Amy  Lai</span>, <span class="hlFld-ContribAuthor ">William R.  Ewing</span>, <span class="hlFld-ContribAuthor ">Karen A.  Rossi</span>, <span class="hlFld-ContribAuthor ">Joseph E.  Myers</span>, <span class="hlFld-ContribAuthor ">Steven  Sheriff</span>, <span class="hlFld-ContribAuthor ">Zhen  Lou</span>, <span class="hlFld-ContribAuthor ">Joanna J.  Zheng</span>, <span class="hlFld-ContribAuthor ">Timothy W.  Harper</span>, <span class="hlFld-ContribAuthor ">Jeffrey M.  Bozarth</span>, <span class="hlFld-ContribAuthor ">Yiming  Wu</span>, <span class="hlFld-ContribAuthor ">Joseph M.  Luettgen</span>, <span class="hlFld-ContribAuthor ">Dietmar A.  Seiffert</span>, <span class="hlFld-ContribAuthor ">Mimi L.  Quan</span>, <span class="hlFld-ContribAuthor ">Ruth R.  Wexler</span>, <span class="hlFld-ContribAuthor ">Patrick Y.S.  Lam</span>. </span><span class="cited-content_cbyCitation_article-title">Macrocyclic inhibitors of Factor XIa: Discovery of alkyl-substituted macrocyclic amide linkers with improved potency. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (16)
                                     , 3833-3839. <a href="https://doi.org/10.1016/j.bmcl.2017.06.058" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.06.058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.06.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.06.058%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DMacrocyclic%252Binhibitors%252Bof%252BFactor%252BXIa%25253A%252BDiscovery%252Bof%252Balkyl-substituted%252Bmacrocyclic%252Bamide%252Blinkers%252Bwith%252Bimproved%252Bpotency%26aulast%3DCorte%26aufirst%3DJames%2BR.%26date%3D2017%26volume%3D27%26issue%3D16%26spage%3D3833%26epage%3D3839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.L.  Quan</span>, <span class="hlFld-ContribAuthor ">P.W.  Glunz</span>, <span class="hlFld-ContribAuthor ">J.M.  Smallheer</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in Anticoagulants. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 600-627. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12433-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12433-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12433-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12433-3%26sid%3Dliteratum%253Aachs%26atitle%3DAdvances%252Bin%252BAnticoagulants%26aulast%3DQuan%26aufirst%3DM.L.%26date%3D2017%26spage%3D600%26epage%3D627%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James R.  Corte</span>, <span class="hlFld-ContribAuthor ">Tianan  Fang</span>, <span class="hlFld-ContribAuthor ">Donald J.P.  Pinto</span>, <span class="hlFld-ContribAuthor ">Michael J.  Orwat</span>, <span class="hlFld-ContribAuthor ">Alan R.  Rendina</span>, <span class="hlFld-ContribAuthor ">Joseph M.  Luettgen</span>, <span class="hlFld-ContribAuthor ">Karen A.  Rossi</span>, <span class="hlFld-ContribAuthor ">Anzhi  Wei</span>, <span class="hlFld-ContribAuthor ">Vidhyashankar  Ramamurthy</span>, <span class="hlFld-ContribAuthor ">Joseph E.  Myers</span>, <span class="hlFld-ContribAuthor ">Steven  Sheriff</span>, <span class="hlFld-ContribAuthor ">Rangaraj  Narayanan</span>, <span class="hlFld-ContribAuthor ">Timothy W.  Harper</span>, <span class="hlFld-ContribAuthor ">Joanna J.  Zheng</span>, <span class="hlFld-ContribAuthor ">Yi-Xin  Li</span>, <span class="hlFld-ContribAuthor ">Dietmar A.  Seiffert</span>, <span class="hlFld-ContribAuthor ">Ruth R.  Wexler</span>, <span class="hlFld-ContribAuthor ">Mimi L.  Quan</span>. </span><span class="cited-content_cbyCitation_article-title">Orally bioavailable pyridine and pyrimidine-based Factor XIa inhibitors: Discovery of the methyl N-phenyl carbamate P2 prime group. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (10)
                                     , 2257-2272. <a href="https://doi.org/10.1016/j.bmc.2016.03.062" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.03.062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.03.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.03.062%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DOrally%252Bbioavailable%252Bpyridine%252Band%252Bpyrimidine-based%252BFactor%252BXIa%252Binhibitors%25253A%252BDiscovery%252Bof%252Bthe%252Bmethyl%252BN-phenyl%252Bcarbamate%252BP2%252Bprime%252Bgroup%26aulast%3DCorte%26aufirst%3DJames%2BR.%26date%3D2016%26volume%3D24%26issue%3D10%26spage%3D2257%26epage%3D2272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monirah A.  Al-Alshaikh</span>, <span class="hlFld-ContribAuthor ">Sheena  Mary Y</span>, <span class="hlFld-ContribAuthor ">C. Yohannan  Panicker</span>, <span class="hlFld-ContribAuthor ">Mohamed I.  Attia</span>, <span class="hlFld-ContribAuthor ">Ali A.  El-Emam</span>, <span class="hlFld-ContribAuthor ">C. Van  Alsenoy</span>. </span><span class="cited-content_cbyCitation_article-title">Spectroscopic investigations and molecular docking study of 3-(1H-imidazol-1-yl)-1-phenylpropan-1-one, a potential precursor to bioactive agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2016,</strong> <em>1109 </em>, 131-138. <a href="https://doi.org/10.1016/j.molstruc.2015.12.075" title="DOI URL">https://doi.org/10.1016/j.molstruc.2015.12.075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2015.12.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2015.12.075%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DSpectroscopic%252Binvestigations%252Band%252Bmolecular%252Bdocking%252Bstudy%252Bof%252B3-%2525281H-imidazol-1-yl%252529-1-phenylpropan-1-one%25252C%252Ba%252Bpotential%252Bprecursor%252Bto%252Bbioactive%252Bagents%26aulast%3DAl-Alshaikh%26aufirst%3DMonirah%2BA.%26date%3D2016%26volume%3D1109%26spage%3D131%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rami A.  Al-Horani</span>, <span class="hlFld-ContribAuthor ">Umesh R.  Desai</span>. </span><span class="cited-content_cbyCitation_article-title">Factor XIa inhibitors: A review of the patent literature. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2016,</strong> <em>26 </em>
                                    (3)
                                     , 323-345. <a href="https://doi.org/10.1517/13543776.2016.1154045" title="DOI URL">https://doi.org/10.1517/13543776.2016.1154045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2016.1154045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2016.1154045%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DFactor%252BXIa%252Binhibitors%25253A%252BA%252Breview%252Bof%252Bthe%252Bpatent%252Bliterature%26aulast%3DAl-Horani%26aufirst%3DRami%2BA.%26date%3D2016%26date%3D2016%26volume%3D26%26issue%3D3%26spage%3D323%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leon M.  Smith</span>, <span class="hlFld-ContribAuthor ">Michael J.  Orwat</span>, <span class="hlFld-ContribAuthor ">Zilun  Hu</span>, <span class="hlFld-ContribAuthor ">Wei  Han</span>, <span class="hlFld-ContribAuthor ">Cailan  Wang</span>, <span class="hlFld-ContribAuthor ">Karen A.  Rossi</span>, <span class="hlFld-ContribAuthor ">Paul J.  Gilligan</span>, <span class="hlFld-ContribAuthor ">Kumar B.  Pabbisetty</span>, <span class="hlFld-ContribAuthor ">Honey  Osuna</span>, <span class="hlFld-ContribAuthor ">James R.  Corte</span>, <span class="hlFld-ContribAuthor ">Alan R.  Rendina</span>, <span class="hlFld-ContribAuthor ">Joseph M.  Luettgen</span>, <span class="hlFld-ContribAuthor ">Pancras C.  Wong</span>, <span class="hlFld-ContribAuthor ">Ranga  Narayanan</span>, <span class="hlFld-ContribAuthor ">Timothy W.  Harper</span>, <span class="hlFld-ContribAuthor ">Jeffrey M.  Bozarth</span>, <span class="hlFld-ContribAuthor ">Earl J.  Crain</span>, <span class="hlFld-ContribAuthor ">Anzhi  Wei</span>, <span class="hlFld-ContribAuthor ">Vidhyashankar  Ramamurthy</span>, <span class="hlFld-ContribAuthor ">Paul E.  Morin</span>, <span class="hlFld-ContribAuthor ">Baomin  Xin</span>, <span class="hlFld-ContribAuthor ">Joanna  Zheng</span>, <span class="hlFld-ContribAuthor ">Dietmar A.  Seiffert</span>, <span class="hlFld-ContribAuthor ">Mimi L.  Quan</span>, <span class="hlFld-ContribAuthor ">Patrick Y.S.  Lam</span>, <span class="hlFld-ContribAuthor ">Ruth R.  Wexler</span>, <span class="hlFld-ContribAuthor ">Donald J.P.  Pinto</span>. </span><span class="cited-content_cbyCitation_article-title">Novel phenylalanine derived diamides as Factor XIa inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (2)
                                     , 472-478. <a href="https://doi.org/10.1016/j.bmcl.2015.11.089" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.11.089</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.11.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.11.089%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252Bphenylalanine%252Bderived%252Bdiamides%252Bas%252BFactor%252BXIa%252Binhibitors%26aulast%3DSmith%26aufirst%3DLeon%2BM.%26date%3D2016%26volume%3D26%26issue%3D2%26spage%3D472%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ravi Kiran  Bhaskarachar</span>, <span class="hlFld-ContribAuthor ">Vijayakumar G.  Revanasiddappa</span>, <span class="hlFld-ContribAuthor ">Subramanya  Hegde</span>, <span class="hlFld-ContribAuthor ">Janardhana P.  Balakrishna</span>, <span class="hlFld-ContribAuthor ">Suman Y.  Reddy</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and anticancer activity of functionalized spiro-quinolines with barbituric and thiobarbituric acids. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2015,</strong> <em>24 </em>
                                    (9)
                                     , 3516-3528. <a href="https://doi.org/10.1007/s00044-015-1408-7" title="DOI URL">https://doi.org/10.1007/s00044-015-1408-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-015-1408-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-015-1408-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Banticancer%252Bactivity%252Bof%252Bfunctionalized%252Bspiro-quinolines%252Bwith%252Bbarbituric%252Band%252Bthiobarbituric%252Bacids%26aulast%3DBhaskarachar%26aufirst%3DRavi%2BKiran%26date%3D2015%26date%3D2015%26volume%3D24%26issue%3D9%26spage%3D3516%26epage%3D3528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D.  Gailani</span>, <span class="hlFld-ContribAuthor ">C. E.  Bane</span>, <span class="hlFld-ContribAuthor ">A.  Gruber</span>. </span><span class="cited-content_cbyCitation_article-title">Factor XI and contact activation as targets for antithrombotic therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Thrombosis and Haemostasis</span><span> <strong>2015,</strong> <em>13 </em>
                                    (8)
                                     , 1383-1395. <a href="https://doi.org/10.1111/jth.13005" title="DOI URL">https://doi.org/10.1111/jth.13005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jth.13005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjth.13005%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Thrombosis%2520and%2520Haemostasis%26atitle%3DFactor%252BXI%252Band%252Bcontact%252Bactivation%252Bas%252Btargets%252Bfor%252Bantithrombotic%252Btherapy%26aulast%3DGailani%26aufirst%3DD.%26date%3D2015%26date%3D2015%26volume%3D13%26issue%3D8%26spage%3D1383%26epage%3D1395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Donald J.P.  Pinto</span>, <span class="hlFld-ContribAuthor ">Joanne M.  Smallheer</span>, <span class="hlFld-ContribAuthor ">James R.  Corte</span>, <span class="hlFld-ContribAuthor ">Erin J.D.  Austin</span>, <span class="hlFld-ContribAuthor ">Cailan  Wang</span>, <span class="hlFld-ContribAuthor ">Tianan  Fang</span>, <span class="hlFld-ContribAuthor ">Leon M.  Smith</span>, <span class="hlFld-ContribAuthor ">Karen A.  Rossi</span>, <span class="hlFld-ContribAuthor ">Alan R.  Rendina</span>, <span class="hlFld-ContribAuthor ">Jeffrey M.  Bozarth</span>, <span class="hlFld-ContribAuthor ">Ge  Zhang</span>, <span class="hlFld-ContribAuthor ">Anzhi  Wei</span>, <span class="hlFld-ContribAuthor ">Vidhyashankar  Ramamurthy</span>, <span class="hlFld-ContribAuthor ">Steven  Sheriff</span>, <span class="hlFld-ContribAuthor ">Joseph E.  Myers</span>, <span class="hlFld-ContribAuthor ">Paul E.  Morin</span>, <span class="hlFld-ContribAuthor ">Joseph M.  Luettgen</span>, <span class="hlFld-ContribAuthor ">Dietmar A.  Seiffert</span>, <span class="hlFld-ContribAuthor ">Mimi L.  Quan</span>, <span class="hlFld-ContribAuthor ">Ruth R.  Wexler</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design of inhibitors of coagulation factor XIa with novel P1 moieties. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (7)
                                     , 1635-1642. <a href="https://doi.org/10.1016/j.bmcl.2015.01.028" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.01.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.01.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.01.028%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-based%252Bdesign%252Bof%252Binhibitors%252Bof%252Bcoagulation%252Bfactor%252BXIa%252Bwith%252Bnovel%252BP1%252Bmoieties%26aulast%3DPinto%26aufirst%3DDonald%2BJ.P.%26date%3D2015%26volume%3D25%26issue%3D7%26spage%3D1635%26epage%3D1642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James R.  Corte</span>, <span class="hlFld-ContribAuthor ">Tianan  Fang</span>, <span class="hlFld-ContribAuthor ">Jon J.  Hangeland</span>, <span class="hlFld-ContribAuthor ">Todd J.  Friends</span>, <span class="hlFld-ContribAuthor ">Alan R.  Rendina</span>, <span class="hlFld-ContribAuthor ">Joseph M.  Luettgen</span>, <span class="hlFld-ContribAuthor ">Jeffrey M.  Bozarth</span>, <span class="hlFld-ContribAuthor ">Frank A.  Barbera</span>, <span class="hlFld-ContribAuthor ">Karen A.  Rossi</span>, <span class="hlFld-ContribAuthor ">Anzhi  Wei</span>, <span class="hlFld-ContribAuthor ">Vidhyashankar  Ramamurthy</span>, <span class="hlFld-ContribAuthor ">Paul E.  Morin</span>, <span class="hlFld-ContribAuthor ">Dietmar A.  Seiffert</span>, <span class="hlFld-ContribAuthor ">Ruth R.  Wexler</span>, <span class="hlFld-ContribAuthor ">Mimi L.  Quan</span>. </span><span class="cited-content_cbyCitation_article-title">Pyridine and pyridinone-based factor XIa inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (4)
                                     , 925-930. <a href="https://doi.org/10.1016/j.bmcl.2014.12.050" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.12.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.12.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.12.050%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPyridine%252Band%252Bpyridinone-based%252Bfactor%252BXIa%252Binhibitors%26aulast%3DCorte%26aufirst%3DJames%2BR.%26date%3D2015%26volume%3D25%26issue%3D4%26spage%3D925%26epage%3D930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010607&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Published active site inhibitors of FXIa.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010607&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Computer model of compound <b>11h</b> (salmon) overlaid onto the X-ray crystal structure of compound <b>3</b>/FXIa complex (cyan). Hydrogen bonds between the amide nitrogen located at C-4 of the terminal phenyl ring of the biphenyl contained in compound <b>3</b> are represented by a series of gray prolate ellipsoids. Figure was prepared with PyMol (Schrödinger).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010607&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray crystal structure of compound <b>11h</b> complexed to FXIa. The initial <i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> electron density contoured at 3 rmsd is shown with the final model. The protein is shown with yellow carbon atoms and secondary structural elements, and <b>11h</b> is shown with orange carbon atoms. Nitrogen atoms are shown in blue, oxygen atoms in red, and sulfur atoms in a darker yellow. The red spheres represent crystallographic water molecules. A single crystallographic ethylene glycol molecule is present. Hydrogen bonds are represented by a series of gray prolate ellipsoids. Figure was prepared with PyMol (Schrödinger).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010607&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray crystal structure of compound <b>16b</b> complexed to FXIa. The initial <i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> electron density contoured at 4 rmsd is shown with the final model. The protein is shown with yellow carbon atoms and secondary structural elements, and <b>16b</b> is shown with green carbon atoms. Nitrogen atoms are shown in blue, oxygen atoms in red, sulfur atoms in a darker yellow, and the chlorine atom in orange. The red spheres represent crystallographic water molecules. Hydrogen bonds are represented by a series of gray prolate ellipsoids. Figure was prepared with PyMol (Schrödinger).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010607&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Rabbit AV-shunt data. Compound <b>16b</b> was given as a single loading dose followed by continuous iv infusion at three doses: 0.1 mg/kg + 0.16 mg kg<sup>–1</sup> h<sup>–1</sup>, 0.5 mg/kg + 0.8 mg kg<sup>–1</sup> h<sup>–1</sup>, 2.5 mg/kg + 4 mg kg<sup>–1</sup> h<sup>–1</sup>. Thrombi formed were removed from the shunt and weighed. % inhibition values are relative to thrombus formation prior to drug treatment. ID<sub>50</sub> = 0.6 mg/kg + 1 mg kg<sup>–1</sup> h<sup>–1</sup>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010607&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Phenylimidazoles <b>11a</b>–<b>s</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010607&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <b>7</b>, Cs<sub>2</sub>CO<sub>3</sub>, EtOH/H<sub>2</sub>O (1:1), rt, 1 h; (b) Cs salt from (a), <b>8a</b>–<b>g</b>, DMF, rt, 1 h; (c) NH<sub>4</sub>OAc, xylenes, reflux (Dean–Stark), 3 h; (d) 10–30% (v/v) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (e) <i>N</i>-Boc-tranexamic acid, BOP, pyridine, DMF, rt, 16 h or EDC, HOBt, <i>N</i>-methylmorpholine, DMF, rt, 16 h; (f) K<sub>2</sub>CO<sub>3</sub>, 30% aq H<sub>2</sub>O<sub>2</sub>, MgO, DMSO, rt, 4 h; (g) NaOH, MgO, CH<sub>3</sub>OH/EtOAc (5:1), rt, 5 h; (h) NaOH, MeOH, rt, 16 h; (i) Br<sub>2</sub>, CHCl<sub>3</sub>, rt, 16 h; (j) NCS, ACN, reflux, 7 h; (k) Selectfluor, DMF/H<sub>2</sub>O (10:1), rt, 2 h; (l) methylamine (<b>10m</b>) or dimethylamine (<b>10n</b>), HOBt, EDC, <i>N</i>-methylmorpholine, DMF, rt, 16 h; (m) conc NH<sub>4</sub>OH, HOAt, EDC, <i>N</i>-methylmorpholine, DMF, rt, 16 h.</p></p></figure><figure data-id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Aminoindazole Analogs <b>16a</b>–<b>c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010607&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Zn(CN)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF, 90 °C, 3 h; (b) (i) oxalyl chloride, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h, then reflux, 1 h, (ii) TMSCH<sub>2</sub>N<sub>2</sub>, ACN, −15 °C, 1 h, (iii) HBr (33% by mass) in HOAc, −15 °C, 20 min (39% over two steps); (c) <b>7</b>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 15 °C, 1 h (61%); (d) NH<sub>4</sub>OAc, xylenes, reflux (Dean–Stark), 2.5 h (41%); (e) NCS, ACN, reflux, 7 h (99%); (f) Selectfluor, DMF/H<sub>2</sub>O (10:1), rt, 2 h (27%); (g) 20% TFA (v/v), CH<sub>2</sub>Cl<sub>2</sub>, rt, 30 min; (h) <i>N</i>-Boc-tranexamic acid, BOP, TEA, THF, 75 °C, 15 min; (i) 20% TFA (v/v), CH<sub>2</sub>Cl<sub>2</sub>, rt, 30 min (>67% for three steps for <b>15b</b>); (j) NH<sub>2</sub>NH<sub>2</sub>·H<sub>2</sub>O, <i>n</i>-BuOH, 120 °C, 1 h (54% for <b>16b</b>).</p></p></figure><figure data-id="sch3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <i>trans</i>-4-(Aminomethyl)-<i>N</i>-((<i>S</i>)-2-phenyl-1-(5-phenyloxazol-2-yl)ethyl)cyclohexanecarboxamide (<b>20</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010607&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) BOP, anhyd pyridine, rt, 16 h (100%); (b) POCl<sub>3</sub>, DMF, 90 °C, 30 min (41%); (c) hydrazine, EtOH, reflux, 2 h (90%); (d) <i>N</i>-Boc-tranexamic acid, HOAt, EDC, <i>N</i>-methylmorpholine, DMF, rt, 1 h; (e) 10% (v/v) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h (26% over two steps).</p></p></figure><figure data-id="sch4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of <i>trans</i>-4-(Aminomethyl)-<i>N</i>-((<i>S</i>)-2-phenyl-1-(3-phenyl-1<i>H</i>-1,2,4-triazol-5-yl)ethyl)cyclohexanecarboxamide (<b>22</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010607&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Hydrazine, BOP-Cl, anhydrous pyridine, rt, 16 h (100%); (b) ethyl benzimidate·HCl, Et<sub>3</sub>N, ACN, reflux, 24 h (42%); (c) 10% (v/v) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h; (d) <i>N</i>-Boc-tranexamic acid, BOP-Cl, anhydrous pyridine, rt, 12 h; (e) 30% (v/v) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 h (28% over three steps).</p></p></figure><figure data-id="sch5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of <i>trans</i>-4-(Aminomethyl)-<i>N</i>-((<i>S</i>)-2-phenyl-1-(3-phenyl-1<i>H</i>-pyrazol-5-yl)ethyl)cyclohexanecarboxamide (<b>27</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010607&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (i) <b>23</b>, 1 N NaOH/EtOH (1:1), rt, 72 h; (ii) Mg(OEt)<sub>2</sub>, MeOH, 4 h; (b) (i) <b>24</b>, CDI, DMF, 2 h, rt; (ii) intermediate from (a), DMF, rt, 24 h (13%); (c) anhydrous hydrazine, EtOH, 60 °C, 3 h (100%); (d) 10% Pd/C, MeOH, 1 atm H<sub>2</sub>, 4 h (57%); (e) <i>N</i>-Boc-tranexamic acid, BOP-Cl, anhydrous pyridine, rt, 12 h; (f) 30% (v/v) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 h (46% over two steps).</p></p></figure><figure data-id="sch6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <i>trans</i>-4-(Aminomethyl)-<i>N</i>-((<i>S</i>)-1-(5-oxo-1-phenyl-4,5-dihydro-1<i>H</i>-1,2,4-triazol-3-yl)-2-phenylethyl)cyclohexanecarboxamide (<b>30</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010607&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (i) NaOCH<sub>3</sub>, MeOH, 30 °C, 3 h, (ii) HOAc, phenylhydrazine, rt, 18 h (28%); (b) carbonyl dimidazole, THF, reflux, 48 h (66%); (c) 10% Pd/C, MeOH, 1 atm H<sub>2</sub>, 4 h (57%); (d) <i>N</i>-Boc-tranexamic acid, BOP-Cl, anhydrous pyridine, rt, 12 h; (e) 30% (v/v) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 h (46% over two steps).</p></p></figure><figure data-id="sch7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/medium/jm-2014-010607_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of <i>trans</i>-4-(Aminomethyl)-<i>N</i>-((<i>S</i>)-2-phenyl-1-(2-phenyl-1<i>H</i>-imidazol-4-yl)ethyl)cyclohexanecarboxamide <b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5010607/20141205/images/large/jm-2014-010607_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5010607&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (i) sodium formate, EtOH, reflux, 14 h, (ii) add benzamidine, NaHCO<sub>3</sub>, reflux, 24 h (8%); (b) 10% Pd/C, MeOH, 1 atm H<sub>2</sub>, 4 h (57%); (c) <i>N</i>-Boc-tranexamic acid, BOP-Cl, anhydrous pyridine, rt, 12 h; (d) 30% (v/v) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 h (46% over two steps).</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i83">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38504" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38504" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 24 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jackson, S. P.</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1423</span><span class="NLM_x">–</span> <span class="NLM_lpage">1436</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1038%2Fnm.2515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=22064432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOisL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Jackson%2C+S.+P.Nat.+Med.+2011%2C+17%2C+1423%E2%80%931436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Arterial thrombosis-insidious, unpredictable and deadly</span></div><div class="casAuthors">Jackson, Shaun P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1423-1436</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The formation of blood clots-thrombosis-at sites of atherosclerotic plaque rupture is a major clin. problem despite ongoing improvements in antithrombotic therapy.  Progress in identifying the pathogenic mechanisms regulating arterial thrombosis has led to the development of newer therapeutics, and there is general anticipation that these treatments will have greater efficacy and improved safety.  However, major advances in this field require the identification of specific risk factors for arterial thrombosis in affected individuals and a rethink of the 'one size fits all' approach to antithrombotic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou9_kt5O0PGbVg90H21EOLACvtfcHk0liTlCu2fK-eKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOisL3E&md5=86c00e091a7225bbc0278d921bc77451</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2Fnm.2515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2515%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DS.%2BP.%26jtitle%3DNat.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D1423%26epage%3D1436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span> </span><span class="NLM_article-title">Global Status Report on Noncommunicable Diseases 2010</span>. <span class="NLM_publisher-name">WHO Press</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Global+Status+Report+on+Noncommunicable+Diseases+2010.+WHO+Press%3A+Geneva%2C+Switzerland%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DGlobal%2520Status%2520Report%2520on%2520Noncommunicable%2520Diseases%25202010%26pub%3DWHO%2520Press%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span> </span><span class="NLM_article-title">WHO Fact Sheet No. 310</span>. <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>, June<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+WHO+Fact+Sheet+No.+310.+World+Health+Organization%3A+Geneva%2C+Switzerland%2C+June+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DWHO%2520Fact%2520Sheet%2520No.%2520310%26pub%3DWorld%2520Health%2520Organization%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mcfarlane, R.</span><span> </span><span class="NLM_article-title">An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">499</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=1964&pages=498-499&author=R.+Mcfarlane&title=An+enzyme+cascade+in+the+blood+clotting+mechanism%2C+and+its+function+as+a+biochemical+amplifier"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcfarlane%26aufirst%3DR.%26atitle%3DAn%2520enzyme%2520cascade%2520in%2520the%2520blood%2520clotting%2520mechanism%252C%2520and%2520its%2520function%2520as%2520a%2520biochemical%2520amplifier%26jtitle%3DNature%26date%3D1964%26volume%3D202%26spage%3D498%26epage%3D499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Davie, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnoff, O.</span><span> </span><span class="NLM_article-title">Waterfall sequence for intrinsic clotting</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">1310</span><span class="NLM_x">–</span> <span class="NLM_lpage">1313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=1964&pages=1310-1313&author=E.+W.+Davieauthor=O.+Ratnoff&title=Waterfall+sequence+for+intrinsic+clotting"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavie%26aufirst%3DE.%2BW.%26aulast%3DRatnoff%26aufirst%3DO.%26atitle%3DWaterfall%2520sequence%2520for%2520intrinsic%2520clotting%26jtitle%3DScience%26date%3D1964%26volume%3D145%26spage%3D1310%26epage%3D1313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Davie, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisiel, W.</span><span> </span><span class="NLM_article-title">The coagulation cascade: initiation, maintenance and regulation</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">10363</span><span class="NLM_x">–</span> <span class="NLM_lpage">10370</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00107a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1991&pages=10363-10370&author=E.+W.+Davieauthor=K.+Fujikawaauthor=W.+Kisiel&title=The+coagulation+cascade%3A+initiation%2C+maintenance+and+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1021%2Fbi00107a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00107a001%26sid%3Dliteratum%253Aachs%26aulast%3DDavie%26aufirst%3DE.%2BW.%26aulast%3DFujikawa%26aufirst%3DK.%26aulast%3DKisiel%26aufirst%3DW.%26atitle%3DThe%2520coagulation%2520cascade%253A%2520initiation%252C%2520maintenance%2520and%2520regulation%26jtitle%3DBiochemistry%26date%3D1991%26volume%3D30%26spage%3D10363%26epage%3D10370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Gailani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broze, G.</span><span> </span><span class="NLM_article-title">Factor XI activation in a revised model of blood coagulation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">253</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">912</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1126%2Fscience.1652157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=1652157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADyaK3MXlvVShtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1991&pages=909-912&author=D.+Gailaniauthor=G.+Broze&title=Factor+XI+activation+in+a+revised+model+of+blood+coagulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2dR"><div class="casContent"><span class="casTitleNuber">2d</span><div class="casTitle"><span class="NLM_cas:atitle">Factor XI activation in a revised model of blood coagulation</span></div><div class="casAuthors">Gailani, David; Broze, George J., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">253</span>
        (<span class="NLM_cas:issue">5022</span>),
    <span class="NLM_cas:pages">909-12</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Coagulation factor XI is activated in vitro by factor XIIa in the presence of high-mol.-wt. kininogen (HMWK) and a neg. charged surface.  Factor XII deficiency is not assocd. with bleeding, which suggests that another mechanism for factor XI activation exists in vivo.  A revised model of coagulation is proposed in which factor XI is activated by thrombin.  In the absence of cofactors, thrombin is more effective (kcat/Km = 1.6 × 105) than factor XIIa (1.7 × 104) in activating factor XI.  Dextran sulfate enhances activation of factor XI by thrombin 2000-fold; part of this effect is due to autoactivation of factor XI by activated factor XI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrM9Iw-blL8N7Vg90H21EOLACvtfcHk0lhYvAwolZvQ3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlvVShtr8%253D&md5=acd04c34f4b36eb87a368b765ffe9cc8</span></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=10.1126%2Fscience.1652157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1652157%26sid%3Dliteratum%253Aachs%26aulast%3DGailani%26aufirst%3DD.%26aulast%3DBroze%26aufirst%3DG.%26atitle%3DFactor%2520XI%2520activation%2520in%2520a%2520revised%2520model%2520of%2520blood%2520coagulation%26jtitle%3DScience%26date%3D1991%26volume%3D253%26spage%3D909%26epage%3D912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Müller, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutch, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esterl, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spronk, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidbauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gahl, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrissey, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renné, T.</span><span> </span><span class="NLM_article-title">Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">1143</span><span class="NLM_x">–</span> <span class="NLM_lpage">1156</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2009&pages=1143-1156&author=F.+M%C3%BCllerauthor=N.+J.+Mutchauthor=W.+A.+Schenkauthor=S.+A.+Smithauthor=L.+Esterlauthor=H.+M.+Spronkauthor=S.+Schmidbauerauthor=W.+A.+Gahlauthor=J.+H.+Morrisseyauthor=T.+Renn%C3%A9&title=Platelet+polyphosphates+are+proinflammatory+and+procoagulant+mediators+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DF.%26aulast%3DMutch%26aufirst%3DN.%2BJ.%26aulast%3DSchenk%26aufirst%3DW.%2BA.%26aulast%3DSmith%26aufirst%3DS.%2BA.%26aulast%3DEsterl%26aufirst%3DL.%26aulast%3DSpronk%26aufirst%3DH.%2BM.%26aulast%3DSchmidbauer%26aufirst%3DS.%26aulast%3DGahl%26aufirst%3DW.%2BA.%26aulast%3DMorrissey%26aufirst%3DJ.%2BH.%26aulast%3DRenn%25C3%25A9%26aufirst%3DT.%26atitle%3DPlatelet%2520polyphosphates%2520are%2520proinflammatory%2520and%2520procoagulant%2520mediators%2520in%2520vivo%26jtitle%3DCell%26date%3D2009%26volume%3D139%26spage%3D1143%26epage%3D1156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Chatterjee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogler, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siedlecki, C. A.</span><span> </span><span class="NLM_article-title">Contributions of contact activation pathways of coagulation factor XII in plasma</span> <span class="citation_source-journal">J. Biomed. Mater. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">90A</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90A&publication_year=2009&pages=27-34&author=K.+Chatterjeeauthor=Z.+Guoauthor=E.+A.+Voglerauthor=C.+A.+Siedlecki&title=Contributions+of+contact+activation+pathways+of+coagulation+factor+XII+in+plasma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChatterjee%26aufirst%3DK.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DVogler%26aufirst%3DE.%2BA.%26aulast%3DSiedlecki%26aufirst%3DC.%2BA.%26atitle%3DContributions%2520of%2520contact%2520activation%2520pathways%2520of%2520coagulation%2520factor%2520XII%2520in%2520plasma%26jtitle%3DJ.%2520Biomed.%2520Mater.%2520Res.%26date%3D2009%26volume%3D90A%26spage%3D27%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Asakai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davie, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seligsohn, U.</span><span> </span><span class="NLM_article-title">Factor XI deficiency in Ashkenazi Jews in Israel</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1056%2FNEJM199107183250303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=2052060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A280%3ADyaK3M3ntVehtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=1991&pages=153-158&author=R.+Asakaiauthor=D.+Chungauthor=E.+Davieauthor=U.+Seligsohn&title=Factor+XI+deficiency+in+Ashkenazi+Jews+in+Israel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Factor XI deficiency in Ashkenazi Jews in Israel</span></div><div class="casAuthors">Asakai R; Chung D W; Davie E W; Seligsohn U</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">153-8</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND AND METHODS:  Severe factor XI deficiency, which is relatively common among Ashkenazi Jews, is associated with injury-related bleeding of considerable severity.  Three point mutations--a splice-junction abnormality (Type I), Glu117----Stop (Type II), and Phe283----Leu (Type III)--have been described in six patients with factor XI deficiency.  Clinical correlations with these mutations have not been carried out.  We determined the relative frequency of the mutations and their association with plasma levels of factor XI clotting activity and bleeding, analyzing the mutations with the polymerase chain reaction and restriction-enzyme digestion.  RESULTS:  The Type II and Type III mutations had similar frequencies among 43 Ashkenazi Jewish probands with severe factor XI deficiency; these two mutations accounted for 49 percent and 47 percent, respectively, of a total of 86 analyzed alleles.  Among 40 of the probands and 12 of their relatives with severe factor XI deficiency, patients homozygous for Type III mutation had a significantly higher level of factor XI clotting activity (mean [+/- SD] percentage of normal values, 9.7 +/- 3.8 percent; n = 13) than those homozygous for Type II mutation (1.2 +/- 0.5 percent, n = 16) or compound heterozygotes with Type II/III mutation (3.3 +/- 1.6 percent, n = 23), as well as significantly fewer episodes of injury-related bleeding.  Each of these three groups had a similarly increased proportion of episodes of bleeding complications after surgery at sites with enhanced local fibrinolysis, such as the urinary tract, or during tooth extraction.  CONCLUSIONS:  Type II and Type III mutations are the predominant causes of factor XI deficiency among Ashkenazi Jews.  Genotypic analysis, assay for factor XI, and consideration of the type and location of surgery can be helpful in planning operations in patients with this disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQVeX6-t8nFPty3lHz94U-GfW6udTcc2eZBcLc1Evhwmbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M3ntVehtQ%253D%253D&md5=25973c99d4f25e1f5ec74bb56b156b33</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1056%2FNEJM199107183250303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199107183250303%26sid%3Dliteratum%253Aachs%26aulast%3DAsakai%26aufirst%3DR.%26aulast%3DChung%26aufirst%3DD.%26aulast%3DDavie%26aufirst%3DE.%26aulast%3DSeligsohn%26aufirst%3DU.%26atitle%3DFactor%2520XI%2520deficiency%2520in%2520Ashkenazi%2520Jews%2520in%2520Israel%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1991%26volume%3D325%26spage%3D153%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gailani, D.; Broze, G. J.</span><span> </span><span class="NLM_article-title">Factor XI and the Contact System</span>. In  <span class="citation_source-book">The Metabolic and Molecular Basis of Inherited Disease</span>, <span class="NLM_edition">8</span>th ed.; <span class="NLM_contrib-group">Scriver, C. R.; Beaudet, A. L.; Sly, W. S.; Valle, D.; Childs, B.; Kinzler, K. W.; Vogelstein, B.</span>, Eds.; <span class="NLM_publisher-name">McGraw-Hill</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2001</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">4433</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=4433&author=D.+Gailani&author=G.+J.+Brozeauthor=C.+R.+Scriver&author=A.+L.+Beaudet&author=W.+S.+Sly&author=D.+Valle&author=B.+Childs&author=K.+W.+Kinzler&author=B.+Vogelstein&title=The+Metabolic+and+Molecular+Basis+of+Inherited+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DGailani%26aufirst%3DD.%26atitle%3DFactor%2520XI%2520and%2520the%2520Contact%2520System%26btitle%3DThe%2520Metabolic%2520and%2520Molecular%2520Basis%2520of%2520Inherited%2520Disease%26aulast%3DScriver%26aufirst%3DC.%2BR.%26pub%3DMcGraw-Hill%26date%3D2001%26spage%3D4433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Gailani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renné, T.</span><span> </span><span class="NLM_article-title">The intrinsic pathway for coagulation: A target for treating thromboembolic disease?</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1106</span><span class="NLM_x">–</span> <span class="NLM_lpage">1112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1111%2Fj.1538-7836.2007.02446.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=17388803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntl2ksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=1106-1112&author=D.+Gailaniauthor=T.+Renn%C3%A9&title=The+intrinsic+pathway+for+coagulation%3A+A+target+for+treating+thromboembolic+disease%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">The intrinsic pathway of coagulation: a target for treating thromboembolic disease?</span></div><div class="casAuthors">Gailani, D.; Renne, T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1106-1112</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">A review.  The classic intrinsic pathway of coagulation is triggered by contact activation of the plasma protease factor (F)XII, followed by sequential proteolytic activation of FXI and FIX.  While a key mechanism for initiating coagulation in some clin. useful in vitro assays, the absence of abnormal bleeding assocd. with congenital FXII deficiency indicates that the intrinsic pathway is not important for normal blood coagulation in vivo.  However, recent work with mice lacking FXII or FXI suggest that these proteases make important contributions to formation of pathol. intravascular thrombi.  In models of arterial injury, FXII or FXI null mice are protected from formation of platelet rich occlusive thrombi to a degree similar to that seen in FIX deficient mice (a model for the severe bleeding disorder hemophilia B) or to wild type mice treated with high dose heparin.  FXII or FXI deficiency does not appear to prevent the initiation of thrombus formation in these models, but instead causes significant thrombus instability that prevents occlusion of the vessel.  These findings raise the possibility that a pathway similar or identical to the intrinsic pathway may operate in vivo under some circumstances.  Furthermore, the disproportionate importance of FXII and FXI to occlusive thrombus formation compared to normal hemostasis makes these proteases attractive candidates for therapeutic inhibitors to treat or prevent thromboembolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjkZhGskIyXrVg90H21EOLACvtfcHk0lhFP4f3Xa0tyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntl2ksLo%253D&md5=07d82612a7c5dd32a756f17739818eeb</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2007.02446.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2007.02446.x%26sid%3Dliteratum%253Aachs%26aulast%3DGailani%26aufirst%3DD.%26aulast%3DRenn%25C3%25A9%26aufirst%3DT.%26atitle%3DThe%2520intrinsic%2520pathway%2520for%2520coagulation%253A%2520A%2520target%2520for%2520treating%2520thromboembolic%2520disease%253F%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2007%26volume%3D5%26spage%3D1106%26epage%3D1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Schumacher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luettgen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiffert, D.</span><span> </span><span class="NLM_article-title">Inhibition of factor XIa as a new approach to anticoagulant</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">388</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1161%2FATVBAHA.109.197178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=20139363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlSgt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=388-392&author=W.+Schumacherauthor=J.+Luettgenauthor=M.+L.+Quanauthor=D.+Seiffert&title=Inhibition+of+factor+XIa+as+a+new+approach+to+anticoagulant"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3dR"><div class="casContent"><span class="casTitleNuber">3d</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Factor XIa as a New Approach to Anticoagulation</span></div><div class="casAuthors">Schumacher, William A.; Luettgen, Joseph M.; Quan, Mimi L.; Seiffert, Dietmar A.</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">388-392</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  The dose-limiting issue with available anticoagulant therapies is bleeding.  Is there an approach that could provide antithrombotic protection with reduced bleeding One hypothesis is that targeting proteases upstream from the common pathway provides a redn. in thrombin sufficient to impede occlusive thrombosis yet allows enough thrombin generation to support hemostasis.  The impairment of intrinsic coagulation by selective inhibition of factor XI (FXI) leaves the extrinsic and common pathways of coagulation intact, making FXI a drug target.  This concept is supported by the observation that human deficiency in FXI results in a mild bleeding disorder compared with other coagulation factor deficiencies, and that elevated levels of FXI are a risk factor for thromboembolic disease.  Moreover, FXI knockout mice have reduced thrombosis with little effect on hemostasis.  The results from genetic models have been supported by studies using neutralizing antibodies, peptide inhibitors, and small-mol. inhibitors.  These agents impede thrombosis without affecting bleeding time in a variety of exptl. animals, including primates.  Together, these data strongly support FXIa inhibition as a viable method to increase the ratio of benefit to risk in an antithrombotic drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEpUMDMvRdj7Vg90H21EOLACvtfcHk0lhFP4f3Xa0tyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlSgt7k%253D&md5=6a34271f438b91dd5978bf5b7c02cca1</span></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.109.197178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.109.197178%26sid%3Dliteratum%253Aachs%26aulast%3DSchumacher%26aufirst%3DW.%26aulast%3DLuettgen%26aufirst%3DJ.%26aulast%3DQuan%26aufirst%3DM.%2BL.%26aulast%3DSeiffert%26aufirst%3DD.%26atitle%3DInhibition%2520of%2520factor%2520XIa%2520as%2520a%2520new%2520approach%2520to%2520anticoagulant%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2010%26volume%3D30%26spage%3D388%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Bolton-Maggs, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wensley, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuddenham, E. G.</span><span> </span><span class="NLM_article-title">Definition of the bleeding tendency in factor XI-deficient kindreds—a clinical and laboratory study</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">194</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=7792729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADyaK2MXjsl2hsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1995&pages=194-202&author=P.+H.+Bolton-Maggsauthor=D.+A.+Pattersonauthor=R.+T.+Wensleyauthor=E.+G.+Tuddenham&title=Definition+of+the+bleeding+tendency+in+factor+XI-deficient+kindreds%E2%80%94a+clinical+and+laboratory+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Definition of the bleeding tendency in factor XI-deficient kindreds - a clinical and laboratory study</span></div><div class="casAuthors">Bolton-Maggs, P. H. B.; Patterson, D. A.; Wensley, R. T.; Tuddenham, E. G. D.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">194-202</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer</span>)
        </div><div class="casAbstract">Individuals with severe factor XI deficiency are prone to excessive bleeding after injury or surgery, but the existence of a haemorrhagic tendency in partial factor XI deficiency is controversial.  In this study, 172 members of 30 kindreds (20 non-Jewish) transmitting factor XI deficiency in North West England were interviewed and a bleeding history questionnaire completed.  Blood was taken for coagulation assays.  The questionnaires were categorized independently by two assessors to det. presence or absence of a bleeding tendency, in the absence of information about the factor XI level of family history.  Anal. shows that 48% of heterozygotes have a bleeding tendency.  Eighteen (60%) families came to attention because of bleeding probalems in heterozygotes.  Comparison of histories between partially deficient and non-deficient individuals demonstrated a higher incidence of menstrual problems, an increased in significant burising, and an increased likelihood of excessive bleeding after tonsillectomy and dental extns.  The incidence of von Willebrand's disease was not increased, but individuals with heterozygous factor XI deficiency who were bleeders tended to have lower levels of factor VIIIc and von Willebrand factor, and were more commonly of blood group 0.  These features may contribute to the bleeding tendency.  There was no evidence of alteration in factor VII activity (as defined by the ratio of activity to antigen) between the bleeders and non-bleeders.  This is convincing evidence for abnormal bleeding in factor XI deficiency which is not confined to severly deficient patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooGoCqeaOT6bVg90H21EOLACvtfcHk0lhFP4f3Xa0tyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjsl2hsro%253D&md5=c1e8d8bc24105f60460f7654d8c0306f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBolton-Maggs%26aufirst%3DP.%2BH.%26aulast%3DPatterson%26aufirst%3DD.%2BA.%26aulast%3DWensley%26aufirst%3DR.%2BT.%26aulast%3DTuddenham%26aufirst%3DE.%2BG.%26atitle%3DDefinition%2520of%2520the%2520bleeding%2520tendency%2520in%2520factor%2520XI-deficient%2520kindreds%25E2%2580%2594a%2520clinical%2520and%2520laboratory%2520study%26jtitle%3DThromb.%2520Haemostasis%26date%3D1995%26volume%3D73%26spage%3D194%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Lozier, J. N.; Kessler, C. M.</span><span> </span><span class="NLM_article-title">Clinical Aspects and Therapy of Hemophilia</span>. In  <span class="citation_source-book">Hematology: Basic Principles and Practice</span>, <span class="NLM_edition">4</span>th ed.; <span class="NLM_contrib-group">Hoffman, R.; Benz, E.; Shattil, S.; Furie, B.; Cohen, H.; Silberstein, L.; McGlave, P.</span>, Eds.; <span class="NLM_publisher-name">Churchill Livingstone</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">2047</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=2047&author=J.+N.+Lozier&author=C.+M.+Kesslerauthor=R.+Hoffman&author=E.+Benz&author=S.+Shattil&author=B.+Furie&author=H.+Cohen&author=L.+Silberstein&author=P.+McGlave&title=Hematology%3A+Basic+Principles+and+Practice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLozier%26aufirst%3DJ.%2BN.%26atitle%3DClinical%2520Aspects%2520and%2520Therapy%2520of%2520Hemophilia%26btitle%3DHematology%253A%2520Basic%2520Principles%2520and%2520Practice%26aulast%3DHoffman%26aufirst%3DR.%26pub%3DChurchill%2520Livingstone%26date%3D2005%26spage%3D2047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gailani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogletree, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiffert, D. A.</span><span> </span><span class="NLM_article-title">Effects of factor XI deficiency on ferric chloride-induced vena cava thrombosis in mice</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1982</span><span class="NLM_x">–</span> <span class="NLM_lpage">1988</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1111%2Fj.1538-7836.2006.02093.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=16961605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A280%3ADC%252BD28rjvVakuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=1982-1988&author=X.+Wangauthor=P.+L.+Smithauthor=M.-Y.+Hsuauthor=D.+Gailaniauthor=W.+A.+Schumacherauthor=M.+L.+Ogletreeauthor=D.+A.+Seiffert&title=Effects+of+factor+XI+deficiency+on+ferric+chloride-induced+vena+cava+thrombosis+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of factor XI deficiency on ferric chloride-induced vena cava thrombosis in mice</span></div><div class="casAuthors">Wang X; Smith P L; Hsu M-Y; Gailani D; Schumacher W A; Ogletree M L; Seiffert D A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of thrombosis and haemostasis : JTH</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1982-8</span>
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    </div><div class="casAbstract">BACKGROUND:  Increased plasma levels of coagulation factor (F) XI are a risk factor for venous thrombosis.  OBJECTIVE:  To further explore the relationship between FXI and venous thrombosis, we evaluated FXI-deficient and wild-type mice in a ferric chloride (FeCl(3))-induced vena cava thrombosis model.  METHODS AND RESULTS:  Thrombosis was induced by 3-min topical application of filter papers containing increasing concentrations of FeCl(3) and the thrombus was measured at 30 min.  In contrast to wild-type mice, FXI-deficient mice failed to form a thrombus with 5% FeCl(3,) and were partially protected against 7.5% and 10% FeCl(3,) respectively.  The protective effect was substantially stronger than a high dose of heparin (1,000 units kg(-1), i.v.), clopidogrel (30 mg kg(-1), p.o.) or argatroban (30 mg kg(-1), i.p.).  These antithrombotic agents resulted in off-scale bleeding in a tail bleeding time assay, whereas the bleeding time of FXI-deficient mice was unchanged compared to wild-type mice.  In addition to its known effect on the coagulation cascade, enhanced clot lysis was demonstrated in FXI-deficient mouse and human plasma compared to those supplemented with FXIa.  CONCLUSION:  Given the strong antithrombotic efficacy (possibly contributed by strong anticoagulant activity associated with increased fibrinolytic activity) and mild bleeding diathesis associated with FXI deficiency, therapeutic inhibition of FXI may be a reasonable therapeutic strategy to treat or prevent venous thrombosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSh8DUHIk-VfIxhnOQkIHOxfW6udTcc2eY08J-AU4NDErntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rjvVakuw%253D%253D&md5=e9e52e88908920ee2e72434a470a1961</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2006.02093.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2006.02093.x%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DP.%2BL.%26aulast%3DHsu%26aufirst%3DM.-Y.%26aulast%3DGailani%26aufirst%3DD.%26aulast%3DSchumacher%26aufirst%3DW.%2BA.%26aulast%3DOgletree%26aufirst%3DM.%2BL.%26aulast%3DSeiffert%26aufirst%3DD.%2BA.%26atitle%3DEffects%2520of%2520factor%2520XI%2520deficiency%2520on%2520ferric%2520chloride-induced%2520vena%2520cava%2520thrombosis%2520in%2520mice%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2006%26volume%3D4%26spage%3D1982%26epage%3D1988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yang, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flanders, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, G. M.</span><span> </span><span class="NLM_article-title">Elevated factor XIa activity levels are associated with an increased odds ratio for cerebrovascular events</span> <span class="citation_source-journal">Am. J. Clin. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1309%2FQC259F09UNMKVP0R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=16880142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVGmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2006&pages=411-415&author=D.+T.+Yangauthor=M.+M.+Flandersauthor=H.+Kimauthor=G.+M.+Rodgers&title=Elevated+factor+XIa+activity+levels+are+associated+with+an+increased+odds+ratio+for+cerebrovascular+events"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events</span></div><div class="casAuthors">Yang, David T.; Flanders, Michele M.; Kim, Hyunhee; Rodgers, George M.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Clinical Pathology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">411-415</span>CODEN:
                <span class="NLM_cas:coden">AJCPAI</span>;
        ISSN:<span class="NLM_cas:issn">0002-9173</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Pathology</span>)
        </div><div class="casAbstract">High levels of factor XI have been implicated as a risk factor for deep venous thrombosis and possibly cardiovascular disease; however, the relationship between elevated factor XI activity and stroke has yet to be established.  We retrospectively evaluated factor XI activity, factor XI antigen, and high-sensitivity C-reactive protein (hs-CRP) values in samples from 65 patients with stroke, 13 with transient ischemic attack (TIA), and 17 with venous thrombosis, younger than 55 years with normal prothrombin and partial thromboplastin times who underwent evaluation for a hypercoagulable state.  Factor XI activity levels were more than normal in 22% of patients with stroke or TIA and 18% of patients with venous thrombosis, producing odds ratios of 5.3 and 4.1 for stroke or TIA and venous thrombosis, resp.  Factor XI activity levels correlate with factor XI antigen levels by Deming regression anal. (slope, 1.3; R = 0.667), and a lack of correlation of both with hs-CRP suggests that factor XI is not an acute phase reactant.  Our findings suggest an assocn. between elevated factor XI activity and stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsES1G-_EdgbVg90H21EOLACvtfcHk0lgKiQbN_IbCrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVGmsA%253D%253D&md5=f0b7fd080dab27c44302eb4ac745b56c</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1309%2FQC259F09UNMKVP0R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1309%252FQC259F09UNMKVP0R%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DD.%2BT.%26aulast%3DFlanders%26aufirst%3DM.%2BM.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DRodgers%26aufirst%3DG.%2BM.%26atitle%3DElevated%2520factor%2520XIa%2520activity%2520levels%2520are%2520associated%2520with%2520an%2520increased%2520odds%2520ratio%2520for%2520cerebrovascular%2520events%26jtitle%3DAm.%2520J.%2520Clin.%2520Pathol.%26date%3D2006%26volume%3D126%26spage%3D411%26epage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Butenas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Undas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gissel, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szuldrzynski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zmudka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, K. G.</span><span> </span><span class="NLM_article-title">Factor XIa and tissue factor activity in patients with coronary artery disease</span> <span class="citation_source-journal">Thomb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">142</span><span class="NLM_x">–</span> <span class="NLM_lpage">149</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=18217146" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=142-149&author=S.+Butenasauthor=A.+Undasauthor=M.+T.+Gisselauthor=K.+Szuldrzynskiauthor=K.+Zmudkaauthor=K.+G.+Mann&title=Factor+XIa+and+tissue+factor+activity+in+patients+with+coronary+artery+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DButenas%26aufirst%3DS.%26aulast%3DUndas%26aufirst%3DA.%26aulast%3DGissel%26aufirst%3DM.%2BT.%26aulast%3DSzuldrzynski%26aufirst%3DK.%26aulast%3DZmudka%26aufirst%3DK.%26aulast%3DMann%26aufirst%3DK.%2BG.%26atitle%3DFactor%2520XIa%2520and%2520tissue%2520factor%2520activity%2520in%2520patients%2520with%2520coronary%2520artery%2520disease%26jtitle%3DThomb.%2520Haemostasis%26date%3D2008%26volume%3D99%26spage%3D142%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Salomon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koren-Morag, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanne, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seligsohn, U.</span><span> </span><span class="NLM_article-title">Reduced incidence of ischemic stroke in patients with severe factor XI deficiency</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">4113</span><span class="NLM_x">–</span> <span class="NLM_lpage">4117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1182%2Fblood-2007-10-120139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=18268095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvFeis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=4113-4117&author=O.+Salomonauthor=D.+M.+Steinbergauthor=N.+Koren-Moragauthor=D.+Tanneauthor=U.+Seligsohn&title=Reduced+incidence+of+ischemic+stroke+in+patients+with+severe+factor+XI+deficiency"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced incidence of ischemic stroke in patients with severe factor XI deficiency</span></div><div class="casAuthors">Salomon, Ophira; Steinberg, David M.; Koren-Morag, Nira; Tanne, David; Seligsohn, Uri</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4113-4117</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Inherited disorders of hemostasis are natural models for investigating mechanisms of thrombosis and development of antithrombotic therapy.  Because mice with total factor XI deficiency are protected against ischemic stroke and do not manifest excessive bleeding, we investigated the incidence of ischemic stroke in patients with severe inherited factor XI deficiency.  Incidence of ischemic stroke in 115 patients aged 45 years or more with severe factor XI deficiency (activity less than 15 U/dL) was compared with incidence in the Israeli population as estd. from a stroke survey of 1528 patients.  Adjustment for major risk factors of stroke (hypertension, diabetes mellitus, hypercholesterolemia, current smoking) was based on comparison of their prevalence in the stroke survey to an Israeli health survey of 9509 subjects.  Incidence of myocardial infarction in the factor XI cohort was also recorded.  After adjustment for the 4 major risk factors of ischemic stroke, the expected incidence of ischemic stroke was 8.56 compared with one obsd.  The reduced 1:115 incidence of ischemic stroke contrasted with a 19:115 incidence of myocardial infarction, similar to the expected incidence.  Thus, severe factor XI deficiency probably is protective against ischemic stroke but not against acute myocardial infarction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr47o3PkQqcu7Vg90H21EOLACvtfcHk0ljnyMHmw2VhJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvFeis7k%253D&md5=5441715115d43fb53dbb011fd7e742ba</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1182%2Fblood-2007-10-120139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2007-10-120139%26sid%3Dliteratum%253Aachs%26aulast%3DSalomon%26aufirst%3DO.%26aulast%3DSteinberg%26aufirst%3DD.%2BM.%26aulast%3DKoren-Morag%26aufirst%3DN.%26aulast%3DTanne%26aufirst%3DD.%26aulast%3DSeligsohn%26aufirst%3DU.%26atitle%3DReduced%2520incidence%2520of%2520ischemic%2520stroke%2520in%2520patients%2520with%2520severe%2520factor%2520XI%2520deficiency%26jtitle%3DBlood%26date%3D2008%26volume%3D111%26spage%3D4113%26epage%3D4117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rynkiewicz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorga, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibbins, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celatka, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagafuji, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannister, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babine, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayward, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benjamin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stassen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Meguid, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickler, J. E.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Evaluation of Peptidimimetic Inhibitors of Factor XIa as Novel Anticoagulants</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7781</span><span class="NLM_x">–</span> <span class="NLM_lpage">7791</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060978s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7781-7791&author=J.+Linauthor=H.+Dengauthor=L.+Jinauthor=P.+Pandeyauthor=J.+Quinnauthor=S.+Cantinauthor=M.+J.+Rynkiewiczauthor=J.+C.+Gorgaauthor=F.+Bibbinsauthor=C.+A.+Celatkaauthor=P.+Nagafujiauthor=T.+D.+Bannisterauthor=H.+V.+Meyersauthor=R.+E.+Babineauthor=N.+J.+Haywardauthor=D.+Weaverauthor=H.+Benjaminauthor=F.+Stassenauthor=S.+S.+Abdel-Meguidauthor=J.+E.+Strickler&title=Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Peptidimimetic+Inhibitors+of+Factor+XIa+as+Novel+Anticoagulants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Fjm060978s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060978s%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DPandey%26aufirst%3DP.%26aulast%3DQuinn%26aufirst%3DJ.%26aulast%3DCantin%26aufirst%3DS.%26aulast%3DRynkiewicz%26aufirst%3DM.%2BJ.%26aulast%3DGorga%26aufirst%3DJ.%2BC.%26aulast%3DBibbins%26aufirst%3DF.%26aulast%3DCelatka%26aufirst%3DC.%2BA.%26aulast%3DNagafuji%26aufirst%3DP.%26aulast%3DBannister%26aufirst%3DT.%2BD.%26aulast%3DMeyers%26aufirst%3DH.%2BV.%26aulast%3DBabine%26aufirst%3DR.%2BE.%26aulast%3DHayward%26aufirst%3DN.%2BJ.%26aulast%3DWeaver%26aufirst%3DD.%26aulast%3DBenjamin%26aufirst%3DH.%26aulast%3DStassen%26aufirst%3DF.%26aulast%3DAbdel-Meguid%26aufirst%3DS.%2BS.%26aulast%3DStrickler%26aufirst%3DJ.%2BE.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Peptidimimetic%2520Inhibitors%2520of%2520Factor%2520XIa%2520as%2520Novel%2520Anticoagulants%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7781%26epage%3D7791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Deng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannister, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babine, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagafuji, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celatka, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarova, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rynkiewice, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibbins, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Meguid, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickler, J. E.</span><span> </span><span class="NLM_article-title">Synthesis, SAR exploration, and X-ray crystal structures of factor XIa inhibitors containing an α-ketothiazole arginine</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3049</span><span class="NLM_x">–</span> <span class="NLM_lpage">3054</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3049-3054&author=H.+Dengauthor=T.+D.+Bannisterauthor=L.+Jinauthor=R.+E.+Babineauthor=J.+Quinnauthor=P.+Nagafujiauthor=C.+A.+Celatkaauthor=J.+Linauthor=T.+I.+Lazarovaauthor=M.+J.+Rynkiewiceauthor=F.+Bibbinsauthor=P.+Pandeyauthor=J.+Gotgaauthor=H.+V.+Meyersauthor=S.+S.+Abdel-Meguidauthor=J.+E.+Strickler&title=Synthesis%2C+SAR+exploration%2C+and+X-ray+crystal+structures+of+factor+XIa+inhibitors+containing+an+%CE%B1-ketothiazole+arginine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DH.%26aulast%3DBannister%26aufirst%3DT.%2BD.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DBabine%26aufirst%3DR.%2BE.%26aulast%3DQuinn%26aufirst%3DJ.%26aulast%3DNagafuji%26aufirst%3DP.%26aulast%3DCelatka%26aufirst%3DC.%2BA.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DLazarova%26aufirst%3DT.%2BI.%26aulast%3DRynkiewice%26aufirst%3DM.%2BJ.%26aulast%3DBibbins%26aufirst%3DF.%26aulast%3DPandey%26aufirst%3DP.%26aulast%3DGotga%26aufirst%3DJ.%26aulast%3DMeyers%26aufirst%3DH.%2BV.%26aulast%3DAbdel-Meguid%26aufirst%3DS.%2BS.%26aulast%3DStrickler%26aufirst%3DJ.%2BE.%26atitle%3DSynthesis%252C%2520SAR%2520exploration%252C%2520and%2520X-ray%2520crystal%2520structures%2520of%2520factor%2520XIa%2520inhibitors%2520containing%2520an%2520%25CE%25B1-ketothiazole%2520arginine%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3049%26epage%3D3054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Schumacher, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiler, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbacher, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bostwick, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartl, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogletree, M. L.</span><span> </span><span class="NLM_article-title">Antithrombotic and hemostatic effects of a small molecule factor XIa inhibitor in rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">570</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1016%2Fj.ejphar.2007.05.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=17597608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1Sjsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=570&publication_year=2007&pages=167-174&author=W.+A.+Schumacherauthor=S.+E.+Seilerauthor=T.+E.+Steinbacherauthor=A.+B.+Stewartauthor=J.+B.+Bostwickauthor=K.+S.+Hartlauthor=E.+C.+Liuauthor=M.+L.+Ogletree&title=Antithrombotic+and+hemostatic+effects+of+a+small+molecule+factor+XIa+inhibitor+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Antithrombotic and hemostatic effects of a small molecule factor XIa inhibitor in rats</span></div><div class="casAuthors">Schumacher, William A.; Seiler, Steven E.; Steinbacher, Thomas E.; Stewart, Anne B.; Bostwick, Jeffrey S.; Hartl, Karen S.; Liu, Eddie C.; Ogletree, Martin L.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">570</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">167-174</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The effect of inhibiting activated blood coagulation factor XIa was detd. in rat models of thrombosis and hemostasis.  BMS-262084 is an irreversible and selective small mol. inhibitor of factor XIa with an IC50 of 2.8 nM against human factor XIa.  BMS-262084 doubled the activated thromboplastin time in human and rat plasma at 0.14 and 2.2 μM, resp.  Consistent with factor XIa inhibition, the prothrombin time was unaffected at up to 100 μM.  BMS-262084 administered as an i.v. loading plus sustaining infusion was effective against FeCl2-induced thrombosis in both the vena cava and carotid artery.  Maximum thrombus wt. redns. of 97 and 73%, resp. (P < 0.05), were achieved at a pretreatment dose of 12 mg/kg + 12 mg/kg/h which increased the ex vivo activated thromboplastin time to 3.0 times control.  This dose level also arrested growth of venous and arterial thrombi when administered after partial thrombus formation.  BMS-262084 was most potent in FeCl2-induced venous thrombosis, decreasing thrombus wt. 38% (P < 0.05) at a threshold dose of 0.2 mg/kg + 0.2 mg/kg/h.  In contrast, doses of up to 24 mg/kg + 24 mg/kg/h had no effect on either tissue factor-induced venous thrombosis or the ex vivo prothrombin time.  Doses of up to 24 mg/kg + 24 mg/kg/h also did not significantly prolong bleeding time provoked by either puncture of small mesenteric blood vessels, template incision of the renal cortex, or cuticle incision.  These results demonstrate that pharmacol. inhibition of factor XIa achieves antithrombotic efficacy with minimal effects on provoked bleeding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0mp5Jl7II4rVg90H21EOLACvtfcHk0liOEfa6IqE4Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1Sjsbc%253D&md5=69442ef81346e93e9ee5c7272cc6fdaa</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2007.05.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2007.05.043%26sid%3Dliteratum%253Aachs%26aulast%3DSchumacher%26aufirst%3DW.%2BA.%26aulast%3DSeiler%26aufirst%3DS.%2BE.%26aulast%3DSteinbacher%26aufirst%3DT.%2BE.%26aulast%3DStewart%26aufirst%3DA.%2BB.%26aulast%3DBostwick%26aufirst%3DJ.%2BB.%26aulast%3DHartl%26aufirst%3DK.%2BS.%26aulast%3DLiu%26aufirst%3DE.%2BC.%26aulast%3DOgletree%26aufirst%3DM.%2BL.%26atitle%3DAntithrombotic%2520and%2520hemostatic%2520effects%2520of%2520a%2520small%2520molecule%2520factor%2520XIa%2520inhibitor%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D570%26spage%3D167%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crain, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, W. A.</span><span> </span><span class="NLM_article-title">A small-molecule factor XIa inhibitor produces antithrombotic efficacy with minimal bleeding time prolongation in rabbits</span> <span class="citation_source-journal">J. Thromb. Thrombolysis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1007%2Fs11239-011-0599-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=21614454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptVOgt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=129-137&author=P.+C.+Wongauthor=E.+J.+Crainauthor=C.+A.+Watsonauthor=W.+A.+Schumacher&title=A+small-molecule+factor+XIa+inhibitor+produces+antithrombotic+efficacy+with+minimal+bleeding+time+prolongation+in+rabbits"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">A small-molecule factor XIa inhibitor produces antithrombotic efficacy with minimal bleeding time prolongation in rabbits</span></div><div class="casAuthors">Wong, Pancras C.; Crain, Earl J.; Watson, Carol A.; Schumacher, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Thrombolysis</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">129-137</span>CODEN:
                <span class="NLM_cas:coden">JTTHFF</span>;
        ISSN:<span class="NLM_cas:issn">0929-5305</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">BMS-262084 is a 4-carboxy-2-azetidinone-contg. irreversible inhibitor of FXIa, which is selective over other coagulation proteases.  We evaluated the in vitro and in vivo properties of BMS-262084 in rabbits.  Studies were conducted in arteriovenous-shunt thrombosis (AVST), venous thrombosis (VT), electrolytic-mediated carotid arterial thrombosis (ECAT) and cuticle bleeding time (BT) models.  BMS-262084 was infused IV from 1 h before thrombus induction or cuticle transection to the end of the expt.  In vitro, BMS-262084 prolonged activated partial thromboplastin time (aPTT) with EC2x (concn. required to double aPTT) of 10.6 μM in rabbit plasma, and did not prolong prothrombin time (PT), thrombin time (TT) and HepTest.  In vivo, BMS-262084 produced dose-dependent antithrombotic effects in rabbits with antithrombotic ED50 (dose that reduced thrombus wt. or increased blood flow by 50% of the control) in AVST, VT and ECAT of 0.4, 0.7 and 1.5 mg/kg/h IV, resp.  BMS-262084 increased ex vivo aPTT dose-dependently without changes in PT and TT.  The antithrombotic effect of BMS-262084 was significantly correlated with its ex vivo aPTT, supporting the use of ex vivo aPTT as a pharmacodynamic biomarker.  BMS-262084 did not alter ex vivo rabbit platelet aggregation to ADP and collagen.  BT (fold-increase) detd. at 3 and 10 mg/kg/h of BMS-262084 were 1.17 ± 0.04 and 1.52 ± 0.07*, resp. (*P < 0.05 vs. control).  This study demonstrated that BMS-262084 prevented exptl. thrombosis at doses with low BT effects in rabbits, and suggests that a small mol. FXIa inhibitor may represent a promising antithrombotic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowBWA5CF6An7Vg90H21EOLACvtfcHk0liOEfa6IqE4Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptVOgt7s%253D&md5=b66ac86fc92f96363968720fe2bfbd54</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1007%2Fs11239-011-0599-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11239-011-0599-0%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DCrain%26aufirst%3DE.%2BJ.%26aulast%3DWatson%26aufirst%3DC.%2BA.%26aulast%3DSchumacher%26aufirst%3DW.%2BA.%26atitle%3DA%2520small-molecule%2520factor%2520XIa%2520inhibitor%2520produces%2520antithrombotic%2520efficacy%2520with%2520minimal%2520bleeding%2520time%2520prolongation%2520in%2520rabbits%26jtitle%3DJ.%2520Thromb.%2520Thrombolysis%26date%3D2011%26volume%3D32%26spage%3D129%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Sutton, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolton, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartl, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogletree, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiler, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slusarchyk, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treuner, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhaler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basicchi, G. S.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3229</span><span class="NLM_x">–</span> <span class="NLM_lpage">3233</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3229-3233&author=J.+C.+Suttonauthor=S.+A.+Boltonauthor=K.+S.+Hartlauthor=M.-H.+Huangauthor=G.+Jacobsauthor=W.+Mengauthor=M.+L.+Ogletreeauthor=Z.+Piauthor=W.+A.+Schumacherauthor=S.+M.+Seilerauthor=W.+A.+Slusarchykauthor=U.+Treunerauthor=R.+Zhalerauthor=G.+Zhaoauthor=G.+S.+Basicchi&title=Synthesis+and+SAR+of+4-carboxy-2-azetidinone+mechanism-based+tryptase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSutton%26aufirst%3DJ.%2BC.%26aulast%3DBolton%26aufirst%3DS.%2BA.%26aulast%3DHartl%26aufirst%3DK.%2BS.%26aulast%3DHuang%26aufirst%3DM.-H.%26aulast%3DJacobs%26aufirst%3DG.%26aulast%3DMeng%26aufirst%3DW.%26aulast%3DOgletree%26aufirst%3DM.%2BL.%26aulast%3DPi%26aufirst%3DZ.%26aulast%3DSchumacher%26aufirst%3DW.%2BA.%26aulast%3DSeiler%26aufirst%3DS.%2BM.%26aulast%3DSlusarchyk%26aufirst%3DW.%2BA.%26aulast%3DTreuner%26aufirst%3DU.%26aulast%3DZhaler%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DBasicchi%26aufirst%3DG.%2BS.%26atitle%3DSynthesis%2520and%2520SAR%2520of%25204-carboxy-2-azetidinone%2520mechanism-based%2520tryptase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3229%26epage%3D3233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Quan, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woerner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smallheer, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbera, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bozarth, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harpel, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luettgen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramamurthy, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rendina, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiffert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">955</span><span class="NLM_x">–</span> <span class="NLM_lpage">969</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401670x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Quan%2C+M.+L.%3B+Wong%2C+P.+C.%3B+Wang%2C+C.%3B+Woerner%2C+F.%3B+Smallheer%2C+J.+M.%3B+Barbera%2C+F.+A.%3B+Bozarth%2C+J.+M.%3B+Brown%2C+R.+L.%3B+Harpel%2C+M.+R.%3B+Luettgen%2C+J.+M.%3B+Morin%2C+P.+E.%3B+Peterson%2C+T.%3B+Ramamurthy%2C+V.%3B+Rendina%2C+A.+R.%3B+Rossi%2C+K.+A.%3B+Watson%2C+C.+A.%3B+Wei%2C+A.%3B+Zhang%2C+G.%3B+Seiffert%2C+D.%3B+Wexler%2C+R.+R.J.+Med.+Chem.+2014%2C+57%2C+955%E2%80%93969"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm401670x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401670x%26sid%3Dliteratum%253Aachs%26aulast%3DQuan%26aufirst%3DM.%2BL.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWoerner%26aufirst%3DF.%26aulast%3DSmallheer%26aufirst%3DJ.%2BM.%26aulast%3DBarbera%26aufirst%3DF.%2BA.%26aulast%3DBozarth%26aufirst%3DJ.%2BM.%26aulast%3DBrown%26aufirst%3DR.%2BL.%26aulast%3DHarpel%26aufirst%3DM.%2BR.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DMorin%26aufirst%3DP.%2BE.%26aulast%3DPeterson%26aufirst%3DT.%26aulast%3DRamamurthy%26aufirst%3DV.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DRossi%26aufirst%3DK.%2BA.%26aulast%3DWatson%26aufirst%3DC.%2BA.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DSeiffert%26aufirst%3DD.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D955%26epage%3D969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Wong, P. C.; Quan, M. L.; Watson, C.; Crain, E.; Wexler, R. R.; Seiffert, D.</span><span> </span><span class="NLM_article-title">Potent Antithrombotic Effect of a Small-Molecule, Reversible and Direct Inhibitor of Factor XIa with Minimum Bleeding Time Effect in Rabbit Models of Arterial Thrombosis and Hemostasis</span>. Presented at the American Heart Association Scientific Sessions, November<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>APS.709.03, Poster 7050.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=P.+C.+Wong&author=M.+L.+Quan&author=C.+Watson&author=E.+Crain&author=R.+R.+Wexler&author=D.+Seiffert&title=Potent+Antithrombotic+Effect+of+a+Small-Molecule%2C+Reversible+and+Direct+Inhibitor+of+Factor+XIa+with+Minimum+Bleeding+Time+Effect+in+Rabbit+Models+of+Arterial+Thrombosis+and+Hemostasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DP.%2BC.%26atitle%3DPotent%2520Antithrombotic%2520Effect%2520of%2520a%2520Small-Molecule%252C%2520Reversible%2520and%2520Direct%2520Inhibitor%2520of%2520Factor%2520XIa%2520with%2520Minimum%2520Bleeding%2520Time%2520Effect%2520in%2520Rabbit%2520Models%2520of%2520Arterial%2520Thrombosis%2520and%2520Hemostasis%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Buchanan, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wessling, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jobling, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zue, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fex, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deinum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooper, J. N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, R. J.</span><span> </span><span class="NLM_article-title">Clavatadine A, a natural product with selective recognition and irreversible inhibition of factor XIa</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3583</span><span class="NLM_x">–</span> <span class="NLM_lpage">3587</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800314b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3583-3587&author=M.+S.+Buchananauthor=A.+R.+Carrollauthor=D.+Wesslingauthor=M.+Joblingauthor=V.+M.+Averyauthor=R.+A.+Davisauthor=Y.+Fengauthor=Y.+Zueauthor=T.+Fexauthor=J.+Deinumauthor=J.+N.+A.+Hooperauthor=R.+J.+Quinn&title=Clavatadine+A%2C+a+natural+product+with+selective+recognition+and+irreversible+inhibition+of+factor+XIa"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm800314b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800314b%26sid%3Dliteratum%253Aachs%26aulast%3DBuchanan%26aufirst%3DM.%2BS.%26aulast%3DCarroll%26aufirst%3DA.%2BR.%26aulast%3DWessling%26aufirst%3DD.%26aulast%3DJobling%26aufirst%3DM.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DDavis%26aufirst%3DR.%2BA.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DZue%26aufirst%3DY.%26aulast%3DFex%26aufirst%3DT.%26aulast%3DDeinum%26aufirst%3DJ.%26aulast%3DHooper%26aufirst%3DJ.%2BN.%2BA.%26aulast%3DQuinn%26aufirst%3DR.%2BJ.%26atitle%3DClavatadine%2520A%252C%2520a%2520natural%2520product%2520with%2520selective%2520recognition%2520and%2520irreversible%2520inhibition%2520of%2520factor%2520XIa%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3583%26epage%3D3587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Lazarova, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rynkiewicz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorga, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibbins, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babine, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickler, J.</span><span> </span><span class="NLM_article-title">Synthesis and in vitro biological evaluation or aryl boronic acids as potential inhibitors of factor XIa</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5022</span><span class="NLM_x">–</span> <span class="NLM_lpage">5027</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5022-5027&author=T.+I.+Lazarovaauthor=L.+Jinauthor=M.+Rynkiewiczauthor=J.+C.+Gorgaauthor=F.+Bibbinsauthor=H.+V.+Meyersauthor=R.+Babineauthor=J.+Strickler&title=Synthesis+and+in+vitro+biological+evaluation+or+aryl+boronic+acids+as+potential+inhibitors+of+factor+XIa"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLazarova%26aufirst%3DT.%2BI.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DRynkiewicz%26aufirst%3DM.%26aulast%3DGorga%26aufirst%3DJ.%2BC.%26aulast%3DBibbins%26aufirst%3DF.%26aulast%3DMeyers%26aufirst%3DH.%2BV.%26aulast%3DBabine%26aufirst%3DR.%26aulast%3DStrickler%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520biological%2520evaluation%2520or%2520aryl%2520boronic%2520acids%2520as%2520potential%2520inhibitors%2520of%2520factor%2520XIa%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5022%26epage%3D5027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Smallheer, J. M.; Wang, S.; Rossi, K. A.; Rendina, A.; Morin, P. E.; Wei, A.; Zhang, G.; Wong, P. C.; Seiffert, D.; Wexler, R. R.; Quan, M. L.</span> <span class="citation_source-book">Abstracts of Papers</span>, 245th National Meeting of the American Chemical Society, New Orleans, LA, U.S., April 7–11, 2013; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>MEDI-415.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=J.+M.+Smallheer&author=S.+Wang&author=K.+A.+Rossi&author=A.+Rendina&author=P.+E.+Morin&author=A.+Wei&author=G.+Zhang&author=P.+C.+Wong&author=D.+Seiffert&author=R.+R.+Wexler&author=M.+L.+Quan&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSmallheer%26aufirst%3DJ.%2BM.%26btitle%3DAbstracts%2520of%2520Papers%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sinha, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badellina, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcinkiewicz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, P. N.</span><span> </span><span class="NLM_article-title">Allosteric modification of factor XIa functional activity upon binding to polyanions</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">7593</span><span class="NLM_x">–</span> <span class="NLM_lpage">7600</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi049808c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=7593-7600&author=D.+Sinhaauthor=K.+O.+Badellinaauthor=M.+Marcinkiewiczauthor=P.+N.+Walsh&title=Allosteric+modification+of+factor+XIa+functional+activity+upon+binding+to+polyanions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Fbi049808c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi049808c%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DD.%26aulast%3DBadellina%26aufirst%3DK.%2BO.%26aulast%3DMarcinkiewicz%26aufirst%3DM.%26aulast%3DWalsh%26aufirst%3DP.%2BN.%26atitle%3DAllosteric%2520modification%2520of%2520factor%2520XIa%2520functional%2520activity%2520upon%2520binding%2520to%2520polyanions%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D7593%26epage%3D7600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Argade, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">Allosteric inhibition of human factor XIa: discovery of monosulfated benzofurans as a class of promising inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">3559</span><span class="NLM_x">–</span> <span class="NLM_lpage">3569</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm5002698" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkvVCku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3559-3569&author=M.+D.+Argadeauthor=A.+Y.+Mehtaauthor=A.+Sarkarauthor=U.+R.+Desai&title=Allosteric+inhibition+of+human+factor+XIa%3A+discovery+of+monosulfated+benzofurans+as+a+class+of+promising+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Inhibition of Human Factor XIa: Discovery of Monosulfated Benzofurans as a Class of Promising Inhibitors</span></div><div class="casAuthors">Argade, Malaika D.; Mehta, Akul Y.; Sarkar, Aurijit; Desai, Umesh R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3559-3569</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Factor XIa (fXIa) is being recognized as a prime target for developing safer anticoagulants.  To discover synthetic, small, allosteric inhibitors of fXIa, we screened an inhouse, unique library of 65 mols. displaying many distinct scaffolds and varying levels of sulfation.  Of these, monosulfated benzofurans were the only group of mols. found to inhibit fXIa (∼100% efficacy) and led to the identification of monosulfated trimer 24 (IC50 0.82 μM) as the most potent inhibitor.  Michaelis-Menten kinetics studies revealed a classic noncompetitive mechanism of action for 24.  Although monosulfated, the inhibitors did not compete with unfractionated heparin alluding to a novel site of interaction.  Fluorescence quenching studies indicated that trimer 24 induces major conformational changes in the active site of fXIa.  Docking studies identified a site near Lys255 on the A3 domain of fXIa as the most probable site of binding for 24.  Factor XIa devoid of the A3 domain displayed a major defect in the inhibition potency of 24 supporting the docking prediction.  Our work presents the sulfated benzofuran scaffold as a promising framework to develop allosteric fXIa inhibitors that likely function through the A3 domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAfSbW5eFY5LVg90H21EOLACvtfcHk0lhaIXmtrg3-EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkvVCku7Y%253D&md5=674dc4a2305c9f95a54b2a9fc2365706</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Fjm5002698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5002698%26sid%3Dliteratum%253Aachs%26aulast%3DArgade%26aufirst%3DM.%2BD.%26aulast%3DMehta%26aufirst%3DA.%2BY.%26aulast%3DSarkar%26aufirst%3DA.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DAllosteric%2520inhibition%2520of%2520human%2520factor%2520XIa%253A%2520discovery%2520of%2520monosulfated%2520benzofurans%2520as%2520a%2520class%2520of%2520promising%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3559%26epage%3D3569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Al-Horani, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">Designing allosteric inhibitors of factor XIa. Lessons from the interactions of sulfated pentagalloylglucopyranosides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4805</span><span class="NLM_x">–</span> <span class="NLM_lpage">4818</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500311e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosVSqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4805-4818&author=R.+A.+Al-Horaniauthor=U.+R.+Desai&title=Designing+allosteric+inhibitors+of+factor+XIa.+Lessons+from+the+interactions+of+sulfated+pentagalloylglucopyranosides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17cR"><div class="casContent"><span class="casTitleNuber">17c</span><div class="casTitle"><span class="NLM_cas:atitle">Designing Allosteric Inhibitors of Factor XIa. Lessons from the Interactions of Sulfated Pentagalloylglucopyranosides</span></div><div class="casAuthors">Al-Horani, Rami A.; Desai, Umesh R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4805-4818</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We recently introduced sulfated pentagalloylglucopyranoside (SPGG) as an allosteric inhibitor of factor XIa (FXIa) (Al-Horani et al., J.  Med Chem. 2013, 56, 867-878).  To better understand the SPGG-FXIa interaction, we utilized eight SPGG variants and a range of biochem. techniques.  The results reveal that SPGG's sulfation level moderately affected FXIa inhibition potency and selectivity over thrombin and factor Xa.  Variation in the anomeric configuration did not affect potency.  Interestingly, zymogen factor XI bound SPGG with high affinity, suggesting its possible use as an antidote.  Acrylamide quenching expts. suggested that SPGG induced significant conformational changes in the active site of FXIa.  Inhibition studies in the presence of heparin showed marginal competition with highly sulfated SPGG variants but robust competition with less sulfated variants.  Resoln. of energetic contributions revealed that nonionic forces contribute nearly 87% of binding energy suggesting a strong possibility of specific interaction.  Overall, the results indicate that SPGG may recognize more than one anion-binding, allosteric site on FXIa.  An SPGG mol. contg. approx. 10 sulfate groups on positions 2 through 6 of the pentagalloylglucopyranosyl scaffold may be the optimal FXIa inhibitor for further preclin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIW7O9ciTuRLVg90H21EOLACvtfcHk0lhaIXmtrg3-EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosVSqtbs%253D&md5=8d6cc598c8ddc9765184231e4dfe794b</span></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=10.1021%2Fjm500311e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500311e%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Horani%26aufirst%3DR.%2BA.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DDesigning%2520allosteric%2520inhibitors%2520of%2520factor%2520XIa.%2520Lessons%2520from%2520the%2520interactions%2520of%2520sulfated%2520pentagalloylglucopyranosides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4805%26epage%3D4818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Al-Horani, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponnusamy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gailani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">Sulfated pentagalloylglucoside is a potent, allosteric, and selective inhibitor of factor XIa</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">867</span><span class="NLM_x">–</span> <span class="NLM_lpage">878</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301338q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVWgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=867-878&author=R.+A.+Al-Horaniauthor=P.+Ponnusamyauthor=A.+Y.+Mehtaauthor=D.+Gailaniauthor=U.+R.+Desai&title=Sulfated+pentagalloylglucoside+is+a+potent%2C+allosteric%2C+and+selective+inhibitor+of+factor+XIa"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17dR"><div class="casContent"><span class="casTitleNuber">17d</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfated Pentagalloylglucoside Is a Potent, Allosteric, and Selective Inhibitor of Factor XIa</span></div><div class="casAuthors">Al-Horani, Rami A.; Ponnusamy, Pooja; Mehta, Akul Y.; Gailani, David; Desai, Umesh R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">867-878</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of factor XIa (FXIa) is a novel paradigm for developing anticoagulants without major bleeding consequences.  We present the discovery of sulfated pentagalloylglucoside (6) as a highly selective inhibitor of human FXIa.  Biochem. screening of a focused library led to the identification of 6, a sulfated arom. mimetic of heparin.  Inhibitor 6 displayed a potency of 551 nM against FXIa, which was at least 200-fold more selective than other relevant enzymes.  It also prevented activation of factor IX and prolonged human plasma and whole blood clotting.  Inhibitor 6 reduced VMAX of FXIa hydrolysis of chromogenic substrate without affecting the KM, suggesting an allosteric mechanism.  Competitive studies showed that 6 bound in the heparin-binding site of FXIa.  No allosteric small mol. has been discovered to date that exhibits equiv. potency against FXIa.  Inhibitor 6 is expected to open up a major route to allosteric FXIa anticoagulants with clin. relevance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGKg_oDquc3LVg90H21EOLACvtfcHk0lhaIXmtrg3-EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVWgsQ%253D%253D&md5=ee6eb18186f2cbe58d954f8d3dea0290</span></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=10.1021%2Fjm301338q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301338q%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Horani%26aufirst%3DR.%2BA.%26aulast%3DPonnusamy%26aufirst%3DP.%26aulast%3DMehta%26aufirst%3DA.%2BY.%26aulast%3DGailani%26aufirst%3DD.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DSulfated%2520pentagalloylglucoside%2520is%2520a%2520potent%252C%2520allosteric%252C%2520and%2520selective%2520inhibitor%2520of%2520factor%2520XIa%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D867%26epage%3D878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Karuturi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Horani, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gailani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, U. R.</span><span> </span><span class="NLM_article-title">Discovery of allosteric modulators of factor XIa by targeting the hydrophobic domains adjacent to its heparin-binding site</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2415</span><span class="NLM_x">–</span> <span class="NLM_lpage">2428</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301757v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2415-2428&author=R.+Karuturiauthor=R.+A.+Al-Horaniauthor=S.+C.+Mehtaauthor=D.+Gailaniauthor=U.+R.+Desai&title=Discovery+of+allosteric+modulators+of+factor+XIa+by+targeting+the+hydrophobic+domains+adjacent+to+its+heparin-binding+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17e&amp;dbid=16384&amp;doi=10.1021%2Fjm301757v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301757v%26sid%3Dliteratum%253Aachs%26aulast%3DKaruturi%26aufirst%3DR.%26aulast%3DAl-Horani%26aufirst%3DR.%2BA.%26aulast%3DMehta%26aufirst%3DS.%2BC.%26aulast%3DGailani%26aufirst%3DD.%26aulast%3DDesai%26aufirst%3DU.%2BR.%26atitle%3DDiscovery%2520of%2520allosteric%2520modulators%2520of%2520factor%2520XIa%2520by%2520targeting%2520the%2520hydrophobic%2520domains%2520adjacent%2520to%2520its%2520heparin-binding%2520site%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2415%26epage%3D2428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Ma, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizurini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assumpcao, T. C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotsyfakis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro, J. M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteiro, R. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francischetti, I. M. B.</span><span> </span><span class="NLM_article-title">Desmolaris, a novel factor XIa anticoagulant from the salivary gland of the vampire bat (<i>Desmodus rotundus</i>) inhibits inflammation and thrombosis in vivo</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">4094</span><span class="NLM_x">–</span> <span class="NLM_lpage">4106</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2013&pages=4094-4106&author=D.+Maauthor=D.+M.+Mizuriniauthor=T.+C.+F.+Assumpcaoauthor=Y.+Liauthor=Y.+Qiauthor=M.+Kotsyfakisauthor=J.+M.+C.+Ribeiroauthor=R.+Q.+Monteiroauthor=I.+M.+B.+Francischetti&title=Desmolaris%2C+a+novel+factor+XIa+anticoagulant+from+the+salivary+gland+of+the+vampire+bat+%28Desmodus+rotundus%29+inhibits+inflammation+and+thrombosis+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DD.%26aulast%3DMizurini%26aufirst%3DD.%2BM.%26aulast%3DAssumpcao%26aufirst%3DT.%2BC.%2BF.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DQi%26aufirst%3DY.%26aulast%3DKotsyfakis%26aufirst%3DM.%26aulast%3DRibeiro%26aufirst%3DJ.%2BM.%2BC.%26aulast%3DMonteiro%26aufirst%3DR.%2BQ.%26aulast%3DFrancischetti%26aufirst%3DI.%2BM.%2BB.%26atitle%3DDesmolaris%252C%2520a%2520novel%2520factor%2520XIa%2520anticoagulant%2520from%2520the%2520salivary%2520gland%2520of%2520the%2520vampire%2520bat%2520%2528Desmodus%2520rotundus%2529%2520inhibits%2520inflammation%2520and%2520thrombosis%2520in%2520vivo%26jtitle%3DBlood%26date%3D2013%26volume%3D122%26spage%3D4094%26epage%3D4106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crain, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knabb, R. M.</span><span> </span><span class="NLM_article-title">Nonpeptide factor Xa inhibitors: studies with SF303 and SK549, a new class of potent antithrombotics</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">292</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">357</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=10604970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhslGrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2000&pages=351-357&author=P.+C.+Wongauthor=M.+L.+Quanauthor=E.+J.+Crainauthor=C.+A.+Watsonauthor=R.+R.+Wexlerauthor=R.+M.+Knabb&title=Nonpeptide+factor+Xa+inhibitors%3A+studies+with+SF303+and+SK549%2C+a+new+class+of+potent+antithrombotics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Nonpeptide factor Xa inhibitors: I. Studies with SF303 and SK549, a new class of potent antithrombotics</span></div><div class="casAuthors">Wong, Pancras C.; Quan, Mimi L.; Crain, Earl J.; Watson, Carol A.; Wexler, Ruth R.; Knabb, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">351-357</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A series of benzamidine isoxazoline derivs. was evaluated for their inhibitory potency against purified human factor Xa (fXa) and in a rabbit model of arteriovenous shunt thrombosis for their antithrombotic activities, expressed as K1 and IC50, resp.  A highly significant correlation was found between K1 and IC50 (r = 0.93, P < .0001).  The antithrombotic effects of SF303 [mol. wt. 536; K1: fXa, 6.3 nM; thrombin, 3,100 nM; trypsin, 110 nM; tissue plasminogen activator >20,000 nM; plasmin, 2,500 nM] and SK549 [mol. wt. 546; K1: fXa, 0.52 nM; thrombin, 400 nM; trypsin, 45 nM; tissue plasminogen activator >33,000 nM; plasmin, 890 nM] were compared with recombinant tick anticoagulant peptide [K1(fXa) = 0.5 nM], DX-9065a [K1(fXa) = 30 nM], and heparin or low mol. wt. heparin (dalteparin) in a rabbit model of arteriovenous shunt thrombosis.  ID50 values for preventing arteriovenous shunt-induced thrombosis were 0.6 μmol/kg/h for SF303, 0.035 μmol/kg/h for SK549, 0.01 μmol/kg/h for recombinant tick anticoagulant peptide, 0.4 μmol/kg/h for DX-9065a, 21 U/kg/h for heparin, and 23 U/kg/h for low mol. wt. heparin.  SK549 produced a concn.-dependent antithrombotic effect with an IC50 of 0.062 μM.  To evaluate its potential oral efficacy, SK549 was given intraduodenally at a dose of 5 mg/kg; it produced a peak antithrombotic effect of 59 ± 4% with a duration of action greater than 6.7 h.  Therefore, our study suggests that SF303, SK549, and their analogs represent a new class of synthetic fXa inhibitors that may be clin. useful as antithrombotic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquCxWNrZ5Py7Vg90H21EOLACvtfcHk0lhdQDZHsW-Q5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhslGrtg%253D%253D&md5=8a93de5d2c71c21af72ba29e96bf6cd9</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DQuan%26aufirst%3DM.%2BL.%26aulast%3DCrain%26aufirst%3DE.%2BJ.%26aulast%3DWatson%26aufirst%3DC.%2BA.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DKnabb%26aufirst%3DR.%2BM.%26atitle%3DNonpeptide%2520factor%2520Xa%2520inhibitors%253A%2520studies%2520with%2520SF303%2520and%2520SK549%252C%2520a%2520new%2520class%2520of%2520potent%2520antithrombotics%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D292%26spage%3D351%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crain, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knabb, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meade, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slee, A. M.</span><span> </span><span class="NLM_article-title">Nonpeptide factor Xa inhibitors II. Antithrombotic evaluation in a rabbit model of electrically induced carotid artery thrombosis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=10991981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1ygu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2000&pages=212-218&author=P.+C.+Wongauthor=E.+J.+Crainauthor=R.+M.+Knabbauthor=R.+P.+Meadeauthor=M.+L.+Quanauthor=C.+A.+Watsonauthor=R.+R.+Wexlerauthor=M.+R.+Wrightauthor=A.+M.+Slee&title=Nonpeptide+factor+Xa+inhibitors+II.+Antithrombotic+evaluation+in+a+rabbit+model+of+electrically+induced+carotid+artery+thrombosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Nonpeptide factor Xa inhibitors. II. Antithrombotic evaluation in a rabbit model of electrically induced carotid artery thrombosis</span></div><div class="casAuthors">Wong, Pancras C.; Crain, Earl J.; Knabb, Robert M.; Meade, Raymond P.; Quan, Mimi L.; Watson, Carol A.; Wexler, Ruth R.; Wright, Matthew R.; Slee, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">212-218</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">SK549 (mol. wt. 546 Da) is a synthetic, selective inhibitor of human coagulation factor Xa (fXa) (Ki = 0.52 nM).  This study compared the antithrombotic effects of SK549 and a series of benzamidine isoxazoline fXa inhibitors with aspirin, DuP 714 (a direct thrombin inhibitor), recombinant tick anticoagulant peptide, or heparin in a rabbit model of elec. induced carotid arterial thrombosis.  Compds. were infused i.v. continuously from 60 min before elec. stimulation to the end of the expt.  Values of ED50 (dose that increases the carotid blood flow to 50% of the control) were 0.12 μmol/kg/h for SK549, 0.56 μmol/kg/h for aspirin, 0.14 μmol/kg/h for DuP 714, 0.06 μmol/kg/h for recombinant tick anticoagulant peptide, and >100 U/kg/h for heparin.  The EC50 (plasma concn. that increased blood flow to 50% of the control) for SK549 was 97 nM.  Unlike aspirin and heparin, SK549 was efficacious and, at 1.5 μmol/kg/h i.v. (n = 9), maintained carotid blood flow at 87±6% of control level for greater than 90 min.  Unlike heparin, SK549 inhibited ex vivo fXa activity but not ex vivo thrombin activity.  There was a highly significant correlation between Ki (fXa) and ED50 of a series of fXa inhibitors (r = 0.85, P <.001).  Therefore, these results suggest that SK549 is a novel, potent, and effective antithrombotic agent in a rabbit model of arterial thrombosis.  It is likely that SK549 exerts its antithrombotic effect through selective inhibition of fXa.  Furthermore, SK549 may be clin. useful for the prevention of arterial thrombosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7m_8Krs2pdrVg90H21EOLACvtfcHk0lhdQDZHsW-Q5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1ygu74%253D&md5=52ed9fac0aeb3b953fd1a5825d03b5af</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DCrain%26aufirst%3DE.%2BJ.%26aulast%3DKnabb%26aufirst%3DR.%2BM.%26aulast%3DMeade%26aufirst%3DR.%2BP.%26aulast%3DQuan%26aufirst%3DM.%2BL.%26aulast%3DWatson%26aufirst%3DC.%2BA.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DWright%26aufirst%3DM.%2BR.%26aulast%3DSlee%26aufirst%3DA.%2BM.%26atitle%3DNonpeptide%2520factor%2520Xa%2520inhibitors%2520II.%2520Antithrombotic%2520evaluation%2520in%2520a%2520rabbit%2520model%2520of%2520electrically%2520induced%2520carotid%2520artery%2520thrombosis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D295%26spage%3D212%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crain, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaspel, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, D. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knabb, R. M.</span><span> </span><span class="NLM_article-title">Nonpeptide factor Xa inhibitors III. Effects of DPC423, an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbits</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1124%2Fjpet.102.040089" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2000&pages=993-1000&author=P.+C.+Wongauthor=E.+J.+Crainauthor=C.+A.+Watsonauthor=A.+M.+Zaspelauthor=M.+R.+Wrightauthor=P.+Y.+Lamauthor=D.+J.+P.+Pintoauthor=R.+R.+Wexlerauthor=R.+M.+Knabb&title=Nonpeptide+factor+Xa+inhibitors+III.+Effects+of+DPC423%2C+an+orally-active+pyrazole+antithrombotic+agent%2C+on+arterial+thrombosis+in+rabbits"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.040089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.040089%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DCrain%26aufirst%3DE.%2BJ.%26aulast%3DWatson%26aufirst%3DC.%2BA.%26aulast%3DZaspel%26aufirst%3DA.%2BM.%26aulast%3DWright%26aufirst%3DM.%2BR.%26aulast%3DLam%26aufirst%3DP.%2BY.%26aulast%3DPinto%26aufirst%3DD.%2BJ.%2BP.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DKnabb%26aufirst%3DR.%2BM.%26atitle%3DNonpeptide%2520factor%2520Xa%2520inhibitors%2520III.%2520Effects%2520of%2520DPC423%252C%2520an%2520orally-active%2520pyrazole%2520antithrombotic%2520agent%252C%2520on%2520arterial%2520thrombosis%2520in%2520rabbits%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D303%26spage%3D993%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Himber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirchhofer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschopp, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, S. P.</span><span> </span><span class="NLM_article-title">Dissociation of antithrombotic effect and bleeding time prolongation in rabbits by inhibiting tissue factor function</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">1142</span><span class="NLM_x">–</span> <span class="NLM_lpage">1149</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18d&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=9308768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18d&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADyaK2sXmtVejsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1997&pages=1142-1149&author=J.+Himberauthor=D.+Kirchhoferauthor=M.+Riedererauthor=T.+B.+Tschoppauthor=B.+Steinerauthor=S.+P.+Roux&title=Dissociation+of+antithrombotic+effect+and+bleeding+time+prolongation+in+rabbits+by+inhibiting+tissue+factor+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18dR"><div class="casContent"><span class="casTitleNuber">18d</span><div class="casTitle"><span class="NLM_cas:atitle">Dissociation of antithrombotic effect and bleeding time prolongation in rabbits by inhibiting tissue factor function</span></div><div class="casAuthors">Himber, Jacques; Kirchhofer, Daniel; Riederer, Markus; Tschopp, Thomas B.; Steiner, Beat; Roux, Sebastien P.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1142-1149</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer</span>)
        </div><div class="casAbstract">The antithrombotic and the antihemostatic effects of a monoclonal anti-TF antibody (AP-1) were compared in a model of arterial thrombosis to those of a direct thrombin inhibitor (napsagatran), and heparin.  In anesthetized rabbits transient arterial thrombi were induced by mech. damage to the subendothelium of a moderately stenosed carotid artery.  Recurrent formation and dislodgement of thrombi resulted in cyclic flow variations (CFVs) which were monitored over 2 h.  Rabbits received i.v. either a placebo (control), a monoclonal anti-rabbit TF antibody (AP-1, 0.05 mg/kg as an i.v. bolus repeated every 15 min), a specific low mol. wt. thrombin inhibitor (napsagatran, 3 μg/kg/min) or heparin (3 and 13 μg/kg/min).  The effect of the inhibitors on the hemostatic system was studied in a sep. set of rabbits by measuring template bleeding times (BT) in the ear arterioles, marginal ear vein, and the nail cuticle of the foreleg.  AP-1 and napsagatran showed a similar antithrombotic activity (78 and 80% abolition of the CFVs, resp.), whereas either low or high dose heparin was poorly effective (43 and 40% inhibition of CFVs, resp.).  At these antithrombotic doses and even at 4-fold higher dosage, AP-1 did not alter the BT, whereas napsagatran and heparin prolonged the ear vessels and cuticle BT in a dose-dependent manner.  Thus, in contrast to direct thrombin inhibition, the blockade of the TF/F.VIIa function did not result in a concomitant prolongation of the bleeding time.  Thus, dissocn. of antithrombotic and antihemostatic effects indicates that inhibition of the coagulation system at its initial stage represents a promising approach for the development of new anticoagulants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbfhcRWuYH4bVg90H21EOLACvtfcHk0ljgLZETptXQmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtVejsbo%253D&md5=6ae2d7e80ee1b6baa3f9a3ef897dc0ca</span></div><a href="/servlet/linkout?suffix=cit18d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHimber%26aufirst%3DJ.%26aulast%3DKirchhofer%26aufirst%3DD.%26aulast%3DRiederer%26aufirst%3DM.%26aulast%3DTschopp%26aufirst%3DT.%2BB.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DRoux%26aufirst%3DS.%2BP.%26atitle%3DDissociation%2520of%2520antithrombotic%2520effect%2520and%2520bleeding%2520time%2520prolongation%2520in%2520rabbits%2520by%2520inhibiting%2520tissue%2520factor%2520function%26jtitle%3DThromb.%2520Haemostasis%26date%3D1997%26volume%3D78%26spage%3D1142%26epage%3D1149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Bird, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbera, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revelli, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiffert, D.</span><span> </span><span class="NLM_article-title">Effects of plasma kallikrein deficiency on haemostasis and thrombosis in mice: murine ortholog of the Fletcher trait</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">1141</span><span class="NLM_x">–</span> <span class="NLM_lpage">1150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1160%2FTH11-10-0682" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=22398951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BC38Xpt1egu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2012&pages=1141-1150&author=J.+E.+Birdauthor=P.+L.+Smithauthor=X.+Wangauthor=W.+A.+Schumacherauthor=F.+Barberaauthor=J.-P.+Revelliauthor=D.+Seiffert&title=Effects+of+plasma+kallikrein+deficiency+on+haemostasis+and+thrombosis+in+mice%3A+murine+ortholog+of+the+Fletcher+trait"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of plasma kallikrein deficiency on haemostasis and thrombosis in mice: murine ortholog of the fletcher trait</span></div><div class="casAuthors">Bird, J. Eileen; Smith, Patricia L.; Wang, Xinkang; Schumacher, William A.; Barbera, Frank; Revelli, Jean-Pierre; Seiffert, Dietmar</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1141-1150</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">Plasma kallikrein is a multifunctional serine protease involved in contact activation of coagulation.  Deficiency in humans is characterised by prolonged activated partial thromboplastin time (aPTT); however, the balance between thrombosis and haemostasis is not fully understood.  A study of plasma kallikrein-deficient mice revealed increased aPTT, without prolonged bleeding time.  Prekallikrein antisense oligonucleotide (ASO) treatment in mice suggested potential for a pos. therapeutic index.  The current goal was to further define the role of plasma kallikrein in coagulation.  Blood pressure and heart rate were normal in plasma kallikrein-deficient mice, and mice were completely protected from occlusion (100 ± 1.3% control flow) in 3.5% FeCl3-induced arterial thrombosis vs. heterozygotes (20 ± 11.4%) and wild-type littermates (8 ± 0%).  Vessels occluded in 8/8 wild-type, 7/8 heterozygotes, and 0/8 knockouts.  Anti-thrombotic protection was less pronounced in 5% FeCl3-induced arterial injury.  Integrated blood flow was 8 ± 0% control in wild-type and heterozygotes, and significantly (p<0.01) improved to 43 ± 14.2% in knockouts.  The no. of vessels occluded was similar in all genotypes.  Thrombus wt. was significantly reduced in knockouts (-47%) and heterozygotes (-23%) vs. wild-type in oxidative venous thrombosis.  Av. tail bleeding time increased modestly in knockout mice compared to wild-type.  Av. renal bleeding times were similar in all genotypes.  These studies confirm and extend studies with prekallikrein ASO, and demonstrate that plasma kallikrein deletion prevents occlusive thrombus formation in mice with a minimal role in provoked bleeding.  Addnl. support for the significance of the intrinsic pathway in the coagulation cascade is provided, as well as for a potential new anti-thrombotic approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFqwTwIoHvLLVg90H21EOLACvtfcHk0ljgLZETptXQmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xpt1egu70%253D&md5=5f3acfb850654d78ac6182717a5cb25c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1160%2FTH11-10-0682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1160%252FTH11-10-0682%26sid%3Dliteratum%253Aachs%26aulast%3DBird%26aufirst%3DJ.%2BE.%26aulast%3DSmith%26aufirst%3DP.%2BL.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSchumacher%26aufirst%3DW.%2BA.%26aulast%3DBarbera%26aufirst%3DF.%26aulast%3DRevelli%26aufirst%3DJ.-P.%26aulast%3DSeiffert%26aufirst%3DD.%26atitle%3DEffects%2520of%2520plasma%2520kallikrein%2520deficiency%2520on%2520haemostasis%2520and%2520thrombosis%2520in%2520mice%253A%2520murine%2520ortholog%2520of%2520the%2520Fletcher%2520trait%26jtitle%3DThromb.%2520Haemostasis%26date%3D2012%26volume%3D107%26spage%3D1141%26epage%3D1150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Contour-Galcera, M.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poitout, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moinet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roubert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurieau, C.</span><span> </span><span class="NLM_article-title">Synthesis of substituted imidazopyrazines as ligands for the human somatostatin receptor subtype 5</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">741</span><span class="NLM_x">–</span> <span class="NLM_lpage">745</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=741-745&author=M.-O.+Contour-Galceraauthor=L.+Poitoutauthor=C.+Moinetauthor=B.+Morganauthor=T.+Gordonauthor=P.+Roubertauthor=C.+Thurieau&title=Synthesis+of+substituted+imidazopyrazines+as+ligands+for+the+human+somatostatin+receptor+subtype+5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DContour-Galcera%26aufirst%3DM.-O.%26aulast%3DPoitout%26aufirst%3DL.%26aulast%3DMoinet%26aufirst%3DC.%26aulast%3DMorgan%26aufirst%3DB.%26aulast%3DGordon%26aufirst%3DT.%26aulast%3DRoubert%26aufirst%3DP.%26aulast%3DThurieau%26aufirst%3DC.%26atitle%3DSynthesis%2520of%2520substituted%2520imidazopyrazines%2520as%2520ligands%2520for%2520the%2520human%2520somatostatin%2520receptor%2520subtype%25205%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D741%26epage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Otwinowski, Z.; Minor, W.</span> <span class="citation_source-book">Macromolecular Crystallography. Part A</span>; Carter, C. W., Sweet, R. M., Eds.; Methods in Enzymology, Vol.  <span class="NLM_volume">276</span>; <span class="NLM_publisher-name">Academic Press, Inc.</span>, <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">1997</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=307-326&author=Z.+Otwinowski&author=W.+Minor&title=Macromolecular+Crystallography.+Part+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26btitle%3DMacromolecular%2520Crystallography.%2520Part%2520A%26volume%3D276%26pub%3DAcademic%2520Press%252C%2520Inc%26date%3D1997%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Blanc, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roversi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vonrhein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flensburg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lea, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bricogne, G.</span><span> </span><span class="NLM_article-title">Refinement of severely incomplete structures with maximum likelihood in BUSTER/TNT</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2210</span><span class="NLM_x">–</span> <span class="NLM_lpage">2221</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2210-2221&author=E.+Blancauthor=P.+Roversiauthor=C.+Vonrheinauthor=C.+Flensburgauthor=S.+M.+Leaauthor=G.+Bricogne&title=Refinement+of+severely+incomplete+structures+with+maximum+likelihood+in+BUSTER%2FTNT"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlanc%26aufirst%3DE.%26aulast%3DRoversi%26aufirst%3DP.%26aulast%3DVonrhein%26aufirst%3DC.%26aulast%3DFlensburg%26aufirst%3DC.%26aulast%3DLea%26aufirst%3DS.%2BM.%26aulast%3DBricogne%26aufirst%3DG.%26atitle%3DRefinement%2520of%2520severely%2520incomplete%2520structures%2520with%2520maximum%2520likelihood%2520in%2520BUSTER%252FTNT%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2210%26epage%3D2221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lokhamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and Development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm5010607&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lokhampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+Development+of+Coot"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0ljzk1fm-T8xQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLokhamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520Development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Laskowski, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacArthur, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, J. M.</span><span> </span><span class="NLM_article-title">PROCHECK: a program to check the stereochemical quality of protein structures</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm5010607&amp;key=10.1107%2FS0021889892009944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm5010607&amp;key=1%3ACAS%3A528%3ADyaK3sXit12lurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1993&pages=283-291&author=R.+A.+Laskowskiauthor=M.+W.+MacArthurauthor=D.+S.+Mossauthor=J.+M.+Thornton&title=PROCHECK%3A+a+program+to+check+the+stereochemical+quality+of+protein+structures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">PROCHECK: a program to check the stereochemical quality of protein structures</span></div><div class="casAuthors">Laskowski, Roman A.; MacArthur, Malcolm W.; Moss, David S.; Thornton, Janet M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">283-91</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    </div><div class="casAbstract">The PROCHECK suite of programs provides a detailed check on the stereochem. of a protein structure.  Its outputs comprise a no. of plots in PostScript format and a comprehensive residue-by-residue listing.  These give an assessment of the overall quality of the structure as compared with well-refined structures of the same resoln. and also highlight regions that may need further investigation.  The PROCHECK programs are useful for assessing the quality not only of protein structures in the process of being solved but also of existing structures and of those being modeled on known structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCe5FgJf4KH7Vg90H21EOLACvtfcHk0ljzk1fm-T8xQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXit12lurY%253D&md5=fb69fc4410cd716aaaa7cc0db06b3ed2</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1107%2FS0021889892009944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889892009944%26sid%3Dliteratum%253Aachs%26aulast%3DLaskowski%26aufirst%3DR.%2BA.%26aulast%3DMacArthur%26aufirst%3DM.%2BW.%26aulast%3DMoss%26aufirst%3DD.%2BS.%26aulast%3DThornton%26aufirst%3DJ.%2BM.%26atitle%3DPROCHECK%253A%2520a%2520program%2520to%2520check%2520the%2520stereochemical%2520quality%2520of%2520protein%2520structures%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D1993%26volume%3D26%26spage%3D283%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TY6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TY6','PDB','4TY6'); return false;">PDB: 4TY6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TY7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TY7','PDB','4TY7'); return false;">PDB: 4TY7</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i79"><a href="/doi/suppl/10.1021/jm5010607">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_37757"></div></div></div></div></div><hr /></hr><p class="last">Crystallographic data and refinement statistics. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5010607/suppl_file/jm5010607_si_001.pdf">jm5010607_si_001.pdf (140.13 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm5010607&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-23%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm5010607%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm5010607" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799542e08ae1949","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
